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General Introduction
Although the exact origin of the use of certain Lactic Acid Bacteria (LAB) in food
fermentations is unknown, the first recordings of possible health promoting effects related to
fermented milk date from the beginning of the 20th century.  Metchnikoff (1907) described the
positive effect of a ‘fermenting bacillus’ on the microflora of the large intestine through the
reduction of toxic microbial activities. Further scientific interest in such fermented milk products
was slowed down by the discovery of antibiotics, although from the moment antibiotic resistance
arose, the ‘health-promoting’ bacteria regained attention and the concept of probiotics was
born (Lilley and Stillwell, 1965). At present, more and more consumers have become aware of
the fact that a well-balanced and healthy nutrition contributes to a good human physical
condition, which explains the strong expansion of the functional foods market (to which
probiotics belong), globally representing €95 billion in the year 2000 (Weststrate et al., 2002).
Furthermore, the European funding for research on functional foods has evolved from €12
million in 1989 to nearly €200 million in 2002 (Lucas, 2002). The long history of safe use,
commonly referred to as the GRAS (Generally Regarded As Safe) status (Holzapfel et al.,
2001), combined with a variety of interesting metabolic characteristics have led to a wide
range of industrial applications for numerous LAB species. In the development of human
probiotics, strains belonging to the genera Lactobacillus and Bifidobacterium are amongst
the most commonly used, primarily because of the perception that they are autochthonous
members of the intestinal microflora. However, some of the probiotic strains currently used in
dairy food industries are not of human origin and do not possess this history of safe use.
Consequently, before these ‘new’ strains can be included into a probiotic product and become
commercially available, it is recommended that profound research addressing safety and
functionality of the strain in question is performed (Sanders and Huis in’t Veld, 1999).
Safety of probiotic strains is of major importance and because the current state of
evidence suggests that probiotic effects are strain specific, a correct identification is crucial to
link a strain to a specific health effect as well as to enable accurate surveillance and
epidemiological studies (Reid et al., 2002). Therefore, in the past decade the scientific
community has paid special attention to the correct identification of bacteria used for human
consumption (Hamilton-Miller et al., 1999). Due to the often indiscriminate use of antibiotics
in human and veterinary medicine and in animal growth promoters, antibiotic resistance has
become an increasingly common characteristic in microorganisms, and it has been suggested
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that also probiotic strains should be frequently subjected to an evaluation of their antibiotic
resistance profiles (Charteris et al., 1998). Besides the safety aspect, several research groups
have recommended that in the frame of functionality, the screening process of potential probiotic
strains should involve determination of their survival capacity during Gastro-Intestinal (GI)-
transit, as well as their adhesion properties to the intestinal surface, two issues that have
been suggested to be an important prerequisite for probiotic action (Salminen et al., 1998b).
A problem impairing all (industrial) fermentations is the contamination of the process
with unknown bacteria. For instance, during the production of yoghurts or probiotic products,
bacterial starter cultures are often joined by additional LAB strains to improve the organoleptic
or functional properties of the end product. The slightest quantitative or qualitative shift in
bacterial composition may compromise the end product quality, resulting in loss of the end-
product metabolites, organoleptic properties, and functionality and/or (bacterial) composition
of the product. As a result, techniques capable of monitoring the bacterial (e.g. LAB)
composition of the product during (and after) the production process are currently much needed.
However, this type of microbiological screening at different stages in the process line of a
food product can be a very laborious task when only culture-dependent techniques are
available. Clearly, on-time interventions in the production process are only possible when
(complex) LAB ecosystems can be analyzed in a reliable and fast culture-independent way.
The need for a profound legislation setting guidelines for quality control by manufacturers as
well as by independent research groups is urgent and of immediate relevance, as indicated
by the Thematic Priority ‘Food Quality and Safety’ of the European Sixth Framework
Programme, having a budget of €685 million (Lucas, 2002). These guidelines should be based
and checked through the use of advanced and standardized methods in order to enable
comparisons of quality control on an international scale.
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Objectives of this work
In order to develop a successful probiotic product with long-term marketing potential,
pre-production research towards the safety and functional properties of the included probiotic
strains has to be performed, as well as an efficient quality control of the product itself. The
goal of this work was to evaluate and optimise new and existing methodologies to
examine the microbial aspects of probiotic product quality control.
- A collection of commercially available European probiotic products was subjected to
culture-dependent microbial analysis using whole-cell protein profiling for identification of the
lactic acid bacteria (LAB) isolated on a range of culture media. In this way, a first indication
was obtained about the label correctness of the products.
- A selected subset of (probiotic) isolates was screened for the presence of antibiotic
resistance and for GI-transit survival capacity, in order to generate information on safety and
functionality of probiotic strains.
- As an alternative for culture-dependent analysis, Denaturing Gradient Gel
Electrophoresis (DGGE) was optimised for the culture-independent detection of bacteria
present in probiotic products. The potential of the DGGE protocol was validated by means of
a parallel culture-dependent analysis.
- As a further development, the direct identification potential of DGGE was elevated
through the use of nested PCR, for its application in the taxonomic characterization of (complex)
bifidobacterial communities.
- Finally, within the DGGE protocol, conventional PCR was replaced by real-time PCR
as a promising quantification technique facilitating an integrated qualitative and quantitative
microbial analysis of probiotic products.
19
Short overview of this thesis
Part 1 presents an overview of the literature relating to the content of this work. Firstly, an
extensive discussion on the probiotic concept is given, also addressing technological, functional
and safety aspects of probiotic products. The second part presents an overview of techniques
used in the identification of lactic acid bacteria. Finally, the analysis of LAB ecosystems is
discussed, mainly focussing on the Denaturing Gradient Gel Electrophoresis technique.
Part 2 presents the experimental work performed in the framework of this PhD study.
- The first chapter includes the culture-dependent microbial analysis of a range of
European probiotic products. The resulting isolates were identified using SDS-PAGE separation
of cellular proteins and subsequently included in trials addressing antibiotic susceptibility and
some aspects of functionality (survival of GI-tract, hydrophobicity).
- The second chapter describes the optimisation of a culture-independent approach to
analyse probiotic products. Denaturing Gradient Gel Electrophoresis was chosen for this
purpose and a comparison of both the culture-dependent and culture-independent approaches
is presented. A further optimisation of the DGGE method is also discussed, allowing the analysis
of any bifidobacterial ecosystem. Finally, in order to obtain a completely culture-independent
quantification of bacteria in probiotic products, the preliminary findings on the combination of
real-time PCR with DGGE are presented.
Part 3 comprises the general conclusions, future perspectives and a summary of this work.
Part 1
Overview of the Literature
Partly published as:
Temmerman R., Huys G. and Swings J. Identification and detection of food-associated Lactic
Acid Bacteria: An overview of culture-dependent and culture-independent methods. Trends in
Food Science and Technology. Submitted.
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Chapter 1
Probiotics
Before discussing the experimental work on the microbial analysis of probiotics, the
first chapter provides some general information about probiotics, as well as about a number
of aspects related to the production of a probiotic product, such as safety, functionality and
legislation.
1.1.  Definitions
At present, there are several economical, social and environmental stress factors that
influence every day life of people in an increasingly negative way. In a way of counteraction,
care and attention for human physical condition and health have become prominent. One of
many ways to achieve such a ‘good health’ is through a well-balanced and healthy nutrition.
In this regard, probiotic products specially designed for their health promoting properties can
be part of the daily diet. Although possible health promoting properties of certain Lactic Acid
Bacteria (LAB) have already been reported at the turn of the 19th century (Döderlein, 1892;
Metchnikoff, 1907), it was not before the mid-1960’s until the term probiotic was used for the
first time by Lilley and Stillwell (1965) to describe substances excreted by a microorganism,
which stimulate the growth of another microorganism. Over the years, numerous definitions
have been proposed. Fuller (1989) described a probiotic as “a live microbial food supplement,
which beneficially affects the host by improving its intestinal microbial balance.” Further
adjustments to this definition have been made in regard to discussions concerning the need
for viability of the strain, the sites and modes of action, etc… This led to sometimes excessively
long definitions going too much into detail. Therefore, the Food and Agriculture Organisation
has recently proposed the following short definition of a probiotic: “a live microorganism
which, when administered in adequate amounts, confers a health benefit to the host”
(http://www.fao.org/es/ESN/food/foodandfood_probio_en.stm). This definition certainly does
not exclude further discussion, but it clearly reflects the probiotic concept as a health-promoting
microorganism.
24
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Together with prebiotics, defined by Gibson and Roberfroid (1995) as “non-digestable
food ingredients, which beneficially affect the host by means of selective stimulation of growth
and/or activity of one or a limited number of bacteria already present in the colon, thereby
improving health of the host,” probiotics belong to the group of functional foods. Although a
clear definition of functional food is currently not available (Menrad et al., 2002), they can be
described as “modified food or food-ingredients confering a beneficial effect on health, beyond
the effects of the traditional nutrients present in the food” (ONFS Committee, 1994). Many
common foods have nutritional qualities that are not recognized as recommended nutrients,
but are considered to have functional benefits such as reducing risk of disease or promoting
health. In this way, however, the definition of a ‘functional food’ is not well delineated. Because
of their specific health-promoting objective, there is no doubt that probiotics are truly functional
foods, partly explaining the substantial increase of the probiotic market (Stanton et al., 2001,
Weststrate et al., 2002).
25
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1.2.   Lactic Acid Bacteria (LAB)
According to the definitions proposed for a probiotic, a great variety of microbial species
and genera is considered to have probiotic potential (Table 1), most of which belong to the
Lactic Acid Bacteria. LAB are constituted of a heterogeneous group of Gram-positive, non-
sporulating, non-respiring cocci or rods, exhibiting a strictly fermentative metabolism with
lactic acid as the key metabolite. The composition of this group of bacteria, originally being
based on morphological and physiological descriptions, has frequently been debated due to
recent phylogenetic studies. The core of LAB is composed by the genera Lactobacillus,
Leuconostoc, Pediococcus and Streptococcus with taxonomical revisions and description of
new genera leading to the following list of LAB genera: Aerococcus, Alloiococcus,
Carnobacterium, Dolosigranulum, Enterococcus, Globicatella, Lactobacillus, Lactococcus,
Lactosphaera, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus,
Vagococcus and Weisella (Axelsson, 1998).
The natural habitat of these organisms includes humans, animals and plants, and
their long history of safe use, commonly referred to as the GRAS (Generally Regarded As
Safe) status (Holzapfel et al., 2001), combined with a variety of interesting metabolic
characteristics has led to a wide range of industrial applications. Flavor, texture and preservative
qualities of many fermented foods such as cheese, yoghurt, sausages, sour dough breads
and silage (Wood, 1998) are established through the use of species belonging to seven key
LAB genera: Lactobacillus (milk, meat, vegetables, cereals), Lactococcus (milk), Leuconostoc
(milk, vegetables), Pediococcus (vegetables, meat), Oenococcus (wine), Enterococcus (milk)
and Streptococcus (milk) (Klaenhammer et al., 2002). Although phylogenetically not belonging
to the LAB, also the genera Bifidobacterium, Propionibacterium and Brevibacterium are used
in food industries because some strains display LAB-like properties. Recent evolutions in
biochemical and biotechnological techniques have also resulted in the use of LAB for the
production of biopolymers and bulk enzymes, or as oral delivery vehicles (Hofvendahl & Hahn-
Hagerdal, 2000; Klaenhammer et al., 2002; Steidler 2002). The most important application
directly targeting human health is the use of a select group of LAB species as probiotic
organisms.
26
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In the development of human probiotics, strains belonging to the genera Lactobacillus,
Bifidobacterium and Streptococcus have been mostly used, primarily because of the perception
that they are autochthonous members of the intestinal microflora (Goldin and Gorbach, 1992).
In addition, these bacteria have traditionally been used in the manufacturing of fermented
dairy products and have GRAS status. For instance, in a Persian version of the Old Testament
(Genesis 18:8) it is stated, “Abraham owed his longevity to the consumption of sour milk,”
which we now know resulted from LAB fermentation (Schrezenmeir and de Vrese, 2001).
However, some of the probiotic strains currently used in dairy food industries are not of human
origin and do not possess this history of safe use. Consequently, before these ‘new’ strains
can be included into a probiotic product and become commercially available, profound research
has to be performed addressing functionality, health benefits, safety and technological
properties of the strain.
28
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Fig 1. Guidelines for the evaluation of potential probiotic strains for food use (based on Reid
et al., 2002).
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1.3.   Criteria for probiotic bacteria
While traditional starter cultures used in the dairy industry are selected for their ability
to rapidly produce desirable organoleptic qualities of cultured dairy products, probiotic bacteria
are selected for the potential to provide specific health or nutritional benefits following
consumption. Such a selection addresses several criteria including safety, technological and
functional aspects (Fig 1) (Saarela et al., 2000).
Safety aspects
The safety of probiotic strains is of major importance and guidelines for the safety
assessment have been addressed in several articles (Donohue and Salminen, 1996; Salminen
et al., 1998a; Adams, 1999). Safety aspects include the following specifications:
- The prerequisite of microbiological safety is the identification of the strain. The current
state of evidence includes that probiotic effects are strain specific, meaning that a correct
identification to the strain level is important to link a strain to a specific health effect as well as
to enable accurate surveillance and epidemiological studies (Reid et al., 2002). Species
discrimination of the bacteria must be established using the most current, valid methodology,
preferably a combination of phenotypic and genotypic methods (chapter 2).
- Although recently debated, it is suggested that probiotic strains should be a normal
inhabitant of the intestinal tract, taking into account the possibility that many of these bacteria
exhibit host specificity (Saarela et al., 2000). Therefore, if a strain is to be used as a probiotic
for humans, it is highly desirable that the probiotic bacterium originates from a healthy human
GI- tract.
- It is advisable that bacterial species have a history of safe use in the production of
fermented dairy foods, often refered to as ‘food grade’ or GRAS organisms (Holzapfel et al,
1998). This is important because it makes regulatory agency approval much easier. Historically,
lactobacilli and bifidobacteria associated with food have been considered to be safe (Adams
& Marteau, 1995). Their occurrence as normal commensals of the mammalian flora and their
established safe use in a diversity of foods and supplement products worldwide support this
conclusion. However, probiotics may theoretically be responsible for four types of side effects
(Marteau, in press): systemic infections, deleterious metabolic activities, excessive immune
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stimulation in susceptible indviduals, and (antibiotic resistance) gene transfer. In this regard,
in vitro tests are crucial to verify several safety aspects of potential probiotic strains, for
instance in order to determine the degree of enzymatic activity (bile salt deconjugation) or to
test whether a strain produces a toxic compound as indicated by the EU Scientific Committee
on Animal Nutrition (SCAN, 2000). SCAN guidelines mainly apply towards animal nutrition,
although extrapollation to human nutrition has been made for certain aspects, mostly more
rigorous.
- Due to the indiscriminate use of antibiotics in human and veterinary medicine and in
animal growth promotors, antibiotic resistance has become an increasingly common
characteristic in (food-borne) microorganisms (Threlfall et al., 2000), causing serious problems
in treatment of microbial infections. Antibiotic resistance in bacteria may be intrinsic or acquired.
Intrinsic resistance is a naturally occurring trait and may be considered as a species
characteristic, whereas acquired resistance derives either from genetic mutations or acquisition
of foreign DNA from other bacteria. Lactobacilli display a wide range of intrinsic antibiotic
resistances (Danielsen and Wind, 2003), but in most cases these resistances are not of the
transferable type. Lactobacillus strains with non-transferable antibiotic resistances do not
usually constitute a safety concern. To some extent, antibiotic resistance might even be a
useful property if the probiotic strain is to be used as a prophylactic agent in the treatment of
antibiotic associated diarrhoea (Charteris et al., 1998). Although plasmid and transposon-
linked antibiotic resistances are not very common among lactobacilli, they do occur (Gevers
et al., 2003b) and their safety implications should be considered. Since transfer of antibiotic
resistance genes may occur between phylogenetically distant bacteria (Courvalin, 1994), strains
harboring mobile elements carrying resistance genes should be carefully assessed if they are
to be used as human or animal probiotics.
- Finally, as for pharmaceutical products, human studies assessing possible side-effects
should also be performed for probiotic products, as well as post-market epidemiological
surveillance verifying possible adverse incidents experienced by consumers.
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Technological aspects
In order to promote the consumption of probiotic products, the food industry has to
respond to the demands of the consumer, meaning that all probiotic foods should be safe and
functional and should possess attractive sensory properties. Before probiotic strains can be
delivered to consumers, they must first be capable of being included into industrial
fermentations. Subsequently, they need to survive and retain their functionality during storage
as frozen or freeze dried cultures as well as in the food products into which they are
commercialized. Finally, also the packaging material and storage conditions determine the
quality of the probiotic product during its shelf life. Because of their long history, fermented
dairy products are by far the most frequently encountered probiotic foods (Svensson, 1999).
However, the use of modern technologies has also resulted in other product types such as
powders, capsules and tablets, which favor oral administration in situations in which dairy
based products can not be applied. Commercially available probiotic cultures may consist of
a single strain or a mixture of several strains. In most cases, the probiotic properties are
affected by the way in which the strain or culture has been produced (German et al., 1999),
meaning that each strain should be characterized extensively in order to allow an effective
optimization of the production process.
In case of fermented dairy products, reliable acid-forming ability is the most important
characteristic in selecting starter microorganisms. When selecting probiotics, however, criteria
should be related to the impact on human health and well-being. Because the environment
within the GI-tract might be quite different from the environment of food, the probiotic is often
not suitable as a starter organism (German et al., 1999). Therefore, it is quite common to use
probiotic bacteria mixed together with other bacteria, e.g. Lactobacillus delbrueckii subsp.
bulgaricus and Streptococcus thermophilus, in order to obtain the desired flavour and texture.
Application of probiotic cultures in non-dairy products and environments represents
an additional challenge in the field of viability and storage (Andersen, 1998). Since the probiotic
cultures are present as additives in these kinds of products, they do not usually multiply,
which sets great demands for the probiotic stability. Factors such as water activity, oxygen
tension and temperature become increasingly important when dealing with these kinds of
products. Storage at room temperature, which is common for several types of non-dairy
probiotic products, can create an overwhelming challenge for probiotic stability. This is mostly
solved by using modern encapsulation technologies, to ensure viability and stability of probiotic
cultures (Myllärinen et al., 1998). More detailed information on different aspects of probiotic
production technology can be found in the review of Saarela and co-workers (2000).
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Functional aspects
Besides the technological and safety aspect, several research groups have
recommended that the screening process of potential probiotics involves determination of
resistance to gastric acidity and bile toxicity, adhesion to gut epithelial tissue, ability to colonize
the GI-tract and ability to modulate immune responses (Table 2).
- Before reaching the intestinal tract, probiotic bacteria must first survive transit through
the stomach, in which the secretion of gastric acid constitutes a primary defense mechanism
against most ingested microorganisms. In vitro tests usually include the assessment of bacterial
growth on MRS medium amended with hydrogen chloride to pH values between 2.0 and 3.4.
However, the survival of bacterial strains in human gastric juice is a more accurate indication
of the ability of strains to survive passage through the stomach, for which bifidobacteria proved
less successful than lactobacilli (Dunne et al., 2001).
Table 2. Desired properties of a probiotic microorganism (based on Salminen et al., 1998a).
Desired property Consequence
Human origin if used for human consumption Good adaptation to human intestinal ecosystem,
applicability as functional and clinical nutrition
Acid and bile resistance Survival in the intestinal tract, preservation of  adhesive
and other properties
Adhesion to human intestinal cells and mucus Immune modulation, competitive exclusion of pathogens
Production of antimicrobial substances Pathogen inactivation and maintaining intestinal balance
Resistance to antibiotics Combined use with antibiotics possible
Profound strain identification Safe use in nutritional and clinical applications
     and characterisation
Data on minimal effective dose Efficient clinical applications
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- Besides gastric juice, probiotic strains should also possess a certain resistance against
the effects of bile acids encountered in the small intestine. Bile acids are synthesized in the
liver from cholesterol and are secreted from the gall bladder into the duodenum in the
conjugated form (500-700 ml/day) (Hoffman et al., 1983). These acids then undergo extensive
chemical modifications in the colon (deconjugation, dehydroxylation, dehydrogenation and
deglucuronidation), almost solely as a result of microbial activity (Hylemon and Glass, 1983).
Both conjugated and deconjugated bile acids exhibit antibacterial activity, however, the
deconjugated forms are more inhibitory. Gram-positive bacteria are found to be more sensitive
than gram-negative bacteria (Floch et al., 1972). Bile acid resistance, based on the relative
ability to grow in the presence of bile acids, differs greatly among strains of each species of
probiotic bacteria (Gilliland, 2002). Therefore, a profound selection of the most resistant strain
is necessary.
- Adhesion of probiotic bacteria to the intestinal surface and the subsequent colonization
of the human GI-tract have been suggested as important prerequisites for probiotic action.
Adherent strains are likely to persist longer in the intestinal tract and thus have better chances
to show metabolic and immunomodulatory effects than non-adhering strains (Salminen et al.,
1996). Adhesion may also provide means of competitive exclusion of pathogenic bacteria
from the intestinal epithelium. HT-29 and Caco-2 cells are human cell lines expressing
morphological and physiological characteristics of normal human enterocytes that have been
exploited to elucidate the mechanisms mediating enteropathogen adhesion (Cocconier et al.,
1993). More recently, these cell lines have been used to select for and subsequently assess
lactic acid bacteria on the basis of their adhesion properties (Tuomola and Salminen, 1998).
Although a lot of research effort went to probiotic adhesion studies, the role of adhesion
in successful probiotic function remains speculative (Saarela et al., 2000). It could also
be argued that strong adhesion ability may increase the risk of infection in the host (Apostolou
et al., 2001). Some probiotic strains are poorly adhering in vitro and/or in vivo but still show
positive effects in the host. Regardless of the adhesion capacity of a probiotic strain, it is now
widely accepted that administration of a daily dose of probiotics is the best way to maintain
probiotic activity in the gut on a safe basis, although discussions on the quantity of this daily
dose remain (Naidu et al., 1999).
- Besides these criteria, related to the potential of a certain strain to successfully reach
the GI-tract, the main and perhaps most difficult research is determining the potential health
benefits of a probiotic strain.
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1.4.   Health benefits and applications
After screening safety, technological properties and basic functionality of a probiotic
strain, its potential health promoting properties are investigated. In general, two research
tasks need to be performed in order to document probiotic activity. First and most crucial are
the clinical trials analysing the beneficial effects of administering a probiotic to a group of
persons. Secondly, if a certain effect has been reported, the involved microbial, biochemical
and molecular mechanisms have to be unraveled. The levels of evidence for health benefits
depend on the study design and the methodological quality. The best evidence originates
from randomized, double-blind, placebo-controlled (DBPC) studies monitoring a test
group, which is large enough and is placed under a complete dietary supervision
(Marteau et al., 2002). A general recommendation for the testing of probiotic foods is that the
placebo consists of the food carrier without the test probiotic. The principle outcome of
efficacy studies on probiotics should be proven benefits such as (i) statistically and
biologically significant improvement in condition, symptoms, signs, well-being or quality
of life; (ii) reduced risk of disease or longer period to next occurrence; (iii) faster recovery
from illness. Each of these items should have a proven correlation with the probiotic
tested (Reid et al., 2002). Furthermore, it is also desirable that these studies are performed
by independent scientific institutions and that results are published in peer-reviewed journals
addressing the appropriate research fields (Ouwehand et al., 2002), thereby also including
publications on negative results because these also contribute to the totality of the evidence
supporting probiotic efficacy.
Numerous (potential) probiotic effects have been reported (Naidu et al., 1999;
Ouwehand et al., 2002), some are better documented than others as a result of the complexity
of the research. The strength of evidence for positive effects of probiotics in intestinal disorders
appears to be most convincing in cases of antibiotic-associated diarrhoea, gastroenteritis
and lactose intolerance. Evidence is increasing, although more slowly, for inflammatory bowel
disease (IBD) and intestinal infections (Marteau et al., 2002). However, one strain should
not be expected to produce all potential benefits. Clearly, each specific type of disorder
will require a careful selection of the most suitable probiotic strain in order to achieve the
optimal health benefits (Gilliland, 2002). As a result of these strain-dependent health benefits,
studies are frequently performed using a mixture of multiple probiotic strains, for example in
the prevention of chronic pouchitis (Gionchetti et al., 2000). A brief list of the most widely
used probiotic species with their claimed probiotic action is presented in Table 3.
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- Modulation of the intestinal microflora. The original idea with probiotics has always
been to change the composition of the normal intestinal microflora from a potentially harmful
composition into a microflora that would be beneficial for the host. In general, this would
mean a reduction of the number of e.g. putrefactive bacteria such as clostridia and coliforms;
and an increase of lactobacilli and bifidobacteria. Due to competition for adhesion sites and
nutrients, and for some strains the production of antimicrobial substances, levels of less
desirable genera can be decreased. Evidence based on DBPC studies has shown that
probiotics are effective against a broad range of intestinal disorders (Marteau et al., 2002).
Although the actual mechanism is not always clear, the stabilization of the intestinal flora by
probiotic strains has proven to be successful in preventing or easing the discomforts of
antibiotic-associated diarrhoea, traveller’s diarrhoea, gastroenteritis mainly due to rotavirus
infection and intestinal infections by pathogenic bacteria (Marteau et al., 2001, 2002). Although
the reduction of extensive growth of pathogens caused by probiotics is beneficial to the host,
in some cases too much emphasis is put on this change in microflora composition without
considering the actual health benefit. For some health effects it may not be necessary to
obtain a measurable modification of the intestinal microflora composition (Ouwehand et al.,
2002).
- Immune modulation. The intestinal mucosa provides a protective host defense
against the constant presence of antigens from food and microorganisms in the gut lumen.
The gut-associated lymphoid tissue (GALT) represents the largest mass of lymphoid tissue in
the human body. Consequently, it constitutes an important element of the total immunologic
capacity of the host. Microbial colonization begins after birth, but the development of the
intestinal microflora and the gut barrier is a gradual process. The adult flora of the large
intestine comprises up to 500 bacterial species (Salminen et al., 1998b) and it is estimated
that bacteria account for 35-50% of the volume of contents in the human colon. The gut flora
is an important constituent in the large intestine’s defense barrier, as shown by increased
antigen transport across the gut mucosa in the absence of an intestinal microflora (Isolauri et
al., 2001). In addition to the effects of probiotics on non-immunologic gut defense (stabilization
of the gut microflora), probiotic bacteria have been shown to enhance humoral immune
responses and thereby promote the intestine’s immunologic barrier (Isolauri et al., 1993).
Probiotic bacteria stimulate nonspecific host resistance to microbial pathogens, and thereby
aid in immune elimination (Perdigón et al., 1998). Probiotics have also shown to modulate the
host’s immune responses to potentially harmful antigens with a potential to down-regulate
hypersensitivity reactions (allergy) (Sütas et al., 1996). The review by Isolauri and co-workers
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(2001) indicates that probiotic bacteria have several immunomodulatory effects, particularly
through stimulation of IgA responses, macrophage activation, cytokine production and
stimulation of antigen uptake, and that these effects should be characterized during the
development of clinical applications for extended target populations.
- Lactose intolerance. Approximately 70% of the world population suffers from a bad
digestion of the disaccharide lactose. Yoghurt, other conventional starter and probiotic bacteria
in fermented and unfermented milk products improve lactose digestion and eliminate symptoms
of intolerance in lactose maldigesters. These beneficial effects are due to microbial b-
galactosidase (lactase) in the (fermented) milk product, delayed gastrointestinal transit, positive
effects on intestinal functions and colonic microflora, and reduced sensitivity to symptoms
(de Vrese et al., 2001). Intact bacterial cell walls, which function as a mechanical protection
of lactase during gastric transit, and the release of this lactase into the small intestine, are
determinants of efficiency. Probiotic bacteria, mainly targeting the colon, normally promote
lactose digestion in the small intestine less efficiently than yoghurt cultures do, because the
better resistance of probiotics towards bile acids prevents b-galactosidase release into the
small intestine. They may, however, alleviate clinical symptoms brought about by undigested
lactose (de Vrese et al., 2001).
- Inflammatory Bowel Disease (IBD). IBD refers to disorders of unknown cause that
are characterized by chronic or recurrent intestinal inflammation. Such disorders include
ulcerative colitis, Crohn’s disease and pouchitis (Marteau et al., 2001). The aetiology of the
disease is currently not completely understood, but IBD may result from abnormal host
responses to some members of the intestinal flora or from a defective mucosal barrier (Sartor,
1995). Several DBPC studies have recently been performed with probiotics in various IBD-
related conditions, and evidence for a relevant effect is now sufficiently strong (Marteau et
al., 2002). Administration of probiotics has demonstrated to reduce the number of relapses
and prolong the period of remission (Gionchetti et al., 2000; Hamilton-Miller, 2001).
- Colorectal Cancer (CRC). The role of diet in the development and occurrence of
CRC is no longer under debate. Diets rich in fat and meat favour an intestinal flora mainly
comprising higher numbers of putrefactive bacteria such as Bacteroides and Clostridium, and
lower numbers of Bifidobacterium (Benno et al., 1991). These putrefactive bacteria enhance
faecal enzyme activity (b-glucuronidase, azoreductase, urease, etc…), thereby converting
pro-carcinogenic food compounds into carcinogens, which aids the development of CRC. It
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should be pointed out that there is no direct experimental evidence for cancer suppression
in man as a result of consumption of probiotics. However, there is a wealth of indirect
evidence, based on laboratory results, although the precise mechanisms by which LAB may
inhibit CRC are currently unknown. They might include alteration of the metabolic activities of
intestinal microflora; alteration of physico-chemical conditions in the colon; binding and
degrading potential carcinogens; quantitative and/or qualitative alterations in the intestinal
microflora incriminated in producing putative carcinogens and promotors; production of
antitumorigenic or antimutagenic compounds; enhancing the host’s immune response; and
effects on the physiology of the host. A review on this topic was made by Rafter (2002).
- Miscellaneous. Besides the main research topics on probiotic health benefits outlined
above, various other applications are to be considered, such as enhancement of the host’s
digestion, production of vitamins, inhibition of Helicobacter pylori colonization, prevention of
urogenital tract infections, reduction of LDL-cholesterol levels… Notwithstanding the remaining
research hurdles ahead, the idea that what one ingests most likely influences the health of
the gut, is conceptually appealing to many consumers. Dietary adjustments for conditions
such as IBD consist largely of nutritional replenishment and correction of specific deficits with
little evidence for a primary therapeutic benefit. Therapeutic modification of the gut flora with
functional foods such as probiotics may empower patients and enable them to achieve an
enchanced sense of control in the management of their illness. In this respect, functional
nutrients promise to become a useful (adjunct to conventional) drug therapy (Shanahan, 2002).
Once healthful attributes of a probiotic strain have been identified, product, regulatory
and labeling issues remain to be addressed prior to marketing. These issues are complicated
because they differ for each country, but are likewise critical because they provide the means
for communication of the product benefits for the consumer. The regulatory climate worldwide
appears to be one of caution about overstating the benefits of such probiotic products, but at
the same time it does not prevent corporate commitment to marketing (Sanders and Huis in’t
Veld, 1999).
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1.5.   Regulations and Quality Control
Regulatory and product labeling issues in the functional foods area (probiotics are
not considered separately in this field) primarily involve two issues, safety and assuring that
product labeling and promotion, while communicating healthful product effects, is not
misleading. This second item involves regulation of health claims. In general, a health claim
can be defined as a direct, indirect or implied claim in food labeling, advertising and promotion
that consumption of a food carries a specific health benefit or avoids a specific health detriment
(Sanders and Huis in’t Veld, 1999). Regulations are far from unanimous worldwide and have,
regarding certain aspects, evolved better for animal feed than for human nutrition (SCAN,
2000). However, recent efforts lead to the slow but certain unification of existing regulatory
frameworks. A brief historic overview of regulatory and labelling issues is presented in Table
4.
- The concept of functional foods was first used in Japan in the late 1980s. Due to the
fact that the market of functional foods was growing rapidly, the demand emerged to have
legal support in order to control the unjustified health claims that were suggested by some
products. In Japan, as in Europe today, it was the industry that stimulated the regulator to
have legal supervision of the claims. The Japanese government, under the Nutritional
Improvement Law, has provided financial grants to stimulate research on the physiological
function of foods. It took the Functional Foods Discussion Group approximately four years
before the Ministry of Health and Welfare issued in 1991 the ‘Labeling Regulation for Foods
for Specified Health Use’ (FOSHU). FOSHU approval requires a collection of information,
including safety reports, scientific evidence of the effects in humans, and nutritional analysis.
A FOSHU product is approved by the Minister of Health and Welfare and of which has been
proven to be effective in the maintenance and the improvement of health. Therefore, the
approval system gives permission to make certain claims in labeling a FOSHU food and is the
first regulatory system for functional foods.
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Table 4. Historical overview of regulatory and labeling issues. (Deduced from Pascal, 2003;
more information on http://www.functionalfoods.nu/)
1991 :
- FOSHU regulation in Japan
- 1st International Conference on nutrition and aging in Tokyo (ILSI-Japan)
1993 :
- FDA regulation on general requirements for health claims in labeling
1995 :
- 1st International Conference on East/West Perspectives on Functional Foods
1996 :
- EU concerted action : Functional Food Science in Europe (FUFOSE)
1999 :
- FUFOSE : in its final consensus document two new types of claims were proposed
2000 :
- SCAN paper : Scientific Committee on Animal Nutrition
- EU Directive 2000/13/EC on labeling
- BEUC : The European Consumer’s Organisation
- EU White Paper on Food Safety (january 2000)
2001 :
- Discussion paper on Nutrition Claims and Functional Claims – SANCO/1341/2001
2002 :
- Draft Proposal for Regulation of the European Parliament and of the Council on Nutrition,
  Functional and Health Claims Made on Foods – Working  Document (SANCO/1832/2002).
- PASSCLAIM
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- In the United States, prior to 1990, no health statements were allowed on conventional
foods, but the passage of the 1990 Nutrition Labeling and Education Act (NLEA) allowed
foods to bear a health claim under the condition that the Food and Drug Administration (FDA)
approved the claim. During the Joint FAO/WHO Food Standards Programme, the Codex
Alimentarius Commission was created in 1963 by the FAO and World Health Organisation
(WHO) to develop food standards, guidelines and related texts such as codes of practice.
The main purposes of this Programme are protecting health of the consumers and ensuring
fair trade practices in the food trade, and promoting coordination of all food standards work
undertaken by international governmental and non-governmental organizations (http://
www.codexalimentarius.net/). The FDA Modernization Act (FDAMA) of 1997 further amended
the Food Drug and Cosmetic Act (FDCA) providing limited authorization of food labeling to
include certain health claims without FDA pre-approval. This provision required that the claims
were based on an ‘authoritative statement’ by a ‘scientific body of the US Government with
official responsibility for public health protection or research’. In addition to this class of health
claims, another type of health statements is allowable on a class of food known as dietary
supplements as stipulated in the Dietary Supplement Health and Education Act of 1994. This
statement, termed a ‘structure/function claim’, relates a substance to normal, healthy
functioning of the human body. Currently, probiotic lactobacilli and bifidobacteria are primarily
sold in the US as dietary supplements or as components of foods, fluid milk, cottage cheese
and yoghurt. As such, they belong to two separate regulatory categories: food ingredients
and dietary supplements. The climate in the US has been conservative with regard to labeling
of foods with health statements.
- The development of probiotics in Europe is a new concept for the European regulator.
Past legislation did not anticipate any specific legal requirement of functional foods. Therefore,
no specific category exists for functional foods or foods on the border between food and
medicine. To complicate matters, interpretation is different according to member states. As
the general knowledge in Europe on LAB and their role in the maintenance of health is high,
industry is pushing to be able to use this knowledge in communications to consumers. Despite
this, in Europe, national authorities do not always know how to deal with functional foods
regarding authorization, certification or approval of labeling requirements. During the past
years, however, substantial attention of the European Commission has been projected towards
functional foods and health claims. In the consensus document resulting in Functional Food
Science in Europe (FUFOSE) funded by the European Commission and coordinated by ILSI
(International Life Science Institute) Europe, a definition of Functional Food was established.
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The purpose of FUFOSE is to develop and establish a science based approach for the emerging
concepts of functional food development. It states that the development of functional foods
must be based on sound scientific knowledge of the target function in the body and must
show that the effects are relevant to improved health or reduction of disease risk. In 1999,
FUFOSE stated two new types of claims in its final consensus document, which were also
included in the Codex by the FDA. In 2000, the EU Directive 2000/13/EC on labeling prohibits
that the presentation and advertising of foods attributes any properties of prevention, treatment
or cure of a human disease or any reference to such properties. The European Consumers
Organisation (BEUC) thinks that to protect consumers from misleading information, it is
necessary to establish harmonised rules for the use of claims and particularly health related
claims in those countries where health claims are permitted or already common practice. In
January 2000, an EU White Paper on Food Safety appeared, stating that consumers have the
right to expect information on food quality and constituents that is helpful and clearly presented,
so informed choices can be made. The Commission proposed consideration of whether to
introduce specific provisions to govern ‘nutrition claims’ and ‘functional claims’, in order to
reach the twin objective of achieving both the free movement of foodstuffs between Member
States and a high level of consumer protection. Recently the PASSCLAIM project consisting
of individual theme groups has been established, which has the objectives to produce a generic
tool with principles for assessing the scientific support for health-related claims for foods and
food components, to evaluate critically the existing schemes which assess the scientific
substantiation of claims, and to select common criteria for how markers should be identified,
validated and used in well-designed studies to explore the links between diet and health. It is
expected that the E.U. proposal to govern “Health claims” should be adopted as soon as
possible by the Member States. A special issue of the European Journal of Nutrition (2003) is
intirely dedicated to health claim regulation.
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Quality control
Besides legislation concerning health claims and labeling issues, effective on the pre-
production phase, a suitable legislation should be established addressing quality control during
and after the production process. The above section shows that regulators worldwide set
priority at the health claim level, and the fact that this topic is far from established indicates
that quality control legislation is still in its infancy. The acronym “GMP” (Good Manufacturing
Practice) is used internationally to describe a set of principles and procedures, which, when
followed by manufacturers of mainly therapeutic goods, helps to ensure that the manufactured
products will have the required quality (http://www.health.gov.au/tga/docs/html/webgmp.htm).
A basic tenet of GMP is that quality cannot be tested into a batch of product but must be built
into each batch of product during all stages of the manufacturing process. Various Codes,
Guides, Regulations relating to GMP have been published by different countries and trade
blocks. For example, the European Union has published a GMP Guide for Medicinal Products.
Most countries use compliance with a specified GMP requirement as the basis for licensing
manufacturers of medicinal products and medical devices. This GMP is now being extrapollated
towards functional food manufacturers, although no profound guidelines have been set up
yet, and quality control is still completely up to the manufacturer himself.
In general, a comprehensive approach to shelf life of probiotic bacteria is tied to
maintenance of efficacy. This implies knowledge of factors responsible for efficacy and how
they are affected by shelf life. Assuming efficacy is tied to viability, the literature suggests that
the performance of probiotic-containing products with regard to shelf life is mixed (Sanders
and Huis in’t Veld, 1999). These studies provide ‘snapshot’ images of commercial products,
some with little knowledge of storage history, or the analysis of a limited number of (national)
products using sometimes doubtful identification methods (Reuter, 1997; Holzapfel et al.,
1998; Hamilton-Miller, 1999 and Hoa et al., 2001). The need for a profound legislation setting
guidelines for quality control by manufacturers as well as by independent research groups is
urgent and of utmost importance as indicated by the Thematic Priority ‘Food Quality and
Safety’ of the Sixth Framework Programme, having a budget of €685 million (Lucas, 2002).
These guidelines should state modern standardized analysis methods in order to facilitate
comparison on the international level.
47
Overview of the literature          Identification methods for LAB
Chapter 2
Identification methods for LAB
It has become clear that the food industry and gastrointestinal microbiologists require
sensitive and reliable methods to identify and characterise the microbial content of foods and
the host’s GI-tract. Particular interest is aimed at the LAB because of: (i) the association of
these organisms with health-promoting properties; (ii) their application in numerous food
products as probiotics; and (iii) the requirements of legislative and industrial bodies, as well
as the consumer, with respect to safety, labeling and strain integrity (McCartney, 2002).
Additional areas of interest address contamination, food-borne pathogens, and any underlying
microbiological basis to GI disorders, or susceptibility to such illnesses. Because of the
extensive use in food fermentations and as food supplements, LAB have been thoroughly
characterized because of their metabolic properties, growth performance, adaptability to
industrial processes, sustainability in the end product and targeted site of action, shelf-life,
etc… In addition to studies that aim to improve technological aspects, also safety and quality
control are crucial and, ideally, should be performed on a frequent basis (Saarela et al., 2000).
In this context, reliable identification of LAB remains a point of crucial importance. Over the
past decade, the scientific community has paid special attention to the correct identification
of bacteria used for human consumption (Hamilton-Miller et al., 1999). A problem impairing all
(industrial) fermentations is the contamination of the process with unknown bacteria, resulting
in loss of the end-product metabolites, organoleptic properties, functionality and/or (bacterial)
composition of the product. As a result, techniques capable of monitoring the bacterial (e.g.
LAB) composition of the product during and after the production process are currently much
needed. At present, a broad range of identification techniques for LAB pure cultures or
communities are available, all displaying differences in discriminatory power, reproducibility
and workload.
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2.1.  Phenotypic methods
Although most industrial applications and probiotic health effects of LAB depend on
the specific characteristics of a particular strain, it is not always necessary to identify bacteria
as accurate as down to the strain level. An optimal balance has to be found between the
desired taxonomic resolution of a certain application and the involved workload, speed and
cost. Most phenotypic methods are much cheaper compared to genotypic methods; hence
the popularity of commercially available miniaturized identification systems such as API or
BIOLOG. Although the application of phenotypic techniques has proven to be useful for certain
LAB, there is a general awareness that similar phenotypes displayed by strains do not always
correspond to similar or even closely related genotypes. Consequently, there has been a shift
towards genotypic characterization in order to provide more robust classification and
differentiation (McCartney, 2002). Additional weaknesses of phenotypic methods include poor
reproducibility, ambiguity of some techniques (largely resulting from bacterial growth), extensive
logistics for large-scale investigations and poor discriminatory power. However, also genotypic
characterization techniques are not without limitations and thus a polyphasic, or combined
approach is prefered. Table 5 summarizes a number of frequently applied identification
techniques, discussed further on.
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Especially in industrial or applied microbiology units, phenotypic tests are still being
used on a routine basis for the identification of (food-associated) LAB. These methods include
morphological and physiological characterisation, carbohydrate fermentation patterns and
protein profiling. Gonzalez and co-workers (2000) identified 249 LAB isolates from freshwater
fish and their environment using 44 morphological and physiological tests. A high percentage
(90%) of the isolates could only be identified at the genus level, demonstrating the low
taxonomic resolution of this labour-intensive approach. In most cases, these physiological
tests are combined with the determination of carbohydrate fermentation patterns, using
commercially available systems. Corsetti and co-workers (2001) analysed 317 presumptive
LAB isolates from sourdoughs based on morphological and physiological characteristics
followed by further identification using the commercial API50CHL system (BioMérieux, France).
Still, only 38% of the isolates could be identified to the species level. A similar approach was
used to identify 113 LAB isolates from a Ugandan traditional fermented beverage (Muyanja et
al., 2003), which resulted in a tentative identification to the species level. Also the combined
use of two carbohydrate fermentation test kits could not allocate 14 LAB isolates to known
species (Wijtzes et al., 1997). These studies demonstrate that phenotypic methods have their
limitations because of a sometimes poor reproducibility and a relatively low taxonomic resolution
that often only allows differentiation on the genus level. The popularity of these methods is
mainly due to the fact that no specialized equipment is required and because of the availability
of an identification database, although only partly focusing on potential environmental or applied
LAB.
In comparison Sodium Dodecyl Sulphate – Polyacrylamide Gel Electrophoresis
(SDS-PAGE) analysis of whole-cell proteins has proven to be a more reliable identification
method for LAB (Pot et al., 1994). Protein profiling has been successfully used by Leisner
and co-workers (2001) to identify 64 LAB isolates from Malaysian condiment at the species
level. However, the major drawback of this method is the rather high workload. In addition,
SDS-PAGE of proteins lacks discriminatory power on the (sub)species level in the Lactobacillus
acidophilus group (L.acidophilus, L. crispatus, L. amylovorus, L. gallinarum, L. johnsonii and
L. gasseri) (Gancheva et al., 1999) and the L. plantarum group (L. plantarum, L. pentosus
and L. paraplantarum) (Torriani et al, 2001). Differentiation of these organisms is performed
using genomic techniques such as RAPD-PCR (Du Plessis et al., 1995), as discussed in the
next section.
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Another phenotypic technique that has been used for identification of LAB isolates,
but with limited success, is Fatty Acid Methyl Ester (FAME) analysis (Yeung et al., 2002).
In order to obtain a reliable identification of LAB at the species level, multiple phenotypic
techniques are often combined along the route of a polyphasic approach. In this way, strong
features of one method can compensate shortcomings of another method.
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2.2.  Genotypic methods
The past two decades have witnessed the development of DNA-based identification
and detection methods. Undoubtedly, one of the main advantages of these methods is their
independence of variations in the growth conditions of the microorganisms. Genotypic
techniques exhibit various levels of discriminatory power, from species level to differentiation
of individual strains (typing). A group of genotypic methods is based on the principle of
Polymerase Chain Reaction (PCR), facilitating the selective amplification of specifically
targeted DNA fragments, through the use of oligonucleotide primers under controlled reaction
conditions. In theory, PCR primers can be designed for amplification at any taxonomic level.
Kaufmann and co-workers (1997) designed primers that amplify a 16S rDNA fragment specific
for bifidobacteria, which enable the genus-specific detection of bifidobacterial isolates in a
food matrix. Beyond genus level, 16S rRNA based species- and group-specific primers have
been designed for Bifidobacterium adolescentis, B. angulatum, B. bifidum, B. breve, the B.
catenulatum group (B. catenulatum and B. pseudocatenulatum), and the B. longum group (B.
longum and B. infantis), which are species commonly found in the human intestinal tract
(Matsuki et al., 1998). A similar approach using species-specific primers for various LAB was
recently used for the identification of 543 cheese isolates (Mannu et al., 2002). At the intra-
specific level, the PCR-based discrimination of Lactococcus lactis subsp. lactis and Lc. lactis
subsp. cremoris was performed by Nomura and co-workers (2002). The highest discriminatory
identification level was reached by Brandt and Alatossava (2003) for the specific detection of
certain Lactobacillus rhamnosus strains using phage-related primers, and by Chagnaud and
co-workers (2001), who designed primers directed at 6 Lactobacillus strains. Overall, the
PCR-based detection of LAB and other bacteria mostly requires a difficult design strategy
and thorough validation before a valuable set of primers is obtained. Therefore, this approach
is only considered suitable if the presence or absence of well-known bacteria is to be verified.
When unknown bacterial isolates have to be identified, a powerful tool with high
discriminatory power is 16S or 23S rDNA sequencing (Vandamme et al., 1996). The obtained
sequence is to be compared with DNA sequences stored in online databases of previously
sequenced DNA, of which the most popular ones are the EMBL (http://www.ebi.ac.uk/embl/)
and Genbank (http://www.ncbi.nlm.nih.gov/Genbank/) databases. Searching these databases
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for corresponding sequences can be performed using a search algorithm, such as BLAST or
FASTA. Booysen and co-workers (2002) sequenced the 16S rDNA for the identification of
LAB isolates from a malting process at the subspecies level, whereas fecal LAB isolates
exhibiting antimicrobial action against Clostridium difficile were identified at the species level
by means of sequencing the 16S rDNA and Internal Transcribed Spacer (ITS) regions by
Yoon-Jong Lee and co-workers (2003). Sequencing analysis of these two regions was also
applied to identify 317 isolates from 25 wheat sourdoughs at the species level (Corsetti et al.,
2001). Although a very powerful tool, sequencing of ribosomal genes is highly dependent on
the reliability and the taxonomic coverage of the available databases. Furthermore, the degree
of strain and inter-operon sequence variation may in some cases yield confusing identification
results (Nubel et al., 1996).
Total DNA or amplicons resulting from a selective PCR reaction can also be digested
by restriction enzymes, resulting in a mixture of fragments different in size. This technique is
commonly referred to as Restriction Fragment Length Polymorphism (RFLP) analysis and
is the prototype of a DNA fingerprinting method mostly used to identify isolates at the intra-
specific level. Giraffa and co-workers (2002) applied RFLP analysis of protein-coding genes
(b-galactosidase, lactose permease, and proline dipeptidase) for molecular typing of 35
Lactobacillus delbrueckii subsp. lactis and L. delbrueckii subsp. bulgaricus isolates used as
starter cultures for dairy products. Furthermore, 46 LAB isolates from wine were analysed by
RFLP to indicate the presence of Oenococcus oeni, a species showing no strain diversity in
its RFLP patterns (Sato et al., 2000). The discriminatory power of these methods is very high
(i.e. strain level) making them very useful for typing LAB starter cultures, of which the strain-
specific properties are crucial to the production process. Pulsed Field Gel Electrophoresis
(PFGE) employs an alternating field of electrophoresis to allow separation of the large DNA
fragments obtained from restriction digests with rare-cutting enzymes. Crucial to PFGE is the
extraction of intact chromosomal DNA, which may render the technique more time consuming
than other fingerprinting strategies. However, since PFGE analyses large DNA fragments,
representing the whole genome, this technique has superior discriminatory power, with excellent
subspecies differentiation for a large number of microorganisms (McCartney, 2002). Multiple
strains of the species Lactobacillus johnsonii were analysed with PFGE by Ventura and Zink
(2002). They demonstrated the highly significant heterogeneity among all L. johnsonii isolates,
potentially linked to their origin of isolation. A more advanced fingerprinting technique that
combines PCR amplification with double restriction digest is Amplified Fragment Length
Polymorphism (AFLP) (Janssen et al., 1996). Originally developed for plant systematics,
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AFLP has been found to be a very useful fingerprinting technique for bacteria, allowing both
species resolution and strain differentiation.  AFLP has mostly been employed in
epidemiological studies and in investigations aiming to distinguish virulence markers in food-
borne pathogens. However, species-level discrimination has also been shown for the
phylogenetically closely related species L. pentosus, L. plantarum and L. pseudoplantarum
(Giraffa and Neviani, 2000).
DNA fingerprinting techniques that solely rely on PCR include Randomly Amplified
Polymorphic DNA (RAPD) and repetitive genomic element (rep)-PCR. RAPD analysis
utilises short arbitrary primers and low-stringency to randomly amplify DNA fragments, which
are seperated to produce a fingerprint.  Booysen and co-workers (2002) recently reported the
use of RAPD to identify LAB isolates from a malting process. The great flexibility in primer
choice offered by this method implies that it can be applied to differentiate LAB at different
taxonomic levels ranging from genus to intra-specific level. However, because RAPD primers
are not directed against a specific sequence, the reproducibility of the technique over a longer
study period has often posed a problem (Olive and Bean, 1999). In contrast, rep-PCR specific
primers amplify repetitive bacterial DNA elements such as ERIC, BOX or (GTG)5 (Versalovic
et al., 1994). In recent studies, (GTG)5-PCR was proven to be useful for the differentiation of
lactobacilli and bifidobacteria on the species, subspecies and potentially on the strain level
(Gevers et al., 2001; Masco et al., 2003).
Ribotyping combines an enzymatic restriction digest with the detection of the resulting
fragments by means of rDNA probes. Lyhs and colleagues (2002) applied ribotyping for the
identification of 296 LAB isolates from vacuum-packed trout. To a large extent, the
discriminatory power of this technique depends on the number and type of restriction enzymes
and probes used. Either fluorescent or radioactively labeled probes can be used to hybridize
with specific DNA sequences. For instance, enterococci were identified using a dot blot
hybridisation method using species-specific probes (Manero and Blanch, 2002), whereas LAB
isolates from wine have been identified using total genomic DNA probes (Sohier and Lonvaud-
Funel, 1998). The authors also applied the same probes directly on wine samples, that were
previously being fixated on a membrane, in which case the technique is referred to as
Fluorescent In Situ Hybridisation (FISH). A technique similar to the use of probes is the
application of fluorescently labeled monoclonal antibodies directed against a specific species
or strain, as demonstrated by Yuki and co-workers (1999) for the identification of the probiotic
strain Lactobacillus casei Shirota. DNA-DNA hybridization is a method in genetics to measure
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the degree of genetic similarity between DNA sequences. The technique is usually used to
determine the genetic “distance” between two species. The DNA from the two species to be
compared is extracted, purified and cut into short pieces. The DNA double strand is then
separated by heating into two single strands, which are allowed to anneal with the DNA pieces
of the other species. The more similar the DNA, the more of the pieces will anneal and form
a hybrid double strand. Strands with a high degree of similarity will bind more firmly, and the
energy required to separate them is determined. This method was used to select probiotic
species out of 297 Lactobacillus isolates (du Toit et al., 1998).
Finally, because many LAB strains harbour plasmids varying in size and number,
plasmid profiling is sometimes used for strain-specific identification as demonstrated for
LAB isolates from Malaysian condiment (Leisner et al., 2001), and from fermented dry sausages
(Gevers et al., 2003a). However, as not all LAB strains actually harbour plasmids, this method
is not universally applicable. Moreover, plasmids can be acquired or lost during horizontal
gene transfer events. To increase the reliability of a genotypic identification, a polyphasic
combination of different techniques is sometimes desirable. Ventura and Zink (2002)
characterized a collection of Lactobacillus johnsonii strains using a combination of multiplex
PCR, rep-PCR, PFGE, AFLP and RAPD.
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Chapter 3
Microbial analysis of LAB ecosystems
3.1.  Introduction
The identification methods described in the previous section rely on the ability to isolate
and cultivate LAB isolates from a given food or environmental sample. Because these culture-
dependent approaches have shown limitations in terms of recovery rate, the set of obtained
isolates may not always truly reflect the microbial composition of the sample (Ampe et al,
1999; Ercolini et al., 2001). Mainly detection of bifidobacteria impairs the reproducibility of
culture-dependent techniques, because of the lack of suitable selective isolation media (Roy,
2001). As a result, culture-independent methods have been developed to circumvent the
limitations of conventional cultivation for the analysis of microbial communities (Vaughan et
al., 2002). For instance, during the production of yoghurts or probiotic products, in which
bacterial starter cultures are often joined by additional LAB strains to improve the organoleptic
or functional properties, the slightest quantitative or qualitative shift in bacterial composition
may compromise the end product quality. The microbiological screening at different steps in
the process line of a food product can, however, be a very laborious task when only culture-
dependent techniques are available. Clearly, on-time interventions in the production process
are only possible when complex LAB ecosystems can be analyzed in a reliable and fast culture-
independent way.
The fastest culture-independent approach for the genus, species or strain specific
detection of LAB in a food matrix is the use of a PCR assay applying specific primers on
bacterial DNA extracted from the sample. However, with an increasing degree of microbial
complexity of the sample, several PCR primers are needed in order to detect different LAB
taxa or strains, thereby substantially increasing workload. Perhaps the main disadvantage of
this approach is the fact that only ‘expected’ microorganisms will be detected, making such
PCR assays of limited value in the analysis of highly complex ecosystems or samples showing
a variable or unknown species composition. Tilsala-Timisjärvi and Alatossava (1997) designed
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6 species-specific primerpairs targeting the 16S-23S intergenic rDNA region of the probiotic
species L. paracasei, L. rhamnosus, L. delbrueckii, L. acidophilus, L. helveticus and S.
thermophilus. Using a Bifidobacterium-specific set of PCR primers, Kaufmann and co-workers
(1997) facilitated genus-specific detection of bifidobacteria in food and fecal samples.
Probing techniques are based on the hybridisation of synthetically prepared
oligonucleotides to specific target sequences on bacterial DNA as it is the case for PCR
primers. But instead of being intended for the amplification of DNA, they are linked to a
radioactive or fluorescent label which enables the visual detection of the target after
hybridisation under controlled conditions. The specificity of the probe is largely dependent on
the target sequence, although the stringency of the hybridisation conditions and washing are
also critical (O’Sullivan, 1999). Labeled oligonucleotide probes are employed in a number of
assays including colony, dot-blot and in situ hybridisations (Giraffa and Neviani, 2000). The
most frequently applied method using probes is Fluorescent In Situ Hybridisation (FISH)
making use of fluorescence microscopy for the counting of fluorescently labeled bacteria.
Using specific probes, Sohier and Lonvaud-Funel (1998) reported on a method to monitor the
bacterial population in wine at different stages of vinification during storage, and to identify
wine spoiling LAB. A more advanced FISH application used an array of genus-specific primers
targeting Bifidobacterium, Bacteroides, Lactobacillus/Enterococcus and Clostridium to monitor
the fecal flora of infants (Kirjavainen et al., 2001). A method that allows both quantitative and
qualitative analysis of samples is Flow Cytometric Analysis. Bacteria in a liquid sample or
suspension are fluorescently labeled using one or more specific dyes or probes after which
the labeled solution is run through a flow cytometer or cell sorter, determining the identity and
quantity of the bacteria (Bunthof and Abee, 2002). The main disadvantage of these probe-
based methods is their high workload, preventing fast analysis. In addition, the use of primers
and probes restricts the number of possible applications because of the limited number of
bacteria targeted.
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3.2.  DGGE – method and applications
At present, Denaturing Gradient Gel Electrophoresis (DGGE) analysis is the most
suitable and widely applied method to study complex bacterial communities originating from
various environments (Muyzer, 1999). This PCR-based technique allows the sequence-
dependent separation of a mixture of amplified DNA fragments, all identical in size, on an
acrylamide gel containing a well-defined gradient of denaturing components (Fig. 2 and 3). In
conventional agarose  or  acrylamide  gel  electrophoresis,  DNA fragments are separated by
size; with the electrophoretic mobility of each fragment being disproportionate with its size. In
DGGE, DNA fragments of the same size are separated by their denaturing profile, i.e. how
the double stranded DNA (dsDNA) becomes (partially) single stranded (ssDNA) when it is
subjected to an increasingly denaturing environment. This physical denaturing of the dsDNA
fragment does not proceed in a zipper-like manner, but gradually discrete portions of the
fragment will denature through so-called melting domains. As a result of this ds to ss
conformational change the DNA  fragment’s  passage  through  the  acrylamide  gel, containing
a   gradient   of   increasing   denaturants,   is drastically slowed and eventually halted. The
position in a gel where the dsDNA fragment melts and becomes ssDNA is dependent on the
nucleotide sequence and %G+C content of the fragment. Different sequences will result in
different origins of melting domains and as a consequence also in different positions in the
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gel where the DNA fragment halts. For each kind of application the optimal denaturing gradient
has to be prepared by means of mixing the desired volumes of a 100% and 0% denaturing
acrylamide solution (100% denaturant is 40% formamide and 7M urea), resulting for instance
in a 35-70% denaturing gel most commonly used in microbiology (Muyzer et al., 1993).
Originally being developed for mutation analysis, DGGE has been shown to detect differences
in the denaturing behaviour of small DNA fragments (200-700bp) that differ by as little as one
base pair.
Fig. 3. Principle of DGGE. PCR amplicons of equal length are electrophoretically separated
in a sequence-dependent manner. The increasing gradient of denaturing components along
the gel confers the double stranded amplicons into single stranded DNA through melting
domains. A GC-clamp attached to the 5’ end of one of both PCR primers prevents the amplicons
from completely denaturing. Different sequences will result in different origins of melting
domains and as a consequence also in different positions in the gel where the DNA fragment
halts.
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At present, DGGE has been widely applied in various research areas including the
detection of LAB in food samples and other environments. For instance, Cocolin and co-
workers (2001) monitored the fermentation of Italian sausages in order to detect shifts in the
involved Micrococcaceae population using primers targeting the V1 region of the 16S rDNA.
Another study analysed cassava dough products to determine the exact composition of the
microbial community (Miambi et al., 2002). The authors made a comparison between DGGE
analysis and conventional bacterial isolation, from which they concluded that it was necessary
to combine both culture-dependent and culture-independent methods to obtain a more detailed
view of the microbial communities associated with indigenous cassava starch fermentations.
A similar conclusion was made by Ercolini and co-workers (2001) after a comparative analysis
of the bacterial composition of Mozarella cheese. The combination of DGGE analysis with
Reverse Transcriptase (RT)-PCR was recently described by Randazzo and co-workers (2002)
to study both the microbial composition and metabolic activity during Ragusano cheese
manufacturing. Many applications of DGGE are however focussed on the study of the human
or animal intestinal microflora, e.g. before, during or after the oral administration of pro- or
prebiotic products (Konstantinov et al., 2003; Plant et al., 2003). General screening of the
fecal flora of human neonates was performed by Favier and co-workers (2002), whereas
DGGE has also been used to determine the differences in general and LAB communities
between human mucosa biopsies and fecal samples (Zoetendal et al., 2002).
Although the above studies clearly demonstrate the broad applicability of DGGE, much
of the capabilities of the technique are determined by the choice of the PCR primers. The use
of universal primers (e.g. those targetting the V3 or V6-V8 region of the 16S rDNA gene)
allows any bacterial community to be analysed, although in case of an ecosystem with a
relatively high bacterial diversity only the dominant flora will be visualised on the DGGE gels
(Zoetendal et al., 1998). In order to improve the detection limit for less abundant groups in the
microbial ecosystem, group-specific primers need to be used. Furthermore, the use of universal
primers will result in complex banding patterns with some of the bands possibly representing
multiple species. Since most applications target the identification of the bands, cloning and
sequencing of the extracted bands becomes necessary, which renders the DGGE method
laborious and time-consuming, impairing the potential of DGGE to analyse rapidly changing
and complex bacterial ecosystems. Therefore, substantial research should address the
transformation of DGGE into a direct identification method, for instance towards LAB food
samples.
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3.3.  Identification potential of DGGE
Recently, DGGE is being increasingly used for the analysis of LAB in food fermentation
processes or products. For these applications, researchers are trying to optimize the DGGE
method for direct identification of LAB without the use of additional identification techniques.
In this regard, the use of genus-specific primers represents an important step, which generally
results in a less complex DGGE banding pattern and a preselective amplification of the less
abundant members of an ecosystem. Within the LAB, specific PCR primers targeting
Bifidobacterium (Rigottier-gois et al., 2003) and Lactobacillus/Pediococcus/Leuconostoc/
Weisella (Walter et al., 2001; Heilig et al., 2002) have been designed. However, if too many
different species are present, the banding pattern can remain very complex and identification
of bands may still require sequencing. To this end, a part of the problem may be overcome by
the inclusion in each DGGE gel of an identification ladder consisting of an artificial mixture
of PCR amplicons from various pure cultures with known taxonomic identity. Band positions
in the unknown sample lane can be visually compared with reference band positions in the
identification ladder, leading to an identification. Meroth and co-workers (2003) used an
identification ladder representing 13 Lactobacillus species for the identification of unknown
Lactobacillus species in a sourdough fermentation process. These authors found this approach
to produce better results compared to culture-dependent analysis using RAPD identification
of purified LAB isolates. In an other study, two identification ladders containing 8 Lactobacillus
species and 7 Bifidobacterium species, respectively, were included to analyse the microbial
composition of probiotic products (Fasoli et al., 2003). Because of the limited complexity
within the probiotic samples, no additional identification techniques were found necessary,
although some probiotic LAB species could not be distinguished. It is evident that the
composition of the identification ladder has to be chosen according to the expected species
composition of the sample to be analysed, meaning that the availability of pre-existing
information on the microbial diversity in the sample is crucial.
By means of changing different parameters, such as the electrophoresis conditions
and denaturing gradient, DGGE can be adjusted in order to aid the optimal separation of
bacterial species. Nevertheless, literature has not yet described DGGE as a completely
independent identification technique for the analysis of bacterial communities.
63
Overview of the literature           References
Reference list
· Adams M.R. and Marteau P. (1995). On the safety of lactic acid bacteria. International Journal of
Food Microbiology 27:263-264.
· Adams M.R. (1999). Safety of industrial lactic acid bacteria. Journal of Biotechnology 68:171-178.
· Ampe F., Ben Omar N., Moizan C., Wacher C. and Guyot J.P. (1999). Polyphasic study of the
spatial distribution of microorganisms in Mexican pozol, a fermented maize dough, demonstrates
the need for cultivation-independent methods to investigate traditional fermentations. Applied and
Environmental Microbiology 65:5464-5473.
· Andersen L. (1998). Pre- and probiotics – sausage science. Functional Foods June:26-29.
· Apostolou E., Kirjavainen P.V., Saxelin M., Rautelin H., Valtonen V., Salminen S. and Ouwehand
A.C. (2001). Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS
Immunology and Medical Microbiology 31:35-39.
· Axelsson L. (1998). Lactic acid bacteria: classification and physiologie. In: Lactic acid bacteria,
microbiology and functional aspects, second edition, (eds. S. Salminen, A. von Wright), Marcel
Dekker, Inc., New York, USA. P. 1-59.
· Benno Y., Mitsuoka T. and Kanazawa K. (1991). Human faecal flora in health and colon cancer.
Acta Chirurgica Scandinavia 521:15-23.
· Booysen C., Dicks L.M.T., Meijering I. and Ackermans A. (2002). Isolation, identification and
changes in the composition of lactic acid bacteria during the malting of two different barley cultivars.
International Journal of Food Microbiology, 76:63-73
· Brandt K. and Alatossava T. (2003). Specific identification of certain probiotic Lactobacillus
rhamnosus strains with PCR primers based on phage-related sequences. International Journal of
Food Microbiology, 84(2):189-196.
· Bunthof C.J. and Abee T. (2002). Development of a Flow Cytometric Method To Analyze
Subpopulations of Bacteria in Probiotic Products and Dairy Starters. Applied and Environmental
Microbiology 68(6):2934–2942.
· Chagnaud P., Machinis K., Coutte L. A., Marecat A. and Mercenier A. (2001). Rapid PCR-based
procedure to identify lactic acid bacteria: application to six common Lactobacillus species. Journal
of Microbiological Methods 44:139–148.
· Charteris W.P., Kelly P.M., Morelli L. and Collins J.K, (1998). Antibiotic Susceptibility of
Potentially Probiotic Lactobacillus Species. Journal of Food Protection 61:1636-1643.
· Cocconier M.H., Bernet M.F., Kerneis S., Chauviere G., Fourniat J. and Servin A.L. (1993).
Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus
acidophilus strain LB decreases bacterial invasion. FEMS Microbiology Letters 110:299-305.
· Cocolin L., Manzano M., Aggio D., Cantoni C. and Comi G. (2001). A novel Polymerase Chain
Reaction (PCR) - Denaturing Gradient Gel Electrophoresis (DGGE) for the identification of
Micrococcaceae strains involved in meat fermentations. Its application to naturally fermented Italian
sausages. Meat Science 57:59-64
64
Overview of the literature           References
· Corsetti A., Lavermicocca P., Morea M., Baruzzi F., Tosti N. and Gobbetti M. (2001). Phenotypic
and molecular identification and clustering of lactic acid bacteria and yeasts from wheat (species
Triticum durum and Triticum aestivum) sourdoughs of Southern Italy. International Journal of
Food Microbiology 64:95–104
· Courvalin P. (1994). Transfer of antibiotic resistance genes between gram-positive and gram-negative
bacteria. Antimicrobial Agents and Chemotherapy 38:1447-1451.
· Danielsen M. and Wind A. (2003). Susceptibility of Lactobacillus spp. to antimicrobial agents.
International Journal of Food Microbiology 82(1):1-11.
· de Vrese M., Stegelmann A., Richter B., Fenselau S., Laue C. and Schrezenmeir J. (2001).
Probiotics – compensation for lactase insufficiency. The American Journal of Clinical Nutrition
73(S):421S-429S.
· Döderlein A. (1892). Das Scheidensekret und seine Bedeutung für das Puerperalfieber. (The vaginal
transsudate and its significance for childbed fever.) Centralblatt für Bacteriologie. 11:699-700.
· Donohue D.C. and Salminen S.J. (1996). Safety of probiotic bacteria. Asian Pacific Journal of
Clinical Nutrition 5:25-28.
· Dunne C., O’mahony L., Murphy L., Thornton G., Morrissey D., O’halloran S., Feeney M.,
Flynn S., Fitzgerald G., Daly C., Kiely B., O ‘sullivan G.C., Shanahan F. and Collins J.K.
(2001). In Vitro Selection Criteria for Probiotic Bacteria of Human Origin: Correlation With in
Vivo Findings. American Journal of Clinical Nutrition 73(S):386S-392S.
· du Toit M., Franz C.M.A.P., Dicks L.M.T., Schillinger U., Haberer P., Warlies B., Ahrens F.,
Holzapfel W.H. (1998). Characterisation and selection of probiotic lactobacilli for a preliminary
minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture
content. International Journal of Food Microbiology 40(1-2):93-104.
· Ercolini D., Moschetti G., Blaiotta G. and Coppola S. (2001). The potential of a polyphasic PCR-
DGGE approach in evaluating microbial diversity of natural whey cultures for water-buffalo
mozzarella cheese production: Bias of culture-dependent and culture-independent analyses.
Systematic and Applied Microbiology 24(4):610-617.
· Fasoli S., Marzotto M., Rizzotti L., Rossi F., Dellaglio F. and Torriani S. (2003). Bacterial
composition of commercial probiotic products as evaluated by PCR-DGGE analysis. International
Journal of Food Microbiology 82:59-70.
· Favier C.F., Vaughan E.E., De Vos W.M. and Akkermans A.D.L. (2002). Molecular Monitoring of
Succession of Bacterial Communities in Human Neonates. Applied and Environmental Microbiology,
68(1):219–226.
· Floch M.H., Binder H.J., Filburn B. and Gershengoren W. (1972). The effect of bile acids on
intestinal microflora. American Journal of Clinical Nutrition 25:1418-1426.
· Fuller R. (1989). Probiotics in man and animals. Journal of Applied Bacteriology 66:365-378.
· Gancheva A., Pot B., Vanhonacker K., Hoste B. and Kersters K. (1999). A polyphasic approach
towards the identification of strains belonging to Lactobacillus acidophilus and related species.
Systematic and Applied Microbiology. 22(4):573-585.
65
Overview of the literature           References
· German B., Schiffrin E.J., Reniero R., Mollet B., Pfeifer A. and Neeser J.-R. (1999). The
development of functional foods: lessons from the gut. TIBTECH 17:492-499.
· Gevers D., Huys G. and Swings J. (2001). Applicability of rep-PCR fingerprinting for identification
of Lactobacillus species. FEMS Microbiology Letters 205:31-36.
· Gevers D., Danielsen M., Huys G. and Swings, J. (2003a). Molecular characterization of tet(M)
genes in Lactobacillus isolates from different types of fermented dry sausage. Applied and
Environmental Microbiology 69(2):1270-1275.
· Gevers D. Huys G., Swings, J. (2003b). In vitro conjugal transfer of tetracycline resistance from
Lactobacillus isolates to other Gram-positive bacteria. FEMS Microbiology Letters. submitted
· Gibson G.R. and Roberfroid M.B. (1995). Dietary modulation of the human colonic microbiota:
introducing the concept of prebiotics. Journal of Nutrition 125:1401-1412.
· Gilliland S. (2002). Technological and commercial applications of lactic acid bacteria; health and
nutritional benefits in dairy products. http://www.fao.org/es/ESN/food/foodandfood_probio_en.stm
· Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli
M. and Campieri M. (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic
pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119(2):305-309.
· Giraffa G. and Neviani E. (2000). Molecular identification and characterisation of food-associated
lactobacilli. Italian Journal of Food Science 4:403-423.
· Giraffa G., Lazzi C., Gatti M., Rossetti L., Mora D. and Neviani E. (2002). Molecular typing of
Lactobacillus delbrueckii of dairy origin by PCR-RFLP of protein-coding genes. International
Journal of Food Microbiology. 82(2):163-172.
· Goldin B.R. and Gorbach S.L. (1992). Probiotics for human consumption. In: Fuller R., ed. Probiotics,
the scientific basis. London: Chapman and Hall pp355-376.
· Gonzalez C.J., Encinas J.P., Garcia-Lopez M.L. and Otero A. (2000). Characterization and
identification of lactic acid bacteria fromfreshwater fishes. Food Microbiology, 17:383-391
· Hamilton-Miller J.M.T., Shah S. and Winkler J.T. (1999). Public health issues arising from
microbiological and labelling quality of foods and supplements containing probiotic microorganisms.
Public Health Nutrition 2:223-229.
· Hamilton-Miller J.M.T. (2001). A review of clinical trials of probiotics in the management of
inflammatory bowel disease. Infectious Diseases Reviews 3:83-87.
· Heilig H., Zoetendal E.G., Vaughan E.E., Marteau P., Akkermans A.D.L. and de Vos W.M.
(2002). Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine
as determined by specific amplification of 16Sribosomal DNA. Applied and Environmental
Microbiology 68(1):114-123.
· Hoa N.T., Baccigalupi L., Huxham A., Smertenko A., Van P.H., Ammendola S., Ricca E. and
Cutting S.M. (2000). Characterization of Bacillus species used for oral bacteriotherapy and
bacterioprophylaxis of gastrointestinal disorders. Applied and Environmental Microbiology 66:5241-
5247.
66
Overview of the literature           References
· Hoffman A.F., Molino G., Milanese M. and Belforte G. (1983). Description and stimulation of a
physiological pharmokinetic model for the metabolism and enterohepatic circulation of bile acids
in man. Journal of Clinical Investigation 71:1003-1022.
· Hofvendahl K. and Hahn-Hagerdal B. (2000). Factors affecting the fermentative lactic acid
production from renewable resources. Enzyme and Microbial Technology 26(2-4):87-107.
· Holzapfel W.H., Haberer P., Snel J., Schillinger U. and Huis in’t Veld J.H.J. (1998). Overview of
gut flora and probiotics. International Journal of Food Microbiology 41:85-101.
· Holzapfel W.H., Haberer P., Geisen R., Bjorkroth J. and Schillinger U. (2001). Taxonomy and
important features of probiotic microorganisms in food and nutrition. American Journal of Clinical
Nutrition 73(2):365S-373S.
· Hylemon P.B. and Glass T.L. (1983). Biotransformation of bile acids and cholesterol by the intestinal
microflora. In: Hentges, D.J. ed. Human intestinal microflora in health and disease. New York:
Academic Press, pp.189-213.
· Isolauri E., Majamaa I.F., Arvola T., Rantala I., Virtanen E. and Arvilommi, H. (1993).
Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in
suckling rats. Gastroenterology 105:1643-1650.
· Isolauri E., Sütas Y., Kankaanpää P., Arvilommi H. and Salminen S. (2001). Probiotics: effects
on immunity. American Journal of Clinical Nutrition 73(2):S444-S450.
· Janssen P., Coopman R., Huys G. Swings J. Bleeker M., Vos P. Zabeau M. and Kersters K.
(1996). Evalutation of the DNA fingerprinting method AFLP as a new tool in bacterial taxonomy.
Microbiology 142:1881-1893.
· Kaufmann P., Pfefferkorn A., Teuber M. and Meile L. (1997). Identification and Quantification of
Bifidobacterium Species Isolated from Food with Genus-Specific 16S rRNA-Targeted Probes by
Colony Hybridization and PCR. Applied and Environmental Microbiology 63(4): 1268–1273
· Kirjavainen P.V., Apostolou E., Arvola T., Salminen S.J., Gibson G.R. and Isolauri E. (2001).
Characterizing the composition of intestinal microflora as a prospective treatment target in infant
allergic disease. FEMS Immunology and Medical Microbiology 32:1-7
· Klaenhammer T., Altermann E., Arigoni F., Bolotin A., Breidt F., Broadbent J., Cano R., Chaillou
S., Deutscher J., Gasson M., van de Guchte M., Guzzo J., Hartke A., Hawkins T., Hols P.,
Hutkins R., Kleerebezem M., Kok J., Kuipers O., Lubbers M., Maguin E., McKay L., Mills
D., Nauta A., Overbeek R., Pel H., Pridmore D., Saier M., van Sinderen D., Sorokin A., Steele
J., O’Sullivan D., de Vos W., Weimer B., Zagorec M. & Siezen R. (2002). Discovering lactic
acid bacteria by genomics. Antonie Van Leeuwenhoek International Journal of General and
Molecular Microbiology 82(1-4):29-58.
· Konstantinov S.R., Zhu W.-Y., Williams B.A., Tamminga S.,. de Vos W.M. and Akkermans
A.D.L. (2003). Effect of fermentable carbohydrates on piglet faecal bacterial communities as revealed
by denaturing gradient gel electrophoresis analysis of 16S ribosomal DNA. FEMS Microbiology
Ecology 43:225-235
· Lee Y.-J., Yu W.-K. and Heo T.-R. (2003). Identification and screening for antimicrobial activity
against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy
infant faeces. International Journal of Antimicrobial Agents. 21(4):340-346.
67
Overview of the literature           References
· Leisner J.J., Vancanneyt M., Rusul G., Pot B., Lefebvre K., Fresi A. and Tee L.K. (2001).
Identification of lactic acid bacteria constituting the predominating microflora in an acid-fermented
condiment (tempoyak) popular in Malaysia. International Journal of Food Microbiology 63:149–
157.
· Lilley D.M. and Stillwell R.H. (1965). Probiotics: growth promoting factors produced by
microorganisms, Science 147:747-748.
· Lyhs U., Korkeala H. and Bjorkroth J. (2002). Identification of lactic acid bacteria from spoiled,
vacuum-packaged ‘gravad’ rainbow trout using ribotyping. International Journal of Food
Microbiology 72:147– 153.
· Lucas J. (2002). EU-funded research on functional foods. British Journal of Nutrition 88(S):S131-
S132
· Manero A. and Blanch A.R. (2002). Identification of Enterococcus spp. based on specific hybridisation
with 16S rDNA probes. Journal of Microbiological Methods 50:115– 121
· Mannu L., Riu G., Comunian R., Fozzi M.C. and Scintu M.F. (2002). A preliminary study of lactic
acid bacteria in whey starter culture and industrial Pecorino Sardo ewes’ milk cheese: PCR-
identification and evolution during ripening. International Dairy Journal 12:17–26.
· Marteau P., de Vrese M., Cellier C. and Schrezenmeir J. (2001). Protection from gastrointestinal
disease with the use of probiotics. The American Journal of Clinical Nutrition 73(S):430S-436S.
· Marteau P., Seksik P. and Jian R. (2002). Probiotics and intestinal health effects: a clinical
perspective. British Journal of Nutrition 88(S1):S51-S57.
· Marteau P. Safety aspects of probiotic products. Scandinavian Journal of Nutrition. In press
· Masco L., Huys G., Gevers D., Verbrugghen L. and Swings J. Identification of Bifidobacterium
species using rep-PCR fingerprinting. Submitted to Systematic and Applied Microbiology.
· Matsuki T., Watanabe K., Tanaka R. and Oyaizu H. (1998). Rapid identification of human intestinal
bifidobacteria by 16S rRNA-targeted species- and group-specific primers. FEMS Microbiology
Letters 167:113-121.
· McCartney A.L. (2002). Application of molecular biological methods for studying probiotics and
the gut flora. British Journal of Nutrition 88:S29-S37.
· Menrad K. (2002). Market and marketing of functional food in Europe. Journal of Food Engineering
56(2-3):181-188
· Meroth B., Walter J., Hertel C., Brandt M.J. and Hammes W.P. (2003). Monitoring the Bacterial
Population Dynamics in Sourdough Fermentation Processes by Using PCR-Denaturing Gradient
Gel Electrophoresis. Applied and Environmental Microbiology 69(1): 475–482.
· Metchnikoff E. (1907). The prolongation of life, Heinemann, London.
· Mercenier A., Pavan S. and Pot B. (2003). Probiotics as biotherapeutic agents: Present knowledge
and future prospects. Current Pharmaceutical Design 8:99-110.
68
Overview of the literature           References
· Miambi E., Guyot J.P. and Ampe F. (2002). Identification, isolation and quantification of
representative bacteria from fermented cassava dough using an integrated approach of culture-
dependent and culture-independent methods. International Journal of Food Microbiology 82(2):111-
120.
· Myllärinen P., Forssell P., von Wright A., Alander M. and Matilla-Sandholm T. (1998). The use
of starch as a capsulation material for lactic acid bacteria. In. Matilla-Sandholm, T. and Kauppila,
T. (Eds.) Functional Food Research in Europe, 3rd workshop, FAIR CT96-1028. PROB-DEMO,
VTT Symposium 187, Haikko, Finland, p. 91.
· Muyanja C., Narvhus J.A., Treimo J. and Langsrud T. (2003). Isolation, characterisation and
identification of lactic acid bacteria from bushera: a Ugandan traditional fermented beverage.
International Journal of Food Microbiology 80:201– 210.
· Muyzer G., de Waal E.C. and Uitterlinden A.G. (1993). Profiling of complex microbial populations
by denaturing gradiënt gel electrophoresis analysis of polymerase chain reaction-amplified genes
coding for 16S rRNA. Applied and Environmental Microbiology 59:695-700.
· Muyzer G. (1999). DGGE/TGGE a method for identifying genes from natural ecosystems. Current
Opinions in Microbiology 2:317-322.
· Naidu A.S., Bidlack W.R. and Clemens R.A. (1999). Probiotic spectra of lactic acid bacteria (LAB).
Critical Reviews of Food Science and Nutrition 39:13-126.
· Nomura M., Kobayashi M. and Okamoto T. (2002). Rapid PCR-Based Method Which Can
Determine Both Phenotype and Genotype of Lactococcus lactis Subspecies. Applied and
Environmental Microbiology 68(5):2209–2213
· Nubel U., Engelen B., Felske A., Snaidr J., Wieshuber A., Amann R.I., Ludwig W. and Backhaus
H. (1996). Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa
detected by temperature gradient gel electrophoresis. Journal of Bacteriology 178(19):5636-5643.
· Olive D.M. and Bean P. (1999). Principles and applications of methods for DNA-beased typing of
microbial organisms. Journal of clinical Microbiology 37(6):1661-1669.
· ONFS Committee (1994). Committee on Opportunities in the Nutrition and Food Sciences. Food
and Nutrition Board, Institute of Medicine. Eds. Thomas P.R. en Earl R. Opportunities in the nutrition
and food sciences, research challenges and the next generation of inverstigators. Washington D.C.,
National Academy Press.
· O’Sullivan D.J. (1999). Methods for analysis of the intestinal microflora. In: Probiotics. A critical
review. pp. 23-44. (Ed. G.W. Tannock) Norfolk, UK: Horizon Scientific Press.
· Ouwenhand A.C., Salminen S. and Isolauri E. (2002). Probiotics: an overview of beneficial effects.
Antonie van Leeuwenhoek 82:279-289.
· Pascal G. (2003). Relationship between scientific and legislative aspects of new functional ingredients
and foods. NFIF2003, Copenhagen, 9-11 April 2003.
· Perdigón G., de Macías M.E., Alvarez S., Oliver G. and de Ruiz Holgado A.A. (1998). Systematic
augmentation of the immune respons in mice by feeding fermented milks with Lactobacillus casei
and Lactobacillus acidophilus. Immunology 63:17-23.
69
Overview of the literature           References
· Plant L., Lam C., Conway P.L. and O’Riordan K. (2003). Gastrointestinal microbial community
shifts observed following oral administration of a Lactobacillus fermentum strain to mice. FEMS
Microbiology Ecology 43:133-140.
· Pot B., Ludwig W., Kersters K. and Schleifer K.-H. (1994). Taxonomy of lactic acid bacteria. In:
De Vuyst L., Vandamme E.J. (Eds.) Bacteriocins of lactic acid bacteria; Microbiology, genetics
and applications. Chapman and Hall, London, UK, pp. 13-90.
· Rafter J. (2002). Lactic acid bacteria and cancer: mechanistic perspective. British Journal of Nutrition
88(S1):S89-S94.
· Randazzo C.L., Torriani S., Akkermans A.D.L., de Vos W.M. and Vaughan E.E. (2002). Diversity,
dynamics, and activity of bacterial communities during production of an artisanal sicilian cheese
as evaluated by 16S rRNA analysis. Applied and Envrionmental Microbiology 68(4):1882-1892.
· Reid G., Araya M., Morelli L., Sanders M.E., Stanton C., Pineiro M. and Ben Embarek P.
(2002). Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of
Probiotics in Food. London Ontario, Canada, April 30 and May 1, 2002.
· Reuter G. (1997). Present and future of probiotics in Germany and in Central Europe. Bioscience and
Microflora 16:43-51.
· Rigottier-Gois L., Le Bourhis A.-G., Gramet G., Rochet V. and Dore J. (2003). Fluorescent
hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the
composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiology
Ecology 43:237-245.
· Roy D. (2001). Media for the isolation and enumeration of bifidobacteria in dairy products.
International Journal of Food Microbiology 69:167-182.
· Saarela M., Mogensen G., Fondén R., Mättö J. and Matilla-Sandholm T. (2000). Probiotic bacteria:
safety, functional and technological properties. Journal of Biotechnology 84:197-215.
· Salminen S., Isolauri E. and Salminen E. (1996). Clinical uses of probiotics for stabilizing the gut
mucosal barrier: Succesfull strains for future challenges. Antonie Van Leeuwenhoek 70:347-358.
· Salminen S., Von Wright A., Morell L., Marteau P., Brassart D., De Vos W. M., Fonden R.,
Saxelin M., Collins K., Mogensen G., Birkeland S.E. and Mattila-Sandholm T. (1998a).
Demonstration of Safety of Probiotics - a Review. International Journal of Food Microbiology
44:93-106.
· Salminen S., Bouley C. and Boutron-Ruault M.C. (1998b). Functional food science and
gastrointestinal physiology and function. British Journal of Nutrition 80(S):S147-S171.
· Sanders M.E. and Huis in’t Veld J. (1999). Bringing a probiotic-containing functional food to the
market: microbiological, product, regulatory and labeling issues. Antonie Van Leeuwenhoek
International Journal of General and Molecular Microbiology 76:293-315.
· Sartor R.B. (1995). Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s
disease. Gastroenterology Clinics of North America 24:475-507.
· Sato H., Yanagida F., Shinohara T. and Yokotsuka K. (2000). Restriction fragment length
polymorphism analysis of 16S rRNA genes in lactic acid bacteria isolated from red wine. Journal
of Bioscience and Bioengineering 90(3):335-337.
70
Overview of the literature           References
· SCAN (2000): Report of the Scientific Committee on Animal Nutrition on the Safety of Use of
Bacillus Species in Animal Nutrition. European Commission Health & Consumer Protection
Directorate-General. http://europa.eu.int/comm/food/fs/sc/scan/out41.pdf
· Schrezenmeier J. and de Vrese M. (2001). Probiotics, prebiotics and synbiotics – approaching a
definition. The American Journal of Clinical Nutrition 73(2):361S-364S.
· Shanahan F. (2002). Probiotics and inflammatory bowel disease: from fads and fancy to facts and
future. British Journal of Nutrition 88(S1):S5-S9.
· Sohier D. and A. Lonvaud-Funel. (1998). Rapid and sensitive in situ hybridization method for
detecting and identifying lactic acid bacteria in wine. Food Microbiology 15:391-397.
· Stanton C., Gardiner G., Meehan H., Collins K., Fitzgerald G., Lynch P. B. and Ross R.P. (2001).
Market Potential for Probiotics. American Journal of Clinical Nutrition 73:476S-483S.
· Steidler L. (2002) In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie
Van Leeuwenhoek International Journal of General and Molecular Microbiology 82(1-4):323-
331.
· Sütas Y., Hurme M. and Isolauri E. (1996). Downregulation of antiCD3 antibody-induced IL-4
production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes. Scandinavian
Journal of Immunology 43:687-689.
· Svensson U. (1999). Industrial perspectives. In. Tannock G.W. (Ed.) Probiotics: A critical review.
Horizon Scientific Press. Wymondham, pp. 57-64.
· Threlfall E., Ward L, Frost J. and Willshaw G. (2000). The emergence and spread of antibiotic
resistance in food-borne bacteria. International Journal of Food Microbiology 62:1-5.
· Tilsala-Timisjärvi A. and Alatossava T. (1997). Development of oligonucleotide primers from the
16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria
by PCR. International Journal of Food Microbiology 35:49-56.
· Torriani S., Clementi F., Vancanneyt M., Hoste B., Dellaglio F. and Kersters K. (2001).
Differentiation of Lactobacillus plantarum, L. pentosus and L-paraplantarum species by RAPD-
PCR and AFLP. Systematic and Applied Microbiology 24(4):554-560.
· Tuomola E.M. and Salminen S. (1998). Adhesion of some probiotic and dairy Lactobacillus strains
to Caco-2 cell cultures. International Journal of Food Microbiology 41:45-51.
· Vandamme P., Pot B., Gillis M., DeVos P., Kersters K. and Swings J. (1996). Polyphasic taxonomy,
a consensus approach to bacterial systematics. Microbiological Reviews. 60(2):407.
· Vandenplas Y. (1999). Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea.
Part I. Bacteria. Clinical Microbiological Infections 5:299-307.
· Vaughan E.E., de Vries, M.C., Zoetendal E.G., Ben-Amor K., Akkermans A.D.L. and de Vos
W.M. (2002). The intestinal LABs. Antonie Van Leeuwenhoek International Journal of General
and Molecular Microbiology 82(1-4):341-352.
· Ventura M. and Zink R. (2002). Specific identification and molecular typing analysis of Lactobacillus
johnsonii by using PCR-based methods and pulsed-field gel electrophoresis. FEMS Microbiology
Letters 217(2):141-154.
71
Overview of the literature           References
· Versalovic J., Schneider M., De Bruijn F.J. and Lupski J.R. (1994). Genomic fingerprinting of
bacteria using repetitive sequence-based polymerase chain reaction. Methods in Molecular Cell
Biology 5:25-40.
· Walter J., Hertel C., Tannock G.W., Lis C.M., Munro K. and Hammes W.P. (2001). Detection of
Lactobacillus, Pediococcus, Leuconostoc, and Weissella Species in Human Feces by Using Group-
Specific PCR Primers and Denaturing Gradient Gel Electrophoresis. Applied and Environmental
Microbiology 67(6):2578–2585.
· Weststrate J., van Poppel G. and Verschuren P.M. (2002). Functional foods, trends and future.
British Journal of Nutrition 88(S):S233-S235.
· Wijtzes T., Bruggeman M.R., Nout M.J.R. and Zwietering M.H. (1997). A computerised system
for the identification of lactic acid bacteria. International Journal of Food Microbiology 38:65–70.
· Wood B.J.B. (1998). Microbiology of fermented foods. Blackie Academic & Professional, London.
· Yeung P., Sanders M.E., Kitts C.L., Cano R. and Tong P.S. (2002). Species-specific identification
of commercial probiotic strains. Journal of Dairy Science 85(5):1039-1051
· Yuki N., Watanabe K., Mike A., Tagami Y., Tanaka R., Ohwaki M. and Morotomi M. (1999).
Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: Selective
isolation from faeces and identification using monoclonal antibodies. International Journal of Food
Microbiology 48:51–57.
· Zoetendal E.G., Akkermans A.D.L. and De Vos W.M. (1998). Temperature Gradient Gel
Electrophoresis Analysis of 16S rRNA from human fecal samples reveals stable and host-specific
communities of active bacteria. Applied and Environmental Microbiology 64:3854-3859.
· Zoetendal E.G., von Wright A., Vilpponen-Salmela T., Ben-Amor K., Akkermans A.D.L. and de
Vos W.M. (2002). Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly
Distributed along the Colon and Differ from the Community Recovered from Feces. Applied and
Environmental Microbiology 68(7):3401–3407.
————————————————————————
Part 2
Experimental Work

77
Part 2: Experimental work
Chapter 4: Culture-dependent microbial analysis of probiotics
4.1. Identification and antibiotic susceptibility of probiotic isolates
This study describes the isolation of bacteria from 55 European probiotic products,
followed by their identification using protein profiling and the determination of their
susceptibility to six antibiotics.
4.2. GI-tract survival capacity and hydrophobicity of probiotic isolates
A selection of 18 isolates representing 12 probiotic species was evaluated towards
GI-tract survival capacity and hydrophobicity, as an indicator for potential adhesion.
Chapter 5: Culture-independent microbial analysis of probiotics
5.1. Development and optimization of Denaturing Gradient Gel Electrophoresis
The research in this section aimed the optimization of the DGGE technique in
order to come to a culture-independent microbial analysis method for probiotic
products on the qualitative level. A comparison with culture-dependent analysis
was made using 10 probiotic products.
5.2.  Nested-PCR DGGE for the microbial analysis of bifidobacterial communities
This study further optimizes DGGE as an identification method for the species-
specific detection of bifidobacteria in various ecosystems, as demonstrated for
fecal samples.
5.3.  Real-time PCR DGGE
The coupling of real-time PCR to DGGE allows the complete culture-independent
microbial analysis of probiotic products, both on a quantitative as well as qualitative
level.
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Summary
In the present study, a total of 55 European probiotic products were evaluated with regard to
the identity and the antibiotic resistance of the bacterial isolates recovered from these products.
Bacterial isolation from 30 dried food supplements and 25 dairy products, yielded a total of 268
bacterial isolates selected from several selective media. Counts of food supplements showed
bacterial recovery in 19 (63%) of the dried food supplements ranging from 103 to 106 CFU/g, whereas
all dairy products yielded growth in the range of 105 to 109 CFU/ml. After identification of the isolates
using whole-cell protein profiling, mislabeling was noted in 47% of the food supplements and 40%
of the dairy products. In six food supplements, Enterococcus faecium was isolated whereas only
two of those products claim this species on their label. Using the disc diffusion method, antibiotic
resistance among 187 isolates was detected against kanamycin (79% of the isolates), vancomy-
cin (65%), tetracycline (26%), penicillinG (23%), erythromycin (16%) and chloramphenicol (11%).
Overall, 68.4% of the isolates showed resistance against multiple antibiotics including intrinsic
resistances. Initially, 38% of the isolated enterococci were classified as vancomycin resistant us-
ing the disc diffusion method, whereas additional phenotypical and PCR assays clearly showed
that all E. faecium isolates were in fact vancomycin sensitive.
Keywords: Probiotics, Label Correctness, Identification, Antibiotic Susceptibility Testing
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Introduction
The past five years have witnessed a strong expansion of the probiotic market and, in
parallel, a rise in the number of research projects addressing fundamental and applied aspects
of probiotics. New research technologies have supported earlier suggestions of health
promoting properties of probiotic lactic acid bacteria (LAB) (reviewed by Naidu et al., 1999)
including stabilisation of the intestinal microflora by competition against pathogens (Gibson et
al., 1997), reduction of lactose intolerance (de Vrese et al., 2001), prevention of antibiotic
induced diarrhoea (Pochapin, 2000), prevention of colon cancer (Wollowski et al., 2001), and
stimulation of the immune system (Isolauri et al., 2001). Bringing a probiotic to the market
involves a step-wise process that needs to be carefully monitored in order to obtain a correctly
labeled, functional, and safe product (Sanders and Huis in’t Veld, 1999; Saarela et al., 2000).
If a product is not labeled correctly, safety and functionality cannot be guaranteed due to lack
of documentation of the product components. However, as many manufacturers rely on the
widely acknowledged but occasionally debated GRAS (‘generally regarded as safe’) status of
lactobacilli and bifidobacteria (Salminen et al., 1998), characterization of probiotic LAB strains
with regard to taxonomic status, antibiotic resistance, and virulence may sometimes be
neglected.
Microbial analyses of probiotic dairy products have demonstrated that the identity and
the number of recovered species do not always correspond to the information stated on the
product label (Reuter, 1997; Holzapfel et al, 1998; Hamilton-Miller et al., 1999). However, it
should be noted, that each of the cited studies were rather limited in number and type of
products or were mainly restricted to national products. Various opinions exist as to whether
it might be desirable that some probiotic strains show resistance to specific antibiotics that
are for instance involved in antibiotic-induced diarrhea (Charteris et al., 1998). On the other
hand, the commercial introduction of probiotics containing antibiotic resistant strains may
also have negative consequences, for example, when resistance is transferred to intestinal
pathogens (Curragh and Colins, 1992).
In the current paper, an extensive study is presented to verify the label correctness of
a range of European probiotic food supplements and dairy products, together with the antibiotic
susceptibility testing of the product isolates. For each of these products, the label information
was checked through taxonomic characterisation of the recoverable bacterial strains using
whole-cell protein profiling. In addition, individual susceptibilities were determined for a selection
of six antimicrobial agents.
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Material and Methods
Bacterial isolation. A total of 55 probiotic products, collected in eight European
countries, comprised 30 dried food supplements (Table 1) and 25 dairy products (Table 2).
Dairy products were collected using a refrigerated box. None of the 55 products had exceeded
their expiry date. All products were examined using a set of four isolation media under
standardized cultivation conditions. For the isolation of Lactobacillus and Lactococcus strains,
De Man Rogosa and Sharpe Agar (MRSA) medium (CM361, Oxoid, Basingstoke, UK) was
used, whereas streptococci and enterococci were isolated on M17 medium (CM785, Oxoid)
and on Kanamycine Aesculine Azide Agar Base (KAAAB)(CM591, Oxoid) respectively. For the
isolation of bifidobacteria, Trans-Galacto-Oligosaccharides (TOS) medium (Matsuki et al.,
1999) was used with the following composition: 10g Trypticase Soy Broth (81-1768-0, Becton
Dickinson, Sparks, USA), 1g Yeast Extract (L21, Oxoid), 3g KH2PO4 (1627, Vel, Leuven,
Belgium), 4.8g K2HPO4 (1628, Vel), 3g (NH4)2SO4 (1.01217.1000, Merck, Darmstadt,
Germany), 0.2g MgSO4-7H2O (1433, Vel), 0.5g L-cystein hydrochloride (C4820, Sigma, Bornem,
Belgium), 15g Na-propionate (P1880, Sigma), 10g Transgalacto-OligoSaccharides (TOS,
Honsha, Tokyo, Japan) and 15g agar (L11, Oxoid) dissolved in 1000 ml of distilled water.
Products were sampled by preparing 10-fold dilutions of 100 µl of the dairy products or 100
mg of the food supplements in 10 ml pepton-physiological solution (PPS). A total of 50 µl of
each dilution was plated in triplicate on all media, using the Whitley Automatic Spiral Plater
(WASPTM; Led Techno, Eksel, Belgium). All plates were incubated at 37°C under aerobic
conditions, except for TOS plates that were incubated anaerobically (80% N2, 10% H2 and
10% CO2) using an anaerobic chamber. After incubation for 48h, colony counts were performed
and 3-5 colonies were picked based on different colony morphologies. Selected colonies were
further purified on MRSA medium except that those recovered from TOS medium were cultured
on Modified Columbia Agar (MCA) comprising 23g special pepton (L72, Oxoid), 1g soluble
starch (1.01252.0250, Merck), 5g NaCl (1.06404.1000, Merck), 0.3g cystein-HCl-H2O, 5g
glucose (500520-887, Vel) and 15g agar dissolved in 1000 ml of distilled water. The latter
medium was also used in a second screening round of products that claimed bifidobacteria
on their labels, but did not produce any Bifidobacterium strain on the TOS medium during the
first isolation round. Products that did not yield any isolates, were again screened, now using
anaerobic and micro-aerophilic (3,5% CO2, 5% O2, 7,5% H2, 84% N2) cultivation conditions. In
addition, these products were subjected to an enrichment step in MRS broth (CM359, Oxoid)
using the same aerobic and anaerobic incubation conditions.
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Identification of recovered isolates. Isolates were identified by Sodium Dodecyl
Sulphate –Polyacrylamide Gelelectrophoresis (SDS-PAGE) analysis of whole-cell proteins,
using standardized cultivation conditions for comparison with the available protein pattern
database of lactic acid bacteria (Pot and Janssens, 1993). Extraction of cellular proteins was
performed according to the method described by Pot et al. (1994) for Gram-positive bacteria.
Extracts were separated using SDS-PAGE with a 5% total acrylamide stacking gel (12 mm
long) and a 12% total acrylamide separation gel (126 mm long) . Gels were stained using
Coomassie Blue R-250. The patterns were then densitometrically digitized using an LKB 2202
Ultrascan Laser Densitometer (LKB, Bromma, Sweden). Subsequently, these digital protein
patterns were normalized using GelCompar software (Applied Maths, Sint-Martens-Latem,
Belgium) so it became possible to identify the isolates by comparison of their protein patterns
with the SDS-PAGE protein pattern database available at the laboratory. Upon repeated
analyses, the inter-gel and intra-gel reproducibility was found to be 90.3% and 97.1%,
respectively. Furthermore, the average correlation between reference patterns and the database
standard was 95.3%, clearly surmounting the 94% limit for reliable identification.
Antibiotic susceptibility testing. At least one isolate per identified species recovered
from a given product was included for antibiotic susceptibility testing, resulting in 187 isolates
screened for possible resistance against a selection of six antibiotics, including kanamycin
(30 µg), vancomycin (30 µg), erythromycin (10 µg), tetracycline (30 µg), chloramphenicol (30
µg) and penicillinG (10 µg) using a slightly modified version of the agar disc diffusion method
(Kirby-Bauer, 1966). Strains were grown in MRS broth (Oxoid, CM 359) for 48h at 37°C.
Following the preparation of a 10-fold dilution in PPS, freshly poured MRSA plates were equally
inoculated with this dilution. Antibiotic discs (Oxoid, Basingstoke, UK) were placed on the
inoculated plates using the Oxoid Disc Dispenser. Following a 24h incubation at 37°C, inhibition
zones around the discs were measured using a digital callipers (Mauser, Switzerland). Results
were interpreted according to the cut-off levels proposed by Charteris and co-workers (1998)
with strains considered resistant if inhibition zone diameters were equal to or smaller than 19
mm for penicillinG, 14 mm for vancomycin and tetracycline, and 13 mm for kanamycin,
chloramphenicol and erythromycin.
In addition to the agar disc-diffusion method, two other methods were used to confirm
the presence of vancomycin resistance in enterococci. First, by growing the enterococci in a
series of Trypticase Soy Broth (L21, Oxoid) Yeast Extract (211768, Becton Dickinson) (TSYE)
tubes containing different concentrations of vancomycin or teicoplanin, the MIC (Minimal
Inhibitory Concentration) for these antibiotics was determined according the protocol as
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described by Arthur and Courvalin (1993). The combination of the MIC value obtained for both
antibiotics is considered indicative for the preliminary classification as to what extent a strain
is vancomycin resistance. In a second approach, the presumptive presence of vancomycin
resistance was assessed, using a PCR protocol according to Dutka-Malen and co-workers,
(1995) with primer pairs (A1, A2 and B1, B2) specific for the vancomycin resistance genes
vanA and vanB.
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Results
Bacterial isolation from probiotic products. Depending on the medium used, colony
counts of the 25 investigated dairy products ranged from 105 CFU/ml to 109 CFU/ml. Among
the 30 food supplements tested in this study, counts varied from 0 to 106 CFU/g. During a first
isolation round, we were unable to isolate viable bacteria out of 12 (i.e. 40%) of the food
supplements. These products were subjected to a second isolation round including an
enrichment step in MRS broth and applying anaerobic as well as micro-aerophilic conditions.
Only one of these 12 products displayed bacterial growth in MRSB but again not on MRS agar
plates. At the end of the two isolation rounds, a total of 323 isolates were obtained. All isolated
genera with exception of Bifidobacterium grew on all media used. However, it was noted that
lactobacilli and enterococci grew best on MRSA and KAAAB, streptococci grew best on M17
and TOS, and bifidobacteria only grew on TOS.
Identification of recovered isolates. Identification results are presented in Tables 1
and 2. From a total of 323 isolates, 268 bacteria could be identified at the species level. The
remaining 55 isolates were classified as yeasts after microscopical investigation or were lost
during purification on MRSA medium. Only six products yielded all species indicated on the
product label. However, when disregarding the presence of the yoghurt components
Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus, this number of
products rises to thirteen. In 19 products the isolated species were entirely different from
those mentioned on the product label, even after a second isolation round using a new batch
of the same products. In Table 3, a brief summary is given of the isolation and identification
results. The most frequently recovered species among the food supplements was
Enterococcus faecium followed by Lactobacillus rhamnosus. Of the 6 products in which E.
faecium was found, only two actually claimed this species on their label. Lactobacillus
acidophilus, which was claimed on the label of 22 food supplements, could only be isolated
out of 2 of these products. Although all 13 food supplements claiming bifidobacteria were
screened twice using two different media for the selective isolation of Bifidobacterium (TOS
and MCA), only 3 of these 13 products produced a bifidobacterial strain. Among the 25 dairy
products, Lactobacillus acidophilus was claimed, as well as isolated most frequently. As it
was the case with the food supplements, only a poor retrieval of bifidobacteria was possible
among the dairy products, despite the use of two different media. Only two out of 14 dairy
products claiming bifidobacteria actually produced a Bifidobacterium strain during isolation.
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Antibiotic susceptibility. Of the 268 identified isolates, 187 strains were subjected to
antibiotic susceptibility testing using the agar disc diffusion method of which the results are
presented in Table 4. It was found that 79% and 65% of the isolates were resistant to kanamycin
and vancomycin, respectively. Furthermore, 23% and 21% of the isolates were grouped as
resistant or intermediately resistant, respectively, to penicillin. Concerning the other antibiotics,
the intermediate resistant fraction was never larger than 6,5%. It was also found that 38% of
the isolated enterococci were vancomycin resistant according to the disc diffusion method.
These resistant enterococci originated from 4 dried food supplements. However, when using
the dilution method and a PCR assay for confirmation, none of the presumptively vancomycin
resistant Enterococcus strains were found to be resistant against vancomycin (MIC < 2 µg/
ml).
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Table 3: Summary of isolation and identification results
Description Food supplements Dairy Products
Number of products 30 25
· from which no viable strains could be isolated 11 (37%) 0
· containing all claimed species 4/30 (13%) 2 (8%)
· containing other species than those claimed 9/19 (47%) 10 (40%)
· claiming more species than found 22/30 (73%) 16 (64%)
Most frequently claimed species L. acidophilus L. acidophilus
Most frequently isolated species E. faecium, S. thermophilus,
L. rhamnosus  L. acidophilus
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Discussion
Considering the significant rise in the annual consumption of probiotic products
worldwide, it is of paramount importance that these products are labeled correctly and that
the probiotic strains are well-documented regarding safety and functionality (Sanders and
Huis in’t Veld, 1999). Hitherto, in Europe, there are no widely acknowledged regulations
concerning the labeling issues and claims that can be made by the manufacturers of functional
foods (Berner et al., 1998; Przyrembel, 2001). Our findings clearly indicate the need for such
regulations. Although freeze- or spray-dried cultures should yield probiotic products with a
high concentration of viable bacteria, counts were subtantially lower among the 30 food
supplements compared to the 25 dairy products. Possibly, higher isolation numbers could
have been obtained when positive food supplements were processed using anaerobic isolation
conditions. However, it can be speculated that the significant difference in relative numbers
between the two main types of products (i.e. dried food supplements and dairy products) will
not be affected by incubation under aerobic or anaerobic conditions. Therefore, it is possible
that a number of the investigated food supplements may comprise a bacterial concentration
below the minimum value required for any probiotic strain to affect the gastro-intestinal tract
and thus to be able to promote a significant health effect. Using our protocol, a total of 11 food
supplements (37%) did not yield any viable bacteria on the four isolation media. It can be
speculated that the absence of living bacteria in a dried food supplement is due to low
efficiencies of the drying and capsulation process, the possibility that some of these food
supplements were sterilised for safety reasons, or because of a too long shelf-life period. The
products investigated had not yet reached the expiry date at the moment of the isolation
procedure. A product is designed to be of good quality upto the date of expiry, therefore the
moment within its shelf life at which the analysis was performed, should have no reflection on
the results obtained. Although some immunological activities have been assigned to dead
bacteria (Wagner et al., 2000), many health promoting properties, e.g. competitive exclusion
of pathogens, nutrient supplementation for the host, and anti-tumor effects can only be exerted
by living bacteria (Ouwehand and Salminen, 1998). Given the present findings, it is therefore
more likely for dairy products to exert these probiotic properties than it is for dried food
supplements. No data on the viability and numbers of bacteria in the product at the time of
consumption could be deduced from the product labels.
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Identification of 268 isolates using protein profiling revealed that Enterococcus faecium
was the most frequently recovered species out of the food supplements. This taxon was
found in 6 out of the 19 food supplements (32%) containing living bacteria. With the exception
of one product, E. faecium was the only species isolated out of these food supplements (Table
1). Because of the high isolation numbers (104 – 105 CFU/g), it is unlikely that E. faecium
entered the production process via contamination. The second most frequently recovered
species in food supplements was Lactobacillus rhamnosus followed by Lactobacillus
acidophilus which was claimed to be present in 22/30 (73%) products but was only found
twice (Table 1). Although a poorer growth was observed for L. acidophilus on MRSA medium
compared to Lb. rhamnosus, Lb. casei and E. faecium, the relatively low recovery rate of the
former species cannot be clearly explained. Likewise, the poor retrieval of bifidobacteria could
not readily be explained because isolation results were comparable after testing various isolation
parameters, e.g. atmosphere, temperature and duration of incubation (data not shown). More
likely, it is possible that the nutritional content of the TOS and MCA medium used in this study
did not meet the specific growth requirements of a number of probiotic bifidobacterial strains.
Therefore, it can be speculated that more products claiming bifidobacteria may have produced
these organisms during isolation, when a series of well-defined strain-specific media were
used. The need for broad-spectrum isolation media for bifidobacteria is clearly demonstrated
by this study and has also been suggested by Roy (2001). Among the tested food supplements,
a total of 9 products contained species other than those stated on the product label. This
mislabeling has also been reported previously by Hoa et al. (2000) for Bacillus containing food
supplements and by Hamilton-Miller et al. (1999) for twenty out of 29 tested food supplements.
Since Streptococcus thermophilus and Lb. delbrueckii subsp. bulgaricus are the main
composites of yoghurt, it could be expected that these two species were among the most
frequently isolated ones from the dairy products. However, Lb. delbrueckii subsp. bulgaricus
was only found once possibly because this species is rapidly overgrown by other lactobacilli
in the dairy products. The fact that Lb. acidophilus was more easily isolated from dairy products
than from food supplements, could be related to (1) the supporting matrix of the product in
which the strains have to survive for the complete shelf-life, (2) the ambient temperature at
which the different products are usually maintained, (3) the total shelf-life (average of 30 days
for dairy products, average of 24 months for food supplements) or (4) to the individual strain
differences with respect to survival in the stationary phase at the given temperature. Fourteen
dairy products also claim to contain bifidobacteria, whereas in only two instances,
Bifidobacterium lactis was recovered instead of the claimed Bf. longum. As outlined above,
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the low recovery of bifidobacteria might be due to the lack of optimal isolation media for specific
Bifidobacterium strains. Although to a lesser extent than with food supplements, our results
suggest that also quite a number of dairy products suffer from mislabeling, which underscores
similar findings of other workers (Reuter, 1997; Holzapfel et al., 1998; Hamilton-Miller et al.,
1999).
Using the disc diffusion method, high frequencies of resistance were detected for
kanamycin (79%) and vancomycin (65%). Most of the kanamycin resistant isolates belonged
to the genera Lactobacillus and Enterococcus. The latter genus is intrinsically resistant against
kanamycin (Franz et al., 1999), but the finding that 81% of the isolated lactobacilli were also
resistant against kanamycin somewhat counteracts the specificity of the Enterococcus-
specific KAAAB medium. Likewise, the relatively high percentage of vancomycin resistance
observed amongst the entire collection of isolates is due to the fact that the majority of the
lactobacilli are intrinsically resistant to this glycopeptide (Nelson, 1999). Noteworthy,
intraspecific variations were found among the Lb. johnsonii and Lb. acidophilus isolates, which
is in agreement with previous observations of Charteris and co-workers (1998). Strikingly,
38% of the Enterococcus faecium isolates also showed to be resistant against vancomycin
according to the disc diffusion method. However, these findings could not be confirmed by the
dilution method (Arthur and Courvalin, 1993) or by a PCR-based van gene detection assay
(Dutka-Malen et al., 1995). Collectively, these findings demonstrate that all enterococci isolated
from probiotic products were susceptible to vancomycin, which again highlights the limited
reliability of the disc diffusion method to determine the occurrence of vancomycin resistance
with enterococci (Swenson et al., 1989). The high frequencies of vancomycin resistance found
among other lactic acid bacterial genera does not pose a problem as this type of vancomycin
resistance is different from the inducible, transferable mechanism observed in enterococci
(Salminen et al. 1998; Klein et al., 2000). The lactobacilli in the present study comprised strains
resistant to tetracycline (29.5%) chloramphenicol (8.5%), and erythromycin (12%) and  overall,
more than 68% of our isolates exhibited resistance to two or more antibiotics (data not shown),
including some intrinsic resistances. With regard to general concerns on biosafety of
probiotics, further research should focus on the location and potential transferability of these
antibiotic resistance determinants.
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In conclusion, it can be stated that quite a number of dried food supplements and - to a
lesser extent - dairy products are incorrectly or inadequately labeled with regard to the correct
identity of the incorporated probiotic strains. Despite earlier reports concerning mislabeling of
probiotic products (Reuter, 1997; Holzapfel et al., 1998, Hamilton-Miller et al., 1999), the new
data indicate that this situation has not significantly improved. Although specific antibiotic
resistance traits among probiotic strains may be desirable (Charteris et al., 1998), the finding
of tetracycline, chloramphenicol and erythromycin resistance among the investigated probiotic
isolates indicates that continuous attention should be paid to the selection of probiotic strains
free of transferable antibiotic resistance. It is of paramount importance that at a time when
consumers become more aware of the importance of good nutrition and health, probiotic
products designed especially for their health promoting purposes are safe and well-documented
in order to provide consumers with the full benefits of the remarkable aspects of probiotics.
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Introduction
Numerous studies have already demonstrated multiple beneficial features of probiotic
bacteria (Naidu et al., 1999). Although the discussion whether probiotic strains should be alive
or not in order to exert beneficial effects is ongoing, it is evident that live bacteria will certainly
facilitate health benefits impossible to result from dead bacterial cells. However, this implies
that these bacteria should also reach the site of action, i.e. large intestine, alive. To survive
passage through the stomach and small intestine, probiotic strains must tolerate the acidic
and protease-rich conditions of the stomach, and survive and grow in the presence of bile
acids. Furthermore, acid tolerance is also important for the probiotics’ survival in food (Lee
and Salminen, 1995). Yoghurts and fermented milks remain the dominant food vehicle for
probiotics; both provide a relatively low-pH environment in which the probiotic bacteria must
survive. Together with passage through the stomach, acid tolerance is thus one of the first
properties screened for when selecting probiotic strains; simple in vitro tests displaying
representative results (Tuomola et al., 2001). Similar in vitro assays examining the inhibitory
effect of bile acids on the growth of probiotic strains are also relatively simple to perform,
although, quantitative extrapolation to probiotic performance in vivo is difficult. Intraspecies
variation in the ability to grow in the presence of bile is often observed between potential
probiotic strains (Dunne et al., 2001), and in vitro tests can be used to select the best strains
on a relative basis. Once a probiotic strain has survived passage to the large intestine, an
important determinant for its functionality is the potential of the strain to adhere to mucus and/
or epithelial cells. In several studies, adhesion was related to a shortening of duration of
diarrhoea, immunogenic effects, competitive exclusion and other health effects (Salminen et
al., 1998). However, adhesion characterization through the use of cell lines may be a rather
laborious procedure and requires expertise. Because the electron donor and acceptor
properties, as well as the hydrophobicity of the bacterial cell wall have been linked to the
adhesion potential of the strain (Wadström et al., 1987, Briandet et al., 1999), these more
easy assessable characteristics represent a good alternative.
The following study applies a series of in vitro tests to screen 18 probiotic isolates,
representing 12 species, for their degree of resistance against pepsine, low pH and pancreatine,
as well as for their growth performance in the presence of bile salts. Furthermore, using the
MATS test (Boonaert et al., 2001), hydrophobicity and the electron donor and acceptor
properties of the isolates were determined, as a possible indication for their adhesive potential
(Girardin et al., 1999). These in vitro tests for selection of acid- and bile tolerant strains can
readily be applied to select probiotic strains with the highest chances towards functionality.
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Material and Methods
Strain collection. From the previous study by Temmerman and co-workers (2003)
eighteen isolates (Table 1) representing twelve different probiotic species were selected on
the basis of their identification, total counts in the source product and antibiotic susceptibility
profile.
Pepsin resistance. In combination with a low pH, the presence of the enzyme pepsin
in the stomach constitutes the first human antimicrobial barrier encountered by a probiotic
bacterium. The potential of the eighteen isolates towards passage through the stomach was
evaluated by determining the percentage of bacteria that survives inoculation in an acidic
pepsin containing solution. Bacterial strains were grown in 10 ml of MRS or M17 broth (Difco)
at 37°C during 24h after which the cell suspension was centrifuged for 5 min at 4000 rpm. The
pellet was washed 3 times in PBS buffer (pH7) and finally dissolved in 1 ml of PBS. Of this cell
suspension 200 µl was added to a series of 4 tubes containing 1 ml of filtered pepsin (Sigma)
solution at pH 2 and 300 µl of NaCl. Immediately after inoculation (T0), a 10-fold dilution series
of 100µl cell suspension from tube 1 was made in Ringer solution (Merck) and subsequently
plated on MRSA or M17 agar (Difco) for incubation at 37°C for 24h. The same procedure for
enumeration was performed for the other 3 tubes after T0 + 20 min, T0 + 40 min and T0 + 60
min, respectively.
Pancreatin resistance. The resistance of the 18 isolates against pancreatin was
assessed in a similar approach as for pepsin. After washing, 200 µl cell suspension was
added to a series of 5 tubes containing 1 ml of filtered pancreatin (Sigma) solution at pH 8 and
300 µl of NaCl. Again, dilution series for enumeration on MRSA and M17 were prepared at T0,
T0 + 20 min, T0 + 40 min, T0 + 60 min and T0 + 120 min.
Bile salt resistance. The resistance of the 18 probiotic isolates to bile salts was
determined by comparing their growth capacity in the presence and absence of a mixture of
bile salts as described by Gilliland and co-workers (1984). Bacterial strains were grown in 10
ml of MRS or M17 broth at 37°C during 24h after which two 30 ml tubes per strain of MRS or
M17 broth were inoculated with the culture until an initial OD (540 nm) between 0.05 and 0.1
was obtained. In one tube, 750 µl of a filter sterilised bile salt solution (Sigma) was added to
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obtain a final concentration of 0.3% of bile salts. Both tubes were incubated at 37°C and OD
was measured frequently until both solutions reached an OD value of 0.3. The difference in
time for both solutions to obtain this OD value is a measure for the sensitivity of the bacterium
to bile salts (Chateau et al., 1994).
Hydrophobicity test. As an indication for adhesion potential, the hydrophobicity (or
polarity) of the 18 isolates was determined by means of using 5 solvents {decane, hexadecane,
ethylacetate, xylene (Sigma) and chloroform (Merck)}. The principle of this MATS (Microbial
Adhesion To Solvents) test (Boonaert et al., 2001) is based on the partition of the bacteria
between two non-intermixible liquid phases in regard to the 5 solvents. Bacterial strains were
grown overnight in 10 ml of MRS or M17 broth at 37°C, after which the cultures were centrifuged
for 10 min at 3500 rpm at 4°C. The pellet was washed twice in 5 ml of PBS, by cetrifugation for
10 min at 3500 rpm, after which the pellet was again dissolved in 5 ml of PBS buffer. The
Optical Density (OD) measured at 540 nm (Beckman DU640B spectrophotometer (Beckman,
USA)) was set at 0.6 (OD = A0) by means of dilluting the cell suspension using PBS. In
triplicate, 3 ml of cell suspension and 250 µl of solvent were joined in a glass tube, followed by
1 min of vortexing. The mixture was set to rest during 30 min, after which the OD of 1 ml of the
watery phase was measured (OD = A). The percentage of bacteria adhering to the solvent
(hydrophobicity nature) was calculated as: (1-A/A0)x100.
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Results and Discussion
Besides health promoting effects, the functional aspect of probiotic strains also involves
their survival capacity to reach the large intestine, as well as their adhesion potential to mucus
or enterocytes. Based on the isolation, identification and antibiotic susceptibility results from
a previous study (Temmerman et al., 2003), 18 isolates representing 12 different probiotic
species were selected for the purpose of this study. Using a number of in vitro tests, all of
these strains were assessed towards their resistance against low pH, pepsin, pancreatin and
bile salts, as well as for their hydrophobic nature as a possible indication of adhesion potential.
Such in vitro studies can be employed in the selection of LAB for use in probiotic functional
foods and nutraceutical preparations (Charteris et al., 1998).
About 2.5 l of gastric juice is secreted each day having a pH of approximately 2.0 and
a salt content of no less than 0.5% w/v (Hill, 1990). In contrast, about 0.7 l of pancreatic juice
is secreted into the proximal small intestine each day having a pH of about 8.0 with a similar
salt content (Keele and Neil, 1965). These secretions present a pH and enzymatic barrier to
the survival of ingested microorganisms during digestion and act in concert with bile and
peristalsis to ensure that the resting small intestine is only heavily colonized in conditions of
stasis (Charteris et al., 1998). Nevertheless, probiotic species will need to survive this barrier
in adequate amounts in order to exert their effects in the large intestine. The potential of the
eighteen isolates towards passage through the stomach was evaluated by determining the
percentage of bacteria that survive a certain inoculation time (i.e. 0, 20, 40 and 60 min) in an
acidic pepsin containing solution (Table 1). Even after 60 min, the reduction in viability of
Lactobacillus crispatus, L. reuteri and both L. johnsonii isolates was very low, as previously
described by du Toit and co-workers (1998). Lactobacillus acidophilus and one isolate of both
the L. casei and L. plantarum isolates survived well up to 40 min and can thus be considered
tolerant to gastric juices. The remaining isolates showed considerably less survival capacity,
although all of the probiotic isolates scored considerably better than the two starter cultures L.
delbrueckii subsp. bulgaricus and S. thermophilus being very sensitive to low pH, confirming
earlier observations (Conway et al., 1987). These results clearly indicate the difference between
selected probiotic strains and starter cultures, which are sometimes considered to be probiotic
as well. Research by Charteris and colleagues (1998) has determined that for certain probiotic
strainspassage through the stomach can be enhanced by the presence of milk proteins, hereby
suggesting that milk-based products constitute an important carrier of probiotic strains.
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After the stomach, probiotic bacteria end up in the small intestine where the presence
of pancreatin together with bile salts and other enzymes form another serious barrier, although
the more neutral pH favours survival of the bacteria. Except for both L. casei isolates (R15649
in particular), all tested isolates showed high resistance against the enzym pancreatin. Also,
both starter cultures survived inoculation with pancreatin completely (Table 1). The observation
that for a number of strains the percentage of survival remounts after a certain time of incubation,
might be due to the fact that most strains are not only resistant to pancreatin, but regain their
ability to grow as well. The classification of the isolates in their resistance against bile acids
was performed according to Chateau et al., 1994: if the difference in time between a bacterial
suspension with or without bile acids to reach OD 0.3 was below 15 minutes, the isolate was
considered to be resistant to bile acids. Between 15 and 40 min, the strain is tolerant and
when the delay is longer than 60 minutes the isolate is sensitive for the presence of bile acids
(between 40 and 60 minutes we talk about weak tolerance). In Table 1  it can be seen that 6 of
the isolates are resistant to bile acids, 7 are tolerant and 5 are sensitive. As expected, the
starter cultures were sensitive, meaning that in combination with their low potential for gastric
survival, these strains are unlikely to reach the large intestine alive. The high resistance for
pancreatin, as well as the variable results among different strains for resistance to bile acids
have also been reported by Charteris and co-workers (1998) among 15 Lactobacillus and
Bifidobacterium strains. Our results show that mainly L. crispatus, L. plantarum, L. reuteri
and L. johnsonii are suitable candidates for functional food product development with regard
to their GI-tract survival capacity, although the strain-dependent nature of the results has to be
taken into account.
Wadström and colleagues (1987) suggested that the hydrophobic or hydrophyllic nature
of the bacterial cell surface may be a determinant for the adhesion potential of the strain,
which is an important criterium for colonization (Finlay and Falkow, 1997). Also the electron
donor and acceptor properties may take part in bacterial adhesion (Briandet et al., 1999). In
vitro tests have been designed and applied to address this issue (Boonaert et al., 2001),
although a clear correlation between hydrophobicity and adhesion of a probiotic strain has not
yet been found (Ouwehand et al., 1999). In this study, partitioning of the isolates into five
solvents (chloroform, decane, hexadecane, xylene and ethylacetate) was determined. An affinity
to chloroform, being an acidic solvent, reflects the reducing (alcalic) nature of the bacteria.
Affinity to ethylacetate, being an alcalic solvent, reflects the oxydising (acidic) nature of the
bacteria. Furthermore, affinity towards the apolar solvents (decane, hexadecane and xylene)
demonstrates the hydrophobic nature of the bacteria; a high hydrophobicity being linked to
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glycoproteins on the bacterial surface, and a low hydrophobicity being linked to the presence
of polysaccharides on the bacterial surface. The results presented in Table 2 show that 75%
of the strains demonstrate a clear affinity to chloroform, and that the remaining 25% is of a
more neutral character. Concerning the hydrophobic nature of the bacteria, approximately a
third of the bacteria displayed high, neutral and low affinity towards the three solvents. Although
the correlation between these results and the actual adhesion potential of the strains was not
determined, these results again demonstrate a high variability among the strains tested.
Although the relevance of some of the performed in vitro tests towards the actual in
vivo situation is not always clear, these kind of tests allow a fast indication about the main
characteristics of a certain probiotic strain. The large strain-dependent results for stomach
survival and hydrophobicity demonstrate that different strains may display substantial
differences in functionality. As a result, these in vitro as well as further in vivo tests are of
great value in selecting the most functional probiotic strain.
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Summary
In order to obtain functional and safe probiotic products for human consumption, a fast
and reliable quality control of these products is crucial. Currently, analysis of most probiotics
is still based on culture-dependent methods involving the use of specific isolation media and
the identification of a limited number of isolates, which renders this approach relatively
insensitive, laborious and time-consuming. In the current study, a collection of ten probiotic
products including four dairy products, one fruit drink and five freeze-dried products were
subjected to microbial analysis using a culture-independent approach in comparison with
conventional culture-dependent analysis. The culture-independent approach involved extraction
of total bacterial DNA directly from the product, PCR amplification of the V3 region of the 16S
rDNA, and separation of the amplicons on a Denaturing Gradient Gel Electrophoresis (DGGE)
gel. Digital capturing and processing of DGGE band patterns, allowed direct identification of
the amplicons on the species level. This whole culture-independent approach can be performed
in less than 30 hours. In comparison with culture-dependent analysis, the DGGE approach
was found to have a much higher sensitivity for the detection of microbial strains in probiotic
products in a fast, reliable and reproducible manner. Unfortunately, as reported in earlier studies
using the culture-dependent approach, a rather high percentage of probiotic products suffered
from an incorrect label and yielded low bacterial counts, impairing beneficial probiotic effects.
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Introduction
According to the Food and Agriculture Organization, a probiotic is a live microorganism
which when administered in adequate amounts confers a health benefit on the host, and due
to the increasing importance of health during the past decade, a proportional expansion of the
probiotic product market can be witnessed (Stanton et al., 2001). Although probiotics were
originally based on fermented dairy products, at present, numerous probiotic food supplements
are now also commercially available as tablets, powders or capsules. Bringing a functional,
safe and correctly labelled probiotic product to the market demands a careful monitoring of
the whole production process (Saarela et al., 2000). Previous analyses of probiotic products
have demonstrated that the identity and number of recovered microbial species do not always
correlate with the information stated on the product labels (Hughes et al., 1990, Hamilton-
Miller et al., 1996, 1999; Yeung et al., 2002, Temmerman et al., 2003). These and other studies
mainly relied on the use of culture media to isolate the bacteria present in the probiotic product,
after which a selection of purified isolates is identified using 16S rDNA sequencing (Holzapfel
et al., 2001; Yeung et al., 2002), Restriction Fragment Length Polymorphism analysis (Zhung
et al., 1998) or protein profiling (Temmerman et al., 2003).
However, because these cultivation-dependent approaches have proven limitations in
terms of recovery rate and reproducibility, the set of recovered isolates may not always truly
reflect the microbial composition of the product (Ampe et al., 1999; Ercolini et al., 2001; Roy,
2001). Moreover, a more comprehensive insight in the production process and the survival
capacity of the introduced strains requires analysis of both viable and non-viable bacteria. In
practice, the need to identify product isolates (mostly lactic acid bacteria) at least to the species
level makes the cultivation-based procedure rather time-consuming.
In the current study, a cultivation-independent method is presented to detect and identify
bacteria in probiotic products in a fast and reliable manner. Essentially, the protocol comprises
three steps: (i) extraction of bacterial DNA from the probiotic product, (ii) PCR amplification of
a specific part of the 16S rDNA gene, and (iii) electrophoresis of 16S rDNA amplicons using
Denaturing Gradient Gel Electrophoresis (DGGE). At present, DGGE analysis is one of the
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most suitable and widely used methods to study complex bacterial communities in various
environments (Muyzer et al., 1998). In comparison to highly complex ecosystems such as the
animal or human intestinal tract, a probiotic product can be considered as a rather simple
microbial community and therefore the DGGE method should allow the qualitative analysis of
any probiotic sample. The DGGE based approach presented in this paper, can also be used
as a culture-independent identification method. In less than 30 hours, a given probiotic product
can be analyzed to verify the species composition stated on its label. In order to validate this
DGGE approach, the same products were also screened using conventional cultivation on
selective isolation media, followed by identification of the recovered isolates using SDS-PAGE
protein profiling.
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Material and Methods
Probiotic products.  A total of 10 commercially available probiotic products were
analysed in this study, including 5 freeze-dried products, 4 dairy products and 1 fruit drink
(Table 1). Besides the type of product, the choice was also based on the number of different
bacterial groups claimed on the product label. As shown in Table 1 , the investigated products
contained one to four different bacterial species.
Bacterial strains. All products were examined using a set of four isolation media under
standardized cultivation conditions. For the isolation of Lactobacillus and Lactococcus strains,
De Man Rogosa and Sharpe Agar (MRSA) medium (CM361, Oxoid, Basingstoke, UK) was
used, whereas streptococci and enterococci were isolated on M17 medium (CM785, Oxoid)
and on Kanamycine Aesculine Azide Agar Base (KAAAB)(CM591, Oxoid) respectively. For the
isolation of bifidobacteria, Trans-Galacto-Oligosaccharides (TOS) medium was used with the
following composition : 10g Trypticase Soy Broth (81-1768-0, Becton Dickinson, Sparks, USA),
1g Yeast Extract (L21, Oxoid), 3g KH2PO4 (1627, Vel, Leuven, Belgium), 4.8g K2HPO4 (1628,
Vel), 3g (NH4)2SO4 (1.01217.1000, Merck, Darmstadt, Germany), 0.2g MgSO4-7H2O (1433,
Vel), 0.5g L-cystein hydrochloride (C4820, Sigma, Bornem, Belgium), 15g Na-propionate
(P1880, Sigma), 10g Transgalacto-OligoSaccharides (TOS, Honsha, Tokyo, Japan) and 15g
agar (L11, Oxoid) dissolved in 1000 ml of distilled water. Identification of the isolates was
performed using  SDS-PAGE separation of extracted cellular proteins as described previously
(Temmerman et al., 2003). In order to verify the reliability of the DNA extraction protocol for
probiotic products and to verify the identification potential of DGGE, cell suspensions of type
strains were made, with the aim to simulate the species composition of the products. These
cell suspensions were prepared by harvesting half a loop of cells with a sterile öse from a
freshly grown pure culture on MRSA medium (Oxoid, CM 361), and homogeneously suspending
these cells in 10 ml of Peptone Physiological Solution (PPS) [0.1% (w/v) peptone (Oxoid,
L37) and 0.85% (w/v) NaCl].
DNA extraction. Extraction of total bacterial DNA was based on the method described
by Pitcher and co-workers (1989) with slight modifications depending on the type of starting
material. For dairy products, 1 ml of product was centrifuged for 10 min at 13.000 rpm
(Eppendorf Centrifuge 5804R, Hamburg, Germany), followed by removal of the supernatant
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and resuspension of the pellet in 1 ml of Tris EDTA (TE-) buffer. Because of the large fruit
components in the fruit drink, 50 ml of the drink was centrifuged for 2 min at 1000 rpm, after
which 1 ml of the top liquid was taken and centrifuged for 10 min at 13.000 rpm. After removal
of the supernatant, the remaining pellet was dissolved in 1 ml of TE-buffer. In case of the
capsule type products, the content of one capsule, corresponding to approximately 100mg,
was dissolved in 10 ml of sterile PPS and softly shaken until a homogeneous suspension was
obtained. One ml of this suspension was transfered to an eppendorf tube and submitted to a
centrifugation step of 10 min at 13.000 rpm, after which the supernatant was removed and the
remaining pellet was suspended in 1 ml of TE buffer. This procedure was also applied for
freeze-dried powders, of which 100 mg was weighted and suspended in 10 ml PPS. For
freeze-dried tablets, one tablet was crushed in a sterile mortar and the obtained powder was
dissolved in 10 ml of PPS and again homogenised. Of this suspension, 1 ml was centrifuged
for 10 min at 13.000 rpm and the remaining pellet was dissolved in 1 ml of TE buffer. All cell
suspensions in TE buffer were centrifuged for 5 min at 13.000 rpm. The supernatant was
removed and 150 µl of a lysozyme solution [5 mg of lysozyme (28262, Serva, Heidelberg,
Germany) in 150 µl of TE buffer] was added, followed by an incubation at 37°C during 40 min.
In case of DNA extraction from pure cultures, only this lysozyme step was added to the proto-
col by Pitcher and co-workers (1989). Obtained DNA was dissolved in 200 µl TE buffer over-
night after which an RNA digesting step was performed by adding 35 µl of an RNase solution
[10 mg RNase (34390, Serva) in 1 ml milli-Q water]. Finally, 8µl DNA solution was mixed with
2 µl loading dye (4 g sucrose and 2.5 mg bromophenolblue dissolved in 6 ml TE buffer) and
run on a 1% (w/v) agarose gel in 1x TAE buffer for 30 min at 100V to verify the DNA extraction.
Quality of the DNA samples was verified by spectrophotometric measurements at 260/280/
234 nm.
PCR.  PCR was performed using a Taq polymerase kit (Applied Bio Systems, New
Jersey, USA). Primers used in this study were those as described by Muyzer et al. (1993)
amplifying the V3 region of bacterial 16S rDNA. The forward primer F357-GC contained the
GC clamp (5’-CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGG-3’) and had
the following sequence : 5’-GC-clamp-TACGGGAGGCAGCAG-3’. The reverse primer 518R
had the sequence: 5’-ATTACCGCGGCTGCTGG-3’. PCR reaction volumes of 50 µl contained
6µl of 10x PCR buffer containing 15 mM MgCl2, 2.5 µl BSA , 2.5 µl dNTP’s (2 mM each), 2 µl of
each primer (5 µM), 0.25 µl Taq polymerase (5 units/µl), 33.75 µl sterile milliQ and 1 µl of 10-
fold diluted DNA solution. The following PCR program was used : initial denaturation at 94°C
for 5 min; 30 cycles of denaturation at 94°C for 20s, annealing at 55°C for 45s and extension
at 72°C for 1 min; final extension at 72°C for 7 min followed by cooling to 4°C. PCR was
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verified by mixing 8 µl of PCR product with 2 µl of loading dye and running it on a 2% (w/v)
agarose gel for 30 min at 100V, flanked by the EZ Load 100bp Molecular Ruler (170-8352,
Biorad) (data not shown).
DGGE analysis. PCR products were analysed on DGGE gels based on the protocol
by Muyzer and co-workers (1993) applying the following modifications. Polyacrylamide gels
(160 x 160 x 1 mm) consisted of 8% (v/v) polyacrylamide (EC-890, National Diagnostics,
Atlanta, USA) in 1x TAE buffer (161-0773, Biorad, Hercules, USA). By diluting a 100% denatur-
ing polyacrylamide solution [containing 7M urea (EC-605, National Diagnostics) and 40%
formamide (F-9037, Sigma, St. Louis, USA)], with a 0% denaturing polyacrylamide solution
(containing no denaturing components), the polyacrylamide solutions of desired denaturing
percentage were obtained. In this study two types of denaturing gradients were used, namely
a 35 – 70% gradient and a 40 – 55% gradient. The 24-ml gradient gels were casted using a
gradient former (165-4120, Biorad) and a pump (731-8142, Biorad) set at a constant speed of
5 ml/min. Denaturing gels were allowed to polymerise for 3h after which a 5-ml non-denatur-
ing stacking gel was poured on top containing a 16-well comb. After 1 h of polymerisation,
PCR samples were loaded into the wells, and electrophoresis was performed for 16 h at 70 V
in a 1x TAE buffer at a constant temperature of 60°C using the Dcode system (170-9081,
Biorad). Gels were stained with ethidium bromide (solution of 50 µl EtBr in 500 ml TAE buffer)
for 1 h, followed by visualisation of DGGE band profiles under UV light. Digital capturing was
performed using the Foto/AnalystTM CCD Camera (Fotodyne Inc., Hartland, WI, USA) com-
bined with the Iris Video DigitizeTM software package (Inside Technology, Amersfoort, The Neth-
erlands).
Processing of DGGE gels. For DGGE to be used as a direct identification method, a
reference pattern was designed consisting of 6 different type strain V3 amplicons  (Fig. 1). By
running this reference pattern every 6 lanes on each DGGE gel, it became possible to digitally
normalise the gel patterns by comparison with a standard pattern using the BioNumerics (BN)
software package version 2.50 (Applied-Maths, St.-Martens-Latem, Belgium, http://www.applied-
maths.com). This normalisation enables comparison of DGGE gels, provided that they consist
of the same denaturing gradient. For all known probiotic species, the band position of their
corresponding type strains was determined and stored in a BN database. The amplicons
obtained from probiotic products were run on a DGGE gel and after normalisation based on
the standard reference pattern of the BN database, individual bands in the product band pattern
could be identified. Amplicons of isolates, identified with SDS-PAGE, corresponding to the
species claimed on the product label, were run next to the amplicon of the probiotic product
itself, as an additional visual confirmatory identification (Fig 1).
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Results
Culture-dependent analysis of probiotic products. Results of the isolation and
identification of probiotic strains from the tested products are presented in Table 1. Isolation
was performed using four selective isolation media, followed by an identification using SDS-
PAGE separation of whole-cell protein extracts and comparison of the species specific patterns
with a laboratory-based identification library as described by Temmerman and co-workers
(2003).  Colony counts on the media used, were substantially lower in case of the freeze-
dried products, yielding between 105 and 107 CFU/g of product, compared to the dairy products
producing between 107 and 109 CFU/ml. Furthermore, from 6 products (i.e. Actimel, Vitamel,
Aciforce, Bacilac, Bififlor and Proflora) not all species claimed on the labels could be isolated
and two products (i.e. Bacilac and Vitamel) contained a probiotic strain belonging to another
species than the ones mentioned on the label (Table 1).
Culture-independent analysis of probiotic products. For the purpose of cultivation-
independent analysis, total bacterial DNA needed to be extracted directly from the product.
This was done on a reproducible basis by adding a lysozyme and a number of centrifugation
steps to the original protocol by Pitcher and co-workers (1989). The PCR program described
in this paper was able to reproducibly amplify the V3 region of the 16S rDNA of all samples
tested. Sometimes it was found that adding 2 µl of DNA to the PCR mixture instead of 1 µl was
needed to enhance the intensity of some bands on the DGGE gels, in order to aid the visual
interpretation of the results. For each of the 10 probiotic products, a 35-70% DGGE gel was
run on which the following PCR amplicons were loaded next to each other : Probiotic product,
artificial mixture of type strains simulating the species composition of the product, individual
type strains of the species claimed on the label (Fig. 1). Every 6 lanes, all gels contained the
reference pattern. A gel on which the amplicons of all 10 product DNAs were included is
presented in Fig 2.
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Fig 1. Example of a 35-70% DGGE gel for product analysis.  Lane 1 and 8: reference
pattern (composition of V3 amplicons of Enterococcus solitarius, Enterococcus flavescens,
Bacillus cereus, Lactobacillus rhamnosus and Bifidobacterium lactis); lane 2: Aciforce
amplicon; lane 3: amplicon from the cell suspension simulating Aciforce; lane 4: Enterococcus
faecium; lane 5: Lactobacillus acidophilus; lane 6: Lactococcus lactis; lane 7: Bifidobacterium
lactis.
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Fig 2. Normalised 35-70% DGGE gel showing the V3 amplicons of 10 probiotic products.
Lane 1, 7 and 13: reference pattern, lane 2: Actimel; lane 3: Activia; lane 4: Provie; lane 5:
Vitamel; lane 6: Yakult; lane 8: Aciforce; lane 9: Bacilac; lane 10: Bactisubtil; lane 11: Bififlor;
lane 12: Proflora.
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Identification was performed after normalisation of the gel using the standard reference
pattern, followed by comparison of the band positions with those of identified type strains
present in a newly built BN database. Verification of this identification was performed by running
the V3 amplicon of type strains or isolates, originating from the culture-dependent analysis,
on a DGGE gel next to the probiotic product amplicon. In a few cases, two phylogenetic closely
related species produced an amplicon that could not be clearly separated on a 35-70% gradient
gel. Therefore, DGGE gels with a more narrow 40-55% denaturing gradient were run, to obtain
a higher band position resolution. As shown in Fig. 3,  the amplicons representing Lactobacillus
delbrueckii subsp. bulgaricus and Lactobacillus acidophilus may be confused with each other
on the 35-70% gradient gel (Fig. 3a), but can be clearly separated electrophoretically using a
40-55% gradient (Fig. 3b).
Results of the culture-independent DGGE analysis of the 10 probiotic products,
compared with the results of the culture-dependent analysis, are presented in Table 1. Two
different scenarios were found. DGGE analysis of 5 products (i.e. Activia, Yakult, Provie,
Bactisubtil and Proflora) detected the same species as with conventional isolation procedures.
In the remaining 5 products (i.e. Actimel, Vitamel, Aciforce, Bacilac and Bififlor), DGGE analysis
was able to detect more claimed species than recovered by isolation. From two products (i.e.
Bacilac and Vitamel), another species than those mentioned on the label could be isolated
and identified, which was confirmed by DGGE analysis.
The detection limit of the DGGE method was also determined by preparing a 10-fold
serial dilution of a pure culture of Lactobacillus rhamnosus (LMG 18243) in PPS. After plating
100 µl of each dilution on MRSA medium for incubation during 48h at 37°C aerobically, DNA
was extracted from each dilution and PCR-DGGE analysis was performed. It was found that
this technique produced a clear band corresponding down to 104 CFU/ml. To determine the
reproducibility of the technique, 3 different batches of each product were analysed at different
points of time. In all cases, identical results were obtained (data not shown).
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A        B
Fig 3a. A 35-70% DGGE gel showing analysis of Proflora. Lane 1 and 8: Reference pattern;
lane 2: Proflora; lane 3: Cell suspension simulating Proflora; lane 4: Lactobacillus acidophilus;
lane 5: Lactobacillus delbrueckii subsp. bulgaricus; lane 6: Streptococcus thermophilus; lane
7: Bifidobacterium lactis. The difference in band position of L. acidophilus and L. delbrueckii
subsp. bulgaricus is not well pronounced on this 35-70% gradient gel.
Fig 3b. A 40-55% DGGE gel focussing in on the difference in band position between L.
acidophilus and L. delbrueckii subsp. bulgaricus.  Lane 1 and 5: Reference pattern; lane 2:
Proflora; lane 3: L. acidophilus; lane 4: L. delbrueckii subsp. bulgaricus.
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Discussion
Despite the expansion of the probiotic market (Stanton et al., 2001) and the
accompanying scientific research (Naidu et al., 1999), a number of recent reports clearly
highlighted the poor quality of many probiotic products concerning their content and label
information (Hughes et al., 1990, Hamilton-Miller et al., 1996, 1999; Yeung et al., 2002,
Temmerman et al., 2003). In relation to their safety and functionality, it is of major importance
that these products are correctly labelled and contain well-documented probiotic strains
(Sanders and Huis in’t Veld, 1999). In this study, the culture-independent DGGE method was
compared with a culture-dependent procedure for the detection and identification of the
constituting strains in probiotic products. As also demonstrated in a previous paper
(Temmerman et al., 2003), it was found that the numbers of bacteria isolated from the freeze-
dried products were substantially lower as compared to the dairy products and the fruit drink.
Furthermore, 6 products were not found to contain all the claimed species as determined with
the culture-dependent analysis. Next to the fact that some of these products may have been
mislabelled or display a low production quality, the poor recovery results might to some extent
also be ascribed to the inherent selectivity of the isolation media used. Previous studies have
already stressed the need for culture-independent methods to circumvent the limitations of
conventional cultivation (Ampe et al., 1999; Ercolini et al., 2001).
As part of such a culture-independent method, a reliable DNA extraction and PCR
method needs to be performed. By preparing artificial mixtures of type strains to simulate the
species composition of the analysed products, we were able to confirm the suitability of our
DNA extraction and PCR method applied to the products. So far, identification of DGGE bands
has not been performed without additional steps such as gel extraction and sequencing
(Ercolini et al., 2001). By means of a reference pattern included in each gel, combined with
the BioNumerics software, it was possible to create a database containing all band positions
of type strains representing probiotic species. Following digital normalisation of the gel by
comparison of the reference patterns with the standard pattern of the database, it was possible
to assign an identity to each band in the band pattern representing the probiotic products.
This identification as determined with DGGE could be confirmed by means of co-running
amplicons of pure cultures, previously identified using protein profiling. Furthermore, multiple
probiotic isolates from a certain species produced bands, which coincide with the band position
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of the type strain amplicon, indicating that banding patterns are species- specific. However, in
case of some phylogenetic closely related species (Schleifer and Ludwig, 1995) differences
in band position between two species may sometimes be too small on a 35-70% gel in order
to obtain a clear-cut identification. This could be solved by applying a more narrow denaturing
gradient, enlarging the difference in band position. Alternatively, the use of other primers might
result in amplicons, which are readily separated, from each other on DGGE, thereby making
it possible to identify species producing overlapping bands with the V3 primers. However,
every change concerning the gradient, primer set or electrophoresis conditions results in the
necessity to build a new database corresponding to these new parameters. This implies that
the use of DGGE as a direct identification method will only be successful with rather simple
microbial ecosystems such as probiotic products. With the rising complexity of a microbial
ecosystem, it becomes necessary to change more and more parameters, making the method
increasingly time-consuming. As such, Ercolini and co-workers (2001) studied the potential
of DGGE to analyse natural whey cultures for cheese production, but found it necessary to
sequence the bands in the DGGE profile. In contrast, probiotic products can be regarded as
ecosystems developed from well-controlled fermentations with a low taxonomic diversity. In
the current study, analysis of type strains representing known probiotic species never resulted
in two species with identical band position. Moreover, from all species investigated, only
Lactobacillus reuteri produced multiple bands on a DGGE gels (data not shown). This species
was not included in any of the tested products, but a previous study (Temmerman et al., 2003)
showed that out of 55 probiotic products, only 2 products contained this species.
When comparing the results of the culture-dependent and culture-independent analysis
of probiotic products, it can be concluded that DGGE has a much higher detection and
identification potential. Whereas conventional isolation revealed that 6 out of 10 products did
not contain the species claimed on their labels, DGGE analysis was able to detect additional
species in 5 of these 6 products. Nevertheless, 4 products (i.e. Vitamel, Bacilac, Bififlor and
Proflora) were considered to have incorrect labels after analysis with both approaches. This
indicates that the previously reported poor product quality of probiotics (Hughes et al., 1990,
Hamilton-Miller et al., 1996, 1999; Yeung et al., 2002, Temmerman et al., 2003) can not solely
be attributed to shortcomings of cultivation-based methods. Evaluation of 3 different batches
of all products indicated that DGGE analysis is very reproducible, since in all cases the same
bacterial species were detected. This was not the case for the culture-dependent approach,
where one product produced a species previously not detected from another batch of the
product. Mainly detection of bifidobacteria impairs the reproducibility of the culture-dependent
132
Experimental work Culture-independent analysis of probiotics
approach, because of the lack of suitable selective isolation media (Roy, 2001). A potential
drawback of the DGGE approach may be that no information is obtained concerning the level
of bacterial viability in probiotic products, implying that culture-dependent analysis may still
add valuable information. Also, the detection limit of 104 CFU/ml as determined by this study
may result in the failure to detect species that are present in lower numbers. In this regard, it
can be seriously questioned whether organisms present in such low numbers can exert any
significant probiotic effect at all. In the near future, the linkage of real-time PCR to the DGGE
method may result in a very powerful tool for both the qualitative and quantitative analysis of
all kinds of (bacterial) fermentation products. As was reported previously by Temmerman and
co-workers (2003), this paper again demonstrates that a substantial percentage of probiotic
products suffers from incorrect labels and low counts. Numerous studies (Naidu et al., 1999)
demonstrated different probiotic effects exerted by different bacteria, but how can the consumer
select the product containing the most suitable strain for his/her symptons if the product labels
are incorrect, or the strains or absent? Nevertheless, this study clearly demonstrates DGGE
to be a fast, reliable and reproducible culture-independent approach for analysis of probiotic
products, with higher detection and identification potential than conventional culture-dependent
analysis.
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Summary
The taxonomic characterization of bacterial communities is difficult to combine with
the monitoring of its temporal changes. None of the currently available identification techniques
are able to visualise a ‘complete’ community, whereas techniques designed for analysing
bacterial ecosystems generally display a limited or labour-intensive identification potential.
This paper describes the optimisation and validation of a nested PCR-DGGE approach for the
species-specific analysis of bifidobacterial communities from any ecosystem. The method
comprises a Bifidobacterium-specific PCR step, followed by purification of the amplicons that
serve as template DNA in the second PCR step amplifying the V3 and V6-V8 region of the 16S
rRNA gene. A mix of both amplicons is analysed on a Denaturing Gradient Gel Electrophoresis
(DGGE) gel, after which the band positions are compared with a previously constructed
database of reference strains. The method was validated through the analysis of four artificial
mixtures mimicking the possible bifidobacterial microbiota of the human and chicken intestine,
rumen and environmental sample, and of two fecal samples. Except for the species B.
coryneforme and B. indicum, all currently known bifidobacteria originating from various
ecosystems can be identified in a highly reproducible manner. Because no further cloning and
sequencing of the DGGE bands is necessary, this nested PCR-DGGE technique can be
completed within a 24 hours span, allowing the species-specific monitoring of temporal changes
in the bifidobacterial community.
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Introduction
The genus Bifidobacterium consists of Gram-positive bacteria with a %G+C content
above 50, currently enclosing over 30 species (Hoyles et al., 2002). The main habitat of
bifidobacteria is the human and animal intestinal tract (Crociani et al., 1996; Matsuki et al.,
1999; Sghir et al., 2000) although sewage (Scardovi et al., 1979), anaerobic digesters (Dong
et al., 2000) and fermented milk (Meile et al., 1997) have also been reported as isolation sources
of certain Bifidobacterium species. The past decade has witnessed a fast growing interest in
bifidobacteria, mainly because of the health-promoting properties of certain species (Ballongue
et al., 1995; Goldin et al., 1992). Because of their growing application in probiotic dairy products
and dried food supplements (Stanton et al., 2001), many of the recent studies emphasize only
on the intestinal bifidobacteria (Matsuki et al., 1999; Satokari et al., 2001; Requena et al.,
2002).
Until recently, routine identification of bifidobacteria was mainly based on phenotypic
characterization, often leading to conflicting or doubtful results. Molecular techniques such as
ARDRA (Hall et al., 2001; Ventura et al., 2001), 16S rRNA gene sequencing (Hoyles et al.,
2002), FISH (Ventura et al., 2001), SDS-PAGE of cellular proteins, RAPD-PCR, PFGE, dot
blot hybridisations (Reuter et al., 2002) and rep-PCR (Masco et al., 2003), have been evaluated
and optimized for identification of bifidobacterial pure cultures to the species or even to the
strain level. However, numerous situations call for the direct species-specific detection of
bifidobacteria in microbial ecosystems in relation to temporal and environmental changes.
Because of their culture-dependent nature, most of the above mentioned techniques are not
suitable for this purpose. Therefore, culture-independent methods have been designed, of
which Denaturing Gradient Gel Electrophoresis (DGGE) is the most commonly used technique.
The DGGE principle relies on the electrophoretic separation of PCR amplicons of equal length
in a sequence-specific manner (Muyzer et al., 1993, 1998). When universal bacterial PCR
primers are used, only the dominant microbiota of an ecosystem will be visualised on a DGGE
gel (Zoetendal et al., 1998), producing complex banding patterns. In case identification of these
bands is desired, additional cloning and sequencing of the extracted bands is required (Ercolini
et al., 2001; Satokari et al., 2001; Favier et al., 2002). However, these extra steps render the
method laborious and time-consuming, impairing the potential of DGGE as a fast method for
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bacterial population fingerprinting. In this regard, the use of species- or genus-specific primers
represents a major step forward, usually resulting in less complex DGGE banding patterns
that only display the diversity of a specific bifidobacterial group within the targetted ecosystem
(Kok et al., 1996; Kaufmann et al., 1997; Matsuki et al., 1999; Requena et al., 2002). Most of
these studies reported the detection of a limited number of mainly intestinal bifidobacterial
species, although cloning and sequencing steps were still needed in order to confirm the
detection results.
In an attempt to enhance the operational time of culture-independent detection of
bifidobacteria, this paper describes the optimisation and validation of a nested PCR-DGGE
approach for the direct identification of all currently known bifidobacterial species present in
ecosystems with a variable degree of complexity, including both artificial and natural samples.
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Material and Methods
Strain collection. All strains used in this study were obtained from the BCCM™/LMG
bacteria collection (http://www.belspo.be/bccm/lmg.htm) (Fig 2). All strains were grown for
24h at 37°C under anaerobic conditions (80% N2, 10% H2, 10% CO2) on Modified Columbia
Agar (MCA) comprising 23g special peptone (L72, Oxoid, Basingstoke, UK), 1g soluble starch
(1.01252.0250, Merck, Darmstadt, Germany), 5g NaCl, 0.3g cystein-HCl-H2O (C4820, Sigma,
Bornem, Belgium), 5g glucose (500520-887, Vel, Leuven, Belgium) and 15g agar (L11, Oxoid)
dissolved in 1 liter of distiled water.
Total DNA preparation. Extraction of total bacterial DNA from pure cultures was based
on the method described by Pitcher and co-workers (1989) with modifications regarding the
concentration of lysozyme and an additional RNase step at the end. Total DNA was extracted
from cells harvested from a 24h culture, grown on MCA, at 37°C under anaerobic conditions.
The cells (half a loop) were washed in 500 µl TE-buffer (1mM EDTA pH 8.0; 10mM Tris-HCl pH
8.0), after which the cells were collected by centrifugation during 2 min at 13000 rpm. Following
the removal of the supernatant, the resulting pellet was then frozen at –20°C for 1 h to facilitate
the rupture of the Gram-positive cell wall. The thawed pellet was suspended in 150µl lysozyme-
solution [5 mg lysozyme (SERVA, # 28262, Heidelberg, Germany) in 150 µl of TE buffer],
followed by incubation at 37°C during 40 min. The remaining steps of the procedure were
performed according to the protocol of Pitcher and co-workers (17). The resulting DNA pellet
was then dissolved in 200 µl TE-buffer overnight at 4°C after which an RNA digesting step was
performed by adding 2 µl of RNase solution [10 mg RNase (SIGMA, # R6513) dissolved in 1 ml
milli-Q water] followed by a 90 min incubation step at 37°C. Finally, 8 µl of DNA solution was
mixed with 2 µl loading dye and run on a 1% (w/v) agarose gel in 1x TAE buffer for 30 min at
100V to verify the DNA extraction. Quali ty of the DNA samples was verif ied by
spectrophotometric measurements at 260/280/234 nm.
DNA extraction from fecal samples was also based on the protocol by Pitcher and co-
workers 1989), with other modifications. Upon collection of the fecal samples, 700 mg (wet
weight) was homogenized in 9,3 ml physiological phosphate buffer. One ml of the fecal sample
suspension was transferred to an Eppendorf tube and centrifuged for 5 min at 13000 rpm.
After removal of the supernatans, the pellet is resuspended in 1 ml TE buffer and is again
centrifuged for 5 min at 13000 rpm. After removal of the supernatans, the pellet is resuspended
in 150 µL enzyme solution to degenerate the bacterial cell wall.  Per sample, this enzyme mix
consists of 6 mg lysozyme powder and 40 µL mutanolysine dissolved in 110 µL TE buffer.
Further steps are according to the protocol of Pitcher and co-workers (1989).
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Nested PCR. A schematic overview of the method is presented in Fig. 1. All PCR
reactions were performed using a Taq polymerase kit (Applied BioSystems, New Jersey, USA).
The first PCR applied primers lm26-f and lm3-r described by Kaufmann and co-workers (1997),
amplifying a 1417 bp fragment of bifidobacterial 16S rDNA (Table 1). PCR reaction volumes of
50 µl contained 8 µl of 10x PCR buffer (incl. 15 mM MgCl2), 3.5 µl BSA , 3.5 µl dNTP’s (2 mM
each), 3 µl of each primer (5 µM), 0.35 µl Taq polymerase (5 units/µl), 27.65 µl sterile milliQ
and 1 µl of 10-fold diluted DNA solution. The following PCR program was used : initial
denaturation at 94°C for 5 min; 3 cycles of denaturation at 94°C for 45s, annealing at 55°C for
2 min and extension at 72°C for 1 min; 30 cycles of denaturation at 94°C for 20s, annealing at
55°C for 1 min and extension at 72°C for 1 min; final extension at 72°C for 7 min followed by
cooling to 4°C. PCR was verified by mixing 8 µl of amplicon with 2 µl of loading dye and
running it on a 1% (w/v) agarose gel for 30 min at 100V, flanked by the EZ Load 100bp Molecular
Ruler (170-8352, Biorad). In order to eliminate remaining oligonucleotides and original template
DNA, purification of the amplicons was performed using the QIAquick PCR Purification Kit
(28104, Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Subsequently,
a second PCR was performed using the amplicons of the first PCR as template DNA. Because
of the length of the first amplicon (positions 15 to 1432), different primer pairs can be used for
the second PCR, depending on the desired application.
This study made use of two sets of primers (Table 1). The first primer set (F357-GC/
518R) amplifies the V3 region of bacterial 16S rDNA (Muyzer et al., 1993), whereas the second
set of primers (U968F-GC/L1401R) targets the V6 to V8 region of bacterial 16S rDNA (Zoetendal
et al., 1998). In both cases, the forward primer contained a GC clamp to facilitate separation of
the amplicons on a DGGE gel. For both primer sets, the PCR reaction volumes of 50 µl contained
6µl of 10x PCR buffer containing 15 mM MgCl2, 2.5 µl BSA , 2.5 µl dNTP’s (2 mM each), 2 µl of
each primer (5 µM), 0.25 µl Taq polymerase (5 units/µl), 33.75 µl sterile milliQ and 1 µl of 10-
fold diluted DNA solution. The following PCR program was used : initial denaturation at 94°C
for 5 min; 30 cycles of denaturation at 94°C for 20s, annealing at 55°C for 45s and extension
at 72°C for 1 min; final extension at 72°C for 7 min followed by cooling to 4°C. PCR was
verified by mixing 8 µl of amplicon with 2 µl of loading dye and running it on a 2% (w/v) agarose
gel for 30 min at 100V, flanked by the EZ Load 100bp Molecular Ruler (170-8352, Biorad).
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Fig. 1: Overview of the nested PCR-DGGE technique.
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DGGE. PCR products were analysed on DGGE gels based on the protocol by
Muyzer and co-workers (1993, 1999) with modifications according to Temmerman and co-
workers (2003). Because of the high %GC content of bifidobacteria, gels with a 50-70%
denaturing gradient were used. Gels were stained with ethidium bromide for 15 min, followed
by visualisation of DGGE band profiles under UV light. Digital capturing was performed using
the Foto/AnalystTM CCD Camera (Fotodyne Inc., Hartland, WI, USA) combined with the Iris
Video DigitizeTM software package (Inside Technology, Amersfoort, The Netherlands). During
the analysis and database construction using pure cultures, the V3 and V6-8 amplicons were
mixed and loaded in the same lane prior to electrophoresis, whereas the analysis of
bifidobacterial mixtures and ecosystems required the two amplicons to be loaded separately
in adjacent lanes.
Gel processing. For direct identification of bands in a given DGGE profile, a database
was created containing the V3 and V6-V8 band positions of bifidobacterial type and reference
strains (Fig. 2), using the BioNumerics (BN) software package version 2.50 (Applied-Maths,
St.-Martens-Latem, Belgium, http://www.applied-maths.com). By mixing several PCR
amplicons, a reference pattern was designed consisting the V3 amplicons of 4 different type
strains. By including this reference pattern every 5 lanes on each DGGE gel, it is possible to
digitally normalise the in-between lying banding patterns by aligning each reference lane with
the standard reference pattern defined in the BN database. This normalisation enables
comparison of banding patterns originating from different DGGE gels, provided that they
comprise the same reference pattern ran under identical electrophoretic conditions. Following
normalization, the identity of bifidobacteria present in any environmental sample was determined
by comparing the band positions in the sample profile with the BN database.
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Fig. 2. Dendrogram showing the normalized band positions of bifidobacterial reference strains.
Numbers behind the species assignment stand for the BCCMTM/LMG accession number.
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Results
Nested PCR. The nested PCR approach described in this study for the identification
of bifidobacteria in various ecosystems applies a first PCR step using the genus-specific
primers lm-3 and lm-26 (Table 1), resulting in an amplicon for all bifidobacterial reference
strains (Fig. 1). Also a broad range of non-target organisms was tested and in contrary to the
results of Kaufmann and co-workers (1997), weak PCR signals for Propionibacterium
freudenreichii and Gardnerella vaginalis were obtained. The bifidobacterial amplicons could
not be analysed directly on a DGGE gel because their length of 1417 bp by far exceeds the
500 bp limit for DGGE analysis. The advantage of generating amplicons of this length is that
they can serve as template DNA for other 16S rRNA gene primers such as the V3 primer
combination F357-GC/518-R (Table 1) during the second PCR step. Because of the universal
nature of these primers, a purification of the amplicons from the first PCR was performed in
order to remove all remaining non-bifidobacterial template DNA. Analysis of the V3 amplicons
on a DGGE gel showed that not all bifidobacterial species could be separated from each
other, necessitating the additional use of a second universal primer set. For this purpose, we
opted for the U968F-GC and L1401R primers (Table 1) targetting the V6-V8 region of the 16S
rRNA gene. Because the same temperature program could be used, amplification of the V3
and V6-V8 regions during the second PCR step could be performed in the same run, although
each in a separate PCR tube (Fig 1). For all bifidobacterial species, an amplicon was obtained
for both the V3 and V6-V8 region (data not shown).
DGGE analysis of V3 and V6-V8 amplicons. Because of the high %GC content of
bifidobacteria, the conventional 35-70% denaturing gradient was replaced by a 50-70%
denaturing gradient. For some species (e.g. B. lactis and B. pseudolongum subsp. globosum),
the band position of the V3 amplicon was indistinguishable (the left-hand band in each lane,
Fig. 2), whereas for other bifidobacteria (e.g. B. longum and B. pseudocatenulatum), identical
band positions were found for the V6-V8 amplicon (the right-hand band in each lane, Fig. 2).
However, clustering analysis of the combined DGGE profile of both amplicons (V3-V6-V8)
allowed to differentiate all bifidobacteria according to their (sub)species designation, except
for the species B. indicum and B. coryneforme (Fig. 2). Although most V3-V6-V8 DGGE profiles
consisted of two strong bands, one or more additional weak bands were noticed for B.
adolescentis, B. pseudocatenulatum, B. animalis and B. ruminantium. Furthermore, in case
of B. thermophilum and B. breve, two or three different combinations of V3 and V6-V8 band
positions exist, respectively, due to slightly different band positions among certain strains.
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Due to its low %G+C, the amplicon of G. vaginalis did not enter the 50-70% DGGE gel, whereas
the band positions of P. freundenreichii could clearly be separated from those of all bifidobacteria
(Fig. 2).
Artificial mixtures and fecal samples. The discriminatory potential of the V3-V6-V8
DGGE technique was further validated using 4 artificial mixtures of bifidobacterial DNA (Table
2), mimicking a human intestine, chicken intestine, rumen and environmental ecosystem
(sewage), respectively, and by means of two human fecal samples. In order to avoid overlap
of the V3 and V6-V8 band positions, both types of amplicons were loaded separately in two
adjacent lanes on the DGGE gel. After normalisation, band positions of both amplicon types
are compared with the BN database of reference strain. Clustering analysis of mixed community
profiles using the BioNumerics software enabled identification of all bifidobacterial species
present in all mixtures. Species with highly similar or identical V3 band positions can be further
differentiated by comparison with the band positions of the V6-V8 amplicons and vice versa.
Fig. 3 shows the resulting identification of bands in the 4 artificial mixtures mimicking the
possible bifidobacterial microbiota of (A) the human intestine, (B) rumen, (C) chicken intestine
and (D) an environmental sample. These four mixtures clearly demonstrate the need to analyse
both the V3 as well as V6-V8 amplicons. Overall, a detection limit of 10E4 CFU/ml was
established and no preferential amplification was noticed resulting from various bacterial
concentrations in the mixtures tested.
Finally, the method was also validated for characterization of bifidobacterial species
present in two fecal samples originating from two volunteers (Fig. 3A). Fecal sample A contained
five bifidobacterial species (B. adolescentis, B. bifidum, B. catenulatum, B. gallicum and B.
infantis), whereas fecal sample B contained four species (B. adolescentis, B. angulatum, B.
bifidum and B. catenulatum). Although some bands are less intense compared to those of the
artificial mixtures or pure cultures, all bands could clearly be linked to Bifidobacterium species.
Furthermore, there were no bands present in the fecal lanes, which could not be assigned to
any of the bifidobacterial species.
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Table 2. Microbial composition of four artificial mixtures mimicking bifidobacterial ecosystems
Mix Mimicks Species composition
1 Human intestine B. angulatum, B. bifidum, B. adolescentis, B. infantis,
B. longum, B. breve, B. catenulatum, B. dentium, B. gallicum,
B. pseudocatenulatum, B. scardovii
2 Rumen B. ruminantium, B. pseudolongum subsp. pseudolongum,
B. merycicum, B. thermophilum, B. boum
3 Chicken intestine B. pullorum, B. pseudolongum subsp. pseudolongum,
B. animalis, B. thermophilum, B. gallinarium
4 Sewage B. thermacidophilum, B. minimum, B. subtile
150
Experimental work    Culture-independent analysis of probiotics
Fig 3. Use of the BioNumerics software for the identification of bifidobacteria present in 4
artificial mixtures, mimicking A: Human intestine, B: Rumen, C: Chicken intestine and D:
Environmental sample. Fig. 3A also contains the V3 and V6-V8 profiles of two fecal samples.
Fecal sample A contains B. adolescentis, B. bifidum, B. catenulatum, B. gallicum and B. infantis
and fecal sample B contains B. adolescentis, B. angulatum, B. bifidum and B. catenulatum.
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Discussion
At present, DGGE is the most applied technique to analyse bifidobacterial ecosystems,
although cloning and sequencing of the DGGE-bands is still necessary to obtain a reliable
identification (Ampe et al., 1999; Ercolini et al., 2001; Satokari et al., 2001; Favier et al., 2002).
Based on previous research on DGGE analysis of probiotic products (Temmerman et al.,
2003), the current study describes the design and validation of a nested PCR-DGGE method
for the direct identification of currently known bifidobacteria present in natural or industrial
ecosystems.
Until now, Bifidobacterium-specific primers suitable for DGGE, which allow the direct
identification of all bifidobacteria, have not been described in literature. Therefore, a nested
PCR approach was applied, combining a first genus-specific PCR step with a second universal
PCR step. In between, a purification of the amplicons was necessary to remove small remaining
fractions of non-bifidobacterial DNA. Amplification of the 16S rRNA gene V3 region alone did
not allow the complete differentiation of all bifidobacteria, necessitating the combination of
both the V3 and V6-V8 regions of the 16S rRNA gene. Because both primer sets can be used
during the same PCR run, though in separate tubes, only a limited amount of extra work was
required. For all bifidobacteria tested, both genus-specific and universal primers produced
sufficient amounts of amplicon. Separation of the V3 and V6-V8 amplicons on a 50-70 %
DGGE gel resulted in a clear identification of all bifidobacteria, except for B. coryneforme and
B. indicum, which displayed identical band positions for both amplicons. The fact that these
two species, originating from the intestinal tract of two different species of bees (Scardovi and
Trovatelli, 1969), cannot be differentiated is in line with the rep-PCR data of Masco and co-
workers (2003). After analysis of 6 different B. breve reference strains, it was found that 3
different combinations of V3 and V6-V8 band positions occurred. Likewise, two different
combinations were observed among 5 B. thermophilum reference strains (Fig. 2). Probably,
this is due to minor sequence variations within these species. As none of the combinations
coincided with other species, this did not impair the identification potential of the method. This,
together with the fact that both subspecies of B. pseudolongum could be readily distinguished,
indicates that DGGE has an identification potential up to the subspecies level. Another
observation was that B. adolescentis, B. animalis, B. pseudocatenulatum and B. ruminantium
displayed additional weak bands for both 16S rRNA gene regions, possibly as a result of operon
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heterogeneity, as previously observed for different genera (Muyzer et al., 1993; Zoetendal et
al., 1998). This heterogeneity does not impair the identification potential of DGGE, because
these additional bands are consistent among different strains of a specific taxon and readily
recognizable. As already observed during a previous study (Temmerman et al., 2003), the V3
and V6-V8 amplicons of B. animalis and B. lactis have completely different band positions with
B. animalis also showing operon heterogeneity, which indicates that both taxa are probably
not belonging to the same species, as confirmed by Masco and co-workers (2003).
Because this technique has been designed and optimized for the analysis of (complex)
mixtures of bifidobacteria, it was validated by means of four representative artificial mixtures
of bifidobacteria and two fecal samples. For these mixtures, a perfect identification of all
bifidobacteria present was possible. Because some band positions of the V3 region coincide
with the V6-V8 band position of other bifidobacteria, it is necessary to load the two different
amplicons in two adjacent lanes, also preventing banding patterns of becoming too complex.
Because most of the bifidobacterial ecosystems also contain non-bifidobacteria, great care
should be taken in the evaluation of the specificity of the approach. In addition to the selectivity
of the genus-specific PCR and the purification of the amplicons, also the use of a 50-70%
DGGE gel prevents amplicons from many non-bifidobacteria with a denaturation point between
35 and 50% denaturant, from entering the gel. This was demonstrated by the fact that
Gardnerella vaginalis did not produce any bands on the 50-70% denaturing gel because of its
%G+C content lower then 50. The only non-bifidobacterial species besides G. vaginalis known
so far to produce an amplicon using the Bifidobacterium-specific primers, namely
Propionibacterium freundenreichii, displays clearly separated band positions on the DGGE
gels, thereby not impairing the identification potential of the technique. The bifidobacterial
specificity of the technique was further demonstrated through the analysis of two fecal samples.
Besides the 4-5 bifidobacterial species detected, respectively, no other bands were present
on the gel that could not be linked to a certain bifidobacterial species. The fact that some
bands were less intense compared to the artificial mixtures is due to the fact that in natural
ecosystems different bifidobacterial species are present in various concentrations. However,
it cannot be guaranteed that the optimized nested-PCR DGGE technique was capable of
detecting all bifidobacteria present in the fecal samples. In this regard, optimization of certain
procedure steps such as DNA extraction might be necessary depending on the ecosystem
analyzed.
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The nested PCR-DGGE approach described in this paper has the potential of analysing
bifidobacterial communities to the subspecies level. From the methodological point of view,
the main advantage of this technique is that a complete analysis of a bifidobacterial community
can be performed within a 24 hours time span. Provided that an identification match is obtained
with the database, the fact that no further cloning and sequencing of the DGGE bands is
necessary makes this technique very suitable for temporal analysis of bifidobacterial
ecosystems. Although not yet verified, this approach also holds great promise if applied to
other genera, provided that suitable primersets are designed and that the intrageneric taxonomic
structure is not too complex.
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Summary
The microbial analysis of probiotic products always comprises a qualitative as well as
quantitative aspect, the first determining the identity of bacterial species present in a certain
product and the latter their total counts. Although a wide array of highly reproducible identification
methods for Lactic Acid Bacteria (LAB) exists, the outcome of the analysis mainly relies on the
culture media used to isolate the bacteria. As a result, culture-independent methods such as
Denaturing Gradient Gel Electrophoresis (DGGE) have been developed to circumvent the
limitations of conventional cultivation. However, a remaining drawback of the DGGE approach
is that no quantitative information concerning the level of bacterial viability in probiotic products
is obtained. This study describes the application of real-time PCR coupled to DGGE for the
completely culture-independent analysis of probiotic products on a qualitative and quantitative
level. A combination of universal V3 primers with SYBR green chemistry showed to be successful
for the total non-specific quantification of species in probiotic products and subsequent DGGE
analysis of the amplicons.
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Introduction
The importance of microbial analysis of probiotic products has been extensively
addressed in previous papers (Holzapfel et al., 1998: Hamilton-Miller et al., 1999; Temmerman
et al., 2003a). These analyses usually comprise both a qualitative and a quantitative aspect.
Although a wide array of valuable identification methods for Lactic Acid Bacteria (LAB) exists
(Temmerman et al., 2003c), the outcome of the analysis mainly relies on the use of culture
media to isolate the bacteria present in the probiotic product. Because these culture-dependent
approaches have proven limitations in terms of recovery rate and reproducibility, the set of
recovered isolates may not always truly reflect the microbial composition of the product (Ampe
et al, 1999; Ercolini et al., 2001). For instance, the detection of bifidobacteria in probiotic
products impairs the reproducibility of the culture-dependent approach, because of the lack of
suitable selective isolation media (Roy, 2001). As a result, culture-independent methods have
been developed to circumvent the limitations of conventional cultivation.
A recent study by Temmerman and co-workers (2003b) has demonstrated that
Denaturing Gradient Gel Electrophoresis (DGGE) is a fast, reliable and reproducible culture-
independent approach for the qualitative analysis of probiotic products and that it has a higher
detection and identification potential compared to conventional culture-dependent methods.
However, a remaining drawback of the DGGE approach is that no quantitative information
concerning the level of bacterial viability in probiotic products is obtained, implying that culture-
dependent analysis is still required in order to obtain total counts. As a result, real-time PCR
(or quantitative PCR) has been developed to enable the quantification of the initial amount of
DNA present in a certain sample, by means of measuring the amount of amplicon generated
throughout the PCR reaction. In the field of microbiology, real-time PCR has been performed
for the fast culture-independent quantification of pathogenic or inculturable micro-organisms
through the combined use of specific primers and intercalating dyes or specific fluorescently
labeled probes. This type of specific probes was recently used by Hein and co-workers (2002)
in order to detect the possible presence of Listeria monocytogenes in milk and other dairy
products.
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However, the application of a real-time PCR based method for the quality analysis of
probiotic products implies that for each possible probiotic species a separate probe or primer
set should be available, resulting in an enormous increase of cost and workload. Therefore, it
was decided to optimise a real-time PCR approach combining the universal V3 primers with
SYBR green chemistry for the total non-specific bacterial quantification in probiotic products.
After this quantification step, the amplicons were further analysed using DGGE as described
by Temmerman and co-workers (2003b).
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Principle of real-time PCR
The ability to monitor the real-time progress of PCR has completely revolutionized the
way one approaches PCR- based quantification of DNA and RNA. Real-time PCR now makes
quantification of DNA and RNA much more precise and reproducible because it relies on
threshold cycle (CT) values determined during the exponential phase of PCR rather than at the
endpoint. By means of fluorophores, either labeled probes or SYBR green (Fig 1 and 2) included
in the PCR mix, fluorescence is recorded during every cycle and represents the amount of
product amplified at that point in the amplification reaction. The more template DNA present at
the beginning of the reaction, the fewer number of PCR cycles it takes to reach a point in
which the fluorescent signal is first recorded as statistically significant above background,
which is the definition of the CT value (Fig 3). From a dilution series of a representative sample,
the Colony Forming Units (CFU) value is determined by plate counting and subsequent plotting
of the CT values against these CFU values provides a standard curve applicable for
quantification of unknown samples of similar nature. The obtained CT value of such an unknown
sample is compared with the standard curve, from which the corresponding CFU value can be
deduced (Fig 4).
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Fig 1. Schematic representation of real-time PCR with TaqMan probes. In the intact
TaqMan probe, energy is transferred (FRET process) from the short-wavelength fluorophore
on one end (green dot) to the long-wavelength fluorophore on the other end (red dot), quenching
the short-wavelength fluorescence. After hybridization, the probe is susceptible to degradation
by the endonuclease activity of a processing Taq polymerase. Upon degradation, FRET is
interrupted, increasing the fluorescence from the short-wavelength fluorophore and decreasing
the fluorescence from the long-wavelength fluorophore, resulting in a fluorescent signal detected
by the real-time PCR machine.
Fig 2. Schematic representation of real-time PCR with the SYBR Green I dye. SYBR
Green I dye (black diamonds) becomes fluorescent (green diamonds) upon binding to double-
stranded DNA, providing a direct method for quantifying PCR products in real time.
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Fig 3. The threshold cycle (CT) is the PCR cycle number for which the fluorescent
signal corresponding to the amount of amplified DNA, is first recorded as statistically significant
above background.
Fig 4. Analysis of a series of bacterial samples. The obtained CT value for each sample
(not indicated on the graph) can be incorporated in the standard curve below (plotting CT
values on the Y-axis against Log concentration values on the X-axis) to determine the
corresponding Log concentration value (i.e. CFU/ml).
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Material and Methods
Sample and strain collection. The following bacterial strains previously isolated from
probiotic products, or originating from the BCCMTM/LMG bacteria collection, were used for the
optimisation of real-time PCR: Lactobacillus casei (R15648), Streptococcus thermophilus
(R15652), Lactococcus lactis subsp. lactis (R15654), Bifidobacterium lactis (LMG 18314T)
and Lactobacillus acidophilus (R15650). Furthermore, the identification potential of the optimised
method was verified for the 16 products listed in Table 1.
DNA extraction. DNA extraction from pure cultures and probiotic products was based
on the protocol by Pitcher and co-workers (1989) with modifications according to Temmerman
and colleagues (2003b).
Real-time PCR efficiency. In order to determine the efficiency of amplification using
the V3 primers described by Muyzer and co-workers (1993) (F357-GC: 5’-GC-clamp-
GCCTACGGAGGCAGCAG-3’ and 518-R: 5’-ATTACCGCGGCTGCTGG-3’), 10-fold dilution
series of 5 pure cultures (Lactobacillus casei, Streptococcus thermophilus, Lactococcus lactis
subsp. lactis, Bifidobacterium lactis and Lactobacillus acidophilus) and of a mixture containing
all 5 species were prepared. Dilutions down to 10-5 were subjected to DNA extraction and real-
time PCR using the following composition of reaction mix per sample: 11.2 µl PCR water, 0.8
µl MgCl2 (final concentration of 2 mM), 2 µl of each primer, 2 µl of template DNA and 2 µl of
master mix (containing Taq polymerase, SYBR green, dNTP’s and PCR-buffer). The PCR
programme performed on the LightcyclerTM (Roche Diagnostics, Basel, Switzerland) consisted
of a denaturation step (5 min 95°C); amplification step (30 cycles of 15 sec 95°C, 35 sec
55°C, 45 sec 72°C); final elongation step (5 min 72°C) and melt-curve determination (from
60°C to 90°C at a 0.1°C/sec rate). The measuring of the fluorescence was performed at the
end of each elongation step (45 sec 72°C) and continuously during the melt-curve determination.
Magnesium titration. The optimal MgCl2-concentration for the PCR reaction mix was
determined by amplifying 2 pure cultures (L. casei and B. lactis) in duplicate using the same
PCR programme as described above. MgCl2 concentrations of 2, 3, 4 and 5 mM were tested
by means of altering the amounts of MgCl2 and PCR water in the PCR reaction mix.
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Standard curve. Before the bacteria in unknown samples can be quantified, it is
necessary to generate a standard curve to be included with an external standard in subsequent
analysis. Ten-fold dilution series of 2 pure cultures (L. casei and B. lactis) and one mixture of
5 pure cultures (see above) were plated on MRSA and incubated at 37°C for 72h in order to
obtain the CFU/ml value of each dilution. These dilutions were analysed using the real-time
protocol described under the determination of the amplification efficiency. The most suitable
dilution series was used as a standard curve plotting the CFU/ml on the X-axis (log
concentration) and the CT value on the Y-axis.
Quantification. For the quantification of bacteria in probiotic products the same real-
time PCR protocol was used (MgCl2 concentration of 2 mM). Each run included one dilution
sample from the series previously used to create a standard curve. The LightcyclerTM software
adjusts the standard curve using this calibration point and calculates the CFU/ml on the basis
of the CT value for each sample (quantification using an external standard curve). Using this
protocol, 16 probiotic products were analysed.
DGGE. Qualitative analysis of probiotic products was performed using Denaturing
Gradient Gel Electrophoresis (DGGE) as previously described by Temmerman and co-workers
(2003b). After real-time PCR, the capillary tubes were centrifuged upside-down to collect the
amplicon in a PCR tube, from which it could be loaded onto the DGGE gel.
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Results and Discussion
A total of 16 probiotic products was subjected to real-time PCR combined with DGGE
in order to perform a fast and completely culture-independent quantitative as well as qualitative
microbial analysis. A study by Malinen and colleagues (2003) verified the potential of both
SYBR and TaqMan chemistry in order to detect the 16S rRNA genes of six bacterial species
typically present in human faeces or used in the dairy industry. The authors found that both
chemistries tested had an equal sensitivity to detect and quantify bacterial subpopulations
present in fecal samples and dairy products. Therefore, we opted for SYBR green, because
this allowed the fast and direct quantification of all bacteria in the products without the need for
a wide range of (expensive) specific probes. Optimisation of the real-time PCR protocol was
performed using a collection of five isolates from probiotic products. Because the amplicons
were to be analysed on a DGGE gel, the same V3-primers were used as described by
Temmerman and co-workers (2003b). As a result, the conventional PCR protocol for these
primers was adopted as the basis for the optimisation of the real-time PCR protocol. Although
this produced satisfying amplification products, it was possible to shorten the duration of each
step in the PCR cycles because of the capillary tubes allowing much faster heating and cooling
of the PCR mixture inside. This ‘shortened’ PCR program showed good results and was used
throughout the rest of the research. An important factor in real-time PCR is the concentration
of MgCl2 in the master mix and magnesium-titration indicated 2 mM of MgCl2 to be the most
suitable concentration.
The efficiency of amplification using this real-time PCR protocol was determined by
analysing 10-fold dilution series of 5 pure cultures and 1 mixture of bacterial species. Both the
species in the mixture as well as all separate pure cultures displayed a similar shape of curve
in the exponential phase of the PCR (Fig. 5). These results indicate that the V3 primers are
suitable for use in real-time PCR and no differences in efficiency of amplification occur between
different species in a bacterial community. Consequently, it is also possible to create a standard
curve based on a certain bacterial pure culture, which can be used for quantification of other
bacterial species or mixtures.
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Fig. 5. The efficiency of amplification using the optimised real-time PCR protocol was
determined by analysing dilution series of 5 different pure cultures and 1 mixture of these pure
cultures. An equal efficiency is obtained when the curves of all samples run parallel to each
other during the exponential phase of the PCR.
In some cases, the negative control also produced an amplicon of which melt-curve
analysis showed this to be resulting from primer dimers originating from the mutual hybridisation
of the GC clamps attached to the primers (Temmerman et al., 2003b). In samples, however,
primers apparently prefered binding to the present bacterial template DNA, so dimers were
not formed. When the number of cycles is too high (e.g. 40), an amplification of the V3 region
from Escherichia coli may occur, because small amounts of this organism are present in the
Taq polymerase master mix. However, the PCR protocol used in this study never exceeded 30
cycles and no E. coli DNA was amplified in amounts surpassing the background level of
fluorescence.
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Preceding the microbial quantification of an unknown sample, a standard curve has to
be created linking CT values to CFU/ml or CFU/g. Usually, in real-time PCR, a standard curve
is generated from a dilution series constructed from a ‘reference’ sample. The identity of the
reference sample is not important as long as the relevant PCR target is present and the efficiency
of amplification is similar for various samples (Fig 5). For accurate relative quantification, it is
essential that the dilution series, from which the standard curve is generated, is carefully
prepared. Subsequently, real-time PCR is performed on several experimental samples and
one sample named the ‘calibrator’, which is one sample from the standard dilution series. For
each unknown experimental sample, the obtained CT values are compared to the standard
curve generated from the reference standard, from which the CFU/ml is obtained (Fig 4). In
our study, a dilution series of L. acidophilus was used to create the standard curve (Fig 6).
Fig 6. Creation of the standard curve based on a dilution series of L. acidophilus. Each 10-fold
dilution invoked an increase in CT value of app. 3.3 cycles indicating that the efficiency of
amplification and the dilution series were sufficient for the use of this curve in further
quantification of unknown samples.
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Table 1 presents the quantification results for 16 products, subjected to conventional
culture-dependent analysis, as well as to quantification using real-time PCR. For only five
products (ABC plus, Actisun, Bifidus, Yakult, Delhaize-yoghurt) the obtained CFU values from
both methods corresponded within one log unit. For six products (Actilus, Actimel, Activia,
Bactisubtil, Beneflora and Proflora) the CFU values obtained with real-time PCR were
substantially lower than those derived from culture media. This may indicate that the DNA
extraction method is not optimal for quantitative extraction of DNA from those products. Since
the efficiency of amplification is equal for all products, the PCR itself is most likely not responsible
for the poor quantification. From two products (Bacilac and Benefact1), no bacteria were
obtained on isolation media, whereas real-time PCR detected high amounts of bacterial cells.
This may indicate that real-time PCR also detects DNA amplified from dead bacteria. In the
future, the application of Reverse-Transcriptase real-time PCR may cope with this issue, being
capable of quantifying only the metabolically active bacteria in the product. Finally, for Benecol,
real-time PCR did not produce any fluorescent signal, although high numbers of bacteria were
detected using culture media. The analysis of the product using conventional PCR and DGGE
identified three bacterial species in the product. The reason why real-time PCR did not detect
any bacteria in this product is not clear and merits further research.
Finally, it was verified whether the amplicons resulting from real-time PCR produced
the same bands on a DGGE gel, as those obtained after conventional PCR. Identification
results are presented in Table 1 and a DGGE gel showing a comparison of both amplicon
types is presented in Fig. 7. For all probiotic species encountered during analysis of the 16
products, all amplicons of both PCR techniques coincided on DGGE gels, on the condition
that the same primers were used (including GC clamp). The same V3 primers, but without the
GC clamp, were also evaluated during real-time PCR in order to completely exclude primer
dimer formation. However, the amplicons were found at band positions higher in the DGGE
gel, and for some species, the amplicon denatured completely and ran through the gel. These
results indicate the need for GC-clamp containing primers (Muyzer et al., 1993), although they
might produce primer dimers in the negative control sample as demonstrated by melt-curve
analysis after real-time PCR.
All together, this study clearly demonstrates that conventional PCR can be replaced by
its real-time variant for the microbial analysis of probiotic products. In the near future, optimisation
of the DNA extraction should improve the reliability of the quantification for all types of probiotic
products. Additionally, implementation of Reverse Transcriptase real-time PCR will allow
differentiating between dead and live bacteria.
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Fig. 7.  DGGE gel containing the amplicons of Lactobacillus acidophilus (lane 2,3), Lactobacillus
rhamnosus (lane 4,5), Bacillus cereus (lane 7,8), Bifidobacterium lactis (lane 9,10) and
Lactobacillus johnsonii (lane 11,12) obtained after conventional (left lane) and real-time PCR
(right lane). Lanes 1, 6 and 13 contain the reference pattern for normalisation of the gel. The
gel was stained in SYBR green solution for 30 min.
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Conclusions and Perspectives
The research performed during this PhD work has contributed to the microbial quality
control of commercial probiotic products, an aspect of probiotics that has often been neglected
in the past. Essentially, both quantitative and qualitative microbial analysis of products was
performed, as well as a screening of probiotic isolates for their antibiotic susceptibility and
their potential to survive passage through the GI-tract. Culture-dependent and culture-
independent microbial analysis of probiotic products revealed that a substantial number of
freeze-dried products and - to a lesser extent - dairy products was incorrectly or inadequately
labeled concerning the total count and identity of the incorporated probiotic strains. Using the
culture-dependent approach, mainly bifidobacterial species were hard to recover, and besides
the total absence of these organisms in many products, this may be due to the applied method
of detection. Although still far from optimal, improved protocols and selective media with a
higher performance have recently been developed, for enumeration of bifidobacteria from
(probiotic) samples. Furthermore, from a substantial percentage of products no strains could
be isolated, indicating that bacteria are either absent or are present in numbers beneath 103
CFU/ml-g, considering the detection limit of culture-dependent analysis. Consequently, it can
be concluded that these products are unlikely to produce any probiotic effect, when bacterial
numbers are well below the desired minimum dose of 106 CFU/ml-g.
In order to circumvent the possible pitfalls of culture-dependent analysis, it was a major
aim of this work to optimise the Denaturing Gradient Gel Electrophoresis (DGGE) technique
as a culture-independent method for qualitative microbial analysis. In comparison, this
technique can overcome some of the major disadvantages or limitations of conventional
culture-dependent analysis, in terms of speed, detection level, taxonomic resolution and
reproducibility. By means of digital capturing and normalisation of the DGGE gel patterns, the
direct identification of the amplicons avoided the use of labour-intensive cloning and sequencing.
For all probiotic species, unique band positions were obtained, which allowed a fast direct
identification. Nevertheless, some of these band positions may coincide with these of other
organisms such as non-probiotic LAB, possible contaminants or food pathogens, after further
extensions of the identification database. In future research, these situations can be avoided
by the application of species- or group-specific primers, the use of narrow gradient gels or the
adjustment of other DGGE parameters. Sequencing of specific DGGE bands can therefore
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not be excluded completely, in case all former modifications to the original setup do not solve
the problems. Furthermore, the design of a well-distributed reference pattern is crucial, because
an optimal normalisation is needed in order to reduce the possible errors in establishing band
positions. These minor inter-gel differences were found to be important in the distinction of
closely related species, such as those of the L. acidophilus group, which could only be
separated using a narrow gradient DGGE-gel. A further optimisation of the DGGE method
combining multiple amplicons demonstrated that this method is suitable for the species-specific
identification of bifidobacterial species present in various ecosystems. However, because
quantification still requires the use of culture media, it was investigated whether the conventional
PCR step in the DGGE approach can be replaced by real-time PCR, in order to allow the
complete culture-independent analysis of bacteria in probiotic products. Nevertheless, culture-
dependent analysis is still necessary to investigate other properties of the probiotic strains
such as antibiotic resistance and GI-tract survival. It was demonstrated that a rather high
number of isolates from probiotic products displayed phenotypic antibiotic resistance against
kanamycin, tetracycline, chloramphenicol and/or erythromycin. The assessment of the ability
to survive passage through the GI-tract, as well as the hydrophobic nature showed these
characteristics to be species- or even strain-specific.
Although the concept of probiotics originates from decades ago, research performed
in this field has witnessed an exponential increase during the past few years, triggered by the
growing importance of healthy nutrition in our society. Most of this research has focussed on
the demonstration of health promoting effects by selected probiotic strains. Ideally, in vivo
studies of probiotic effects are performed according to the double-blind placebo-controlled
crossover concept. Current research is also shifting towards molecular and biochemical work
in order to unravel the underlying mechanisms of these health effects. So far, the attention
paid to safety and quality control of probiotic strains and products is almost negligible. A few
papers have highlighted the importance of this type of studies. In the framework of the European
PROEUHEALTH cluster (http://www.vtt.fi/virtual/proeuhealth/), one out of 8 research projects
is dedicated to assess the biosafety of probiotic bacteria for human consumption, i.e. the
PROSAFE project (http://lmg.UGent.be/prosafe/).
The work performed in this thesis has clearly demonstrated the need for microbial
analysis of probiotic products. The optimised DGGE method resulting from this research allows
a fast product quality control at various stages of the production process, which makes the
technique highly applicable for the industry. In this context, the further optimisation of the real-
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time PCR technology is of major importance. Although the concept of culture-independent
quantitative microbial analysis has been clearly demonstrated in this thesis, the reproducibility
of the method has to be further evaluated. Such an evaluation will certainly include optimisation
of the DNA extraction protocol, which is essential in the interpretation of real-time PCR data.
The search for a range of genus-, species- or even strain-specific probes is expected to
improve the detection limit and the reliability of quantification. This will also allow qualitative
analysis in such a way that DGGE analysis of the PCR amplicons may become redundant for
samples with a rather simple microbial composition. On the other hand, further optimization
is of crucial importance to develop a universally applicable method, which allows a fast,
reproducible, reliable and complete microbial analysis of probiotic products. Evaluation of
other molecular techniques, such as micro-array technology, is also expected to contribute to
a reliable quality control of (probiotic) products and samples. Finally, on the taxonomic level,
the possible influence of operon heterogeneity and strain-to-strain differences on the stability
of the DGGE patterns should be investigated by means of other genotypic methods, in order
to gain a better insight in the underlying phylogenetic structure of certain heterogeneous groups
of bacteria.
Although specific antibiotic resistance traits among probiotic strains may be desirable,
the finding of atypical resistance in probiotic isolates indicates that continuous attention should
be paid to the selection of probiotic strains free of transferable antibiotic resistance. Because
of the magnitude of such research, this issue was not addressed any further in the scope of
this thesis. Expert research groups such as those involved in the ‘PROSAFE’ project are
currently investigating the presence of antibiotic resistance determinants in probiotic strains.
Meanwhile, new and more optimised protocols for the determination of antibiotic susceptibility
in anaerobic bacteria have been developed, and should be further assessed in the near future.
In addition to this safety aspect, the ability of probiotic strains to survive passage through the
GI-tract in order to reach the large intestine is an important issue of functionality. As
demonstrated in this thesis, such properties appear to be species- or even strain-specific.
Fluctuations and seemingly contradictory results (e.g. in case of the hydrophobicity testing)
may be due to a wide number of parameters, such as the inconsistency of the bacterial cell
wall, the presence of multiple clones in a pure culture, the influence of temperature, etc…
Therefore, in order to further elaborate on the conclusions from in vitro tests, in vivo studies
are needed to determine their correspondence to real-life situations. Depending on the outcome
of the ongoing discussion about whether dead bacteria may exert probiotic effects, the
importance of GI-tract survival will either be enforced or weakened. An even greater
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disagreement exists about the need of colonisation or adhesion of probiotic strains in a certain
region of the GI-tract. However, demonstration of these properties by means of in vivo trials
remains very difficult because of the lack of healthy human volunteers.
The development of a successful probiotic product includes many aspects of safety,
functionality as well as technological and labeling issues. All together, the results obtained in
the course of this work demonstrate the need for a profound microbial analysis of probiotic
products, in which DGGE has demonstrated its high competence. It is of paramount importance
that in an era during which consumers become more aware of the importance of functional
nutrition and health, probiotic products are safe and well documented in order to provide
consumers with all beneficial aspects of probiotics. Mainly because of the lack of legislation,
profound quality control is currently lacking. Clearly, Working Committees and Discussion
Groups of the EC and the FAO/WHO should take the lead in establishing a sound scientific
basis for a broadly acceptable legislation on the safety and quality of probiotics.
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Summary
In order to develop a successful probiotic product with long-term marketing potential,
pre-production research towards safety and functional properties of the included probiotic
strains has to be performed, as well as an efficient quality control of the product itself. The
goal of this PhD work was to evaluate and optimise new and existing methodologies to
examine the microbial aspects of probiotic product quality control. Essentially,
quantitative and qualitative microbial analysis of products was performed, as well as screening
probiotic isolates for their antibiotic susceptibility and potential to survive passage through the
Gastro Intestinal (GI)-tract.
In a first study, culture-dependent analysis of 55 European probiotic products was
performed with regard to total bacterial counts, as well as the identity and antibiotic resistance
of the recovered isolates (Temmerman et al., 2003a). Using a range of elective culture media,
a total of 268 bacterial isolates was obtained from 30 dried food supplements and 25 dairy
products. Bacterial recovery was obtained from 63% of the dried food supplements, with total
counts ranging from 103 to 106 CFU/g. In contrast, all dairy products yielded growth in the
range of 105 to 109 CFU/ml. Mainly bifidobacterial species were hard to recover, and besides
the total absence of these organisms in many products, this may be due to the applied method
of detection; for instance no reliable medium for enumeration of these organisms exists. For
each product, the microbial label information was checked through taxonomic characterization
of the recovered isolates using whole-cell protein profiling. Mislabeling was noted in 47% and
40% of the food supplements and dairy products, respectively. In 19 products, the isolated
species were entirely different from those mentioned on the product label. For instance,
Enterococcus faecium was isolated from six food supplements whereas only two of those
products actually claim this species on their label.
Using the disc diffusion method, antibiotic resistance among 187 isolates was
detected against kanamycin (79% of the isolates), vancomycin (65%), tetracycline (26%),
penicillinG (23%), erythromycin (16%) and chloramphenicol (11%). Overall, 68.4% of the
isolates showed resistance against multiple antibiotics, including intrinsic resistances.
Furthermore, 38% of the E. faecium isolates displayed vancomycin resistance, which was
disproved by additional phenotypic and PCR assays. Although specific antibiotic resistance
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traits among probiotic strains may be desirable, the finding of atypical resistance in probiotic
isolates indicates that continuous attention should be paid to the selection of probiotic strains
free of transferable antibiotic resistance. Because of the magnitude of such research, this
issue was not addressed any further in the scope of this thesis. Expert research groups
(http://lmg.UGent.be/prosafe/) are currently investigating the presence of antibiotic resistance
determinants in probiotic strains.
In addition to this safety aspect, the ability of probiotic strains to survive passage
through the GI-tract in order to reach the large intestine is an important issue of functionality.
Probiotic strains must tolerate the acidic and protease-rich conditions of the stomach, and
survive and grow in the presence of bile acids. A series of in vitro tests was applied to screen
18 probiotic isolates, representing 12 species, for their resistance against pepsin, low pH and
pancreatin, as well as for their growth performance in the presence of bile salts. Furthermore,
using 5 solvents, the hydrophobic nature of the isolates was determined as an indication of
their adhesion potential. L. crispatus, L. reuteri and both L. johnsonii isolates were shown to
be highly resistant against an acidic pepsin-containing solution, with L. reuteri showing slight
bacterial growth. Although the remaining probiotic isolates demonstrated less survival capacity,
they scored significantly better than the two starter cultures L. delbrueckii subsp. bulgaricus
and S. thermophilus, being very susceptible to low pH. Except for both L. casei isolates, all
strains showed high resistance against pancreatin, for which survival capacity was tested in
a more neutral solution of pH 8. Classification of the isolates according to their resistance
against bile acids was determined as the difference in time needed for bacterial suspensions
to reach an optical density of 0.3 in the presence or absence of bile acids. Six isolates were
resistant to bile acids, seven were tolerant and five were sensitive. As expected, both L.
delbrueckii subsp. bulgaricus and S. thermophilus were sensitive. In combination with their
very low potential for gastric survival  these species are unlikely to reach the large intestine
alive. Finally, the hydrophobic nature of the isolates was assessed as a measure for potential
adhesion, and again substantial strain differences were noticed. Fluctuations and seemingly
contradictory results may be due to a wide number of parameters, such as the inconsistency
of the bacterial cell wall, the presence of multiple clones in a pure culture, the influence of
temperature, etc. Therefore, in order to further elaborate on the conclusions from in vitro
tests, in vivo studies are needed to determine their correspondence to real-life situations.
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In order to circumvent the possible pitfalls of culture-dependent analysis, it was a major
aim of this work to optimise the Denaturing Gradient Gel Electrophoresis (DGGE) technique
as a culture-independent method for qualitative microbial analysis. In order to validate the
DGGE approach, a collection of ten probiotic products, including four dairy products, one fruit
drink and five freeze-dried products, was screened by means of parallel DGGE and culture-
dependent analysis (Temmerman et al., 2003b). The culture-independent DGGE approach
involved extraction of total bacterial DNA directly from the product, PCR amplification of the
16S rDNA - V3 region, and separation of the amplicons on a DGGE gel. Identification was
performed after normalisation of the gel pattern using a standard reference pattern, followed
by comparison of the band positions with those of well-characterized type and reference strains
present in a new user-generated BioNumerics database. As determined earlier, culture-
dependent analysis revealed colony counts that were substantially lower in case of the freeze-
dried products, yielding counts between 105 and 107 CFU/g of product, compared to the dairy
products producing numbers between 107 and 109 CFU/ml. Furthermore, 6 products
demonstrated mislabeling in terms of bacterial identity. A comparison of these results with
those of the culture-independent DGGE analysis produced two different scenarios. In case of
5 products both methods produced the same results, whereas in case of the 5 remaining
products DGGE analysis was able to detect more species than those recovered by isolation.
In general, this study clearly demonstrated DGGE to overcome some of the major
disadvantages or limitations of conventional culture-dependent analysis, in terms of speed,
detection level, taxonomic resolution and reproducibility.
The identification to the species level of bacterial communities is difficult to combine
with the monitoring of its temporal changes. Most identification methods are not designed to
visualise entire microbial communities, whereas techniques developed for the analysis of
bacterial ecosystems generally exhibit a poor or labour-intensive identification potential.
Previously, it was demonstrated that DGGE is suitable for the analysis of probiotic products,
each of which represent a bacterial community with a rather low taxonomic complexity. The
following study focussed on more complex communities and involved the optimisation and
validation of a nested PCR-DGGE approach for the species-specific analysis of bifidobacterial
communities (Temmerman et al., 2003c). The method comprises a Bifidobacterium-specific
PCR, followed by purification of the amplicons, which serve as template DNA for the second
PCR step amplifying the V3 and V6-V8 region of the 16S rDNA. Both amplicons are analysed
on a DGGE gel, after which the combined band positions are compared with a previously
constructed database of Bifidobacterium reference strains. The method was validated by means
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of four artificial mixtures mimicking the possible bifidobacterial flora of the human and chicken
intestine, rumen and sewage, and by means of two faecal samples. Except for B. coryneforme
and B. indicum, all bifidobacteria originating from various ecosystems could be identified in a
highly reproducible manner. Because no further cloning and sequencing of the DGGE bands
is necessary, this nested PCR-DGGE technique can be completed within a 24 hours span.
Furthermore, it shows great promise for the species-specific monitoring of temporal changes
in bifidobacterial communities, such as tracking probiotic bifidobacteria in faecal samples.
The importance of DGGE for culture-independent analysis of probiotic products on the
qualitative level was demonstrated to be very accurate, although quantification still requires
the use of culture media. In this context, the final study performed in the course of this PhD
work involved the coupling of real-time PCR to DGGE, in order to obtain a fast and completely
culture-independent approach of quantitative as well as qualitative microbial analysis of 16
probiotic products. Real-time PCR has been developed to determine the initial amount of DNA
present in a sample by means of measuring the formation of amplicon throughout the PCR
reaction. In practice, the application of this method for the quality analysis of probiotic products
would imply that for each possible probiotic species a separate probe or primer set should be
used, which will significantly increase cost and workload. Therefore, it was decided to optimize
a real-time PCR approach combining the universal V3 primers with SYBR green chemistry for
the total non-specific quantification of species in probiotic products. After this quantification
step, the amplicons were further analyzed using DGGE. The study pointed out that the applied
protocol resulted in a successful and reproducible PCR, with equal amplification efficiencies
for all tested pure cultures and products. Subsequent DGGE analysis showed perfect
correlation between the amplicons resulting from real-time PCR, compared to conventional
PCR. However, the actual quantification seemed unreliable compared to the results obtained
using culture media, most probably due to the applicability of the DNA extraction method on
different types of products. Although the research in this PhD has clearly demonstrated the
possibility to replace conventional PCR by its real-time version and to couple it to DGGE, an
extensive optimization of the procedure including the DNA extraction protocol has to be
performed.
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The development of a successful probiotic product includes many aspects of safety,
functionality as well as technological and labeling issues. Generally speaking, the results
obtained in the course of this work demonstrate the need for a profound microbial analysis of
probiotic products, in which DGGE has demonstrated its high competence. It is of paramount
importance that in an era in which consumers become more aware of the importance of
functional nutrition and health, probiotic products are safe and well documented in order to
provide consumers with all beneficial aspects of probiotics. Mainly because of the absence of
legislation, profound quality control is currently lacking. Clearly, Working Committees and
Discussion Groups of the EC and the FAO/WHO should take the lead in establishing a sound
scientific basis for a broadly acceptable legislation on the safety and quality of probiotics.
· Temmerman, R., Pot, B., Huys, G., Swings, J. (2003a). Identification and antibiotic susceptibility of
bacterial isolates from probiotic products. International Journal of Food Microbiology. 81(1):1-10.
· Temmerman, R., Scheirlinck, I., Huys, G. and Swings, J. (2003b). Culture-independent Analysis of
Probiotic Products using Denaturing Gradient Gel Electrophoresis (DGGE). Applied and Environmental
Microbiology 69(1):220-226.
· Temmerman, R., Masco, L., Vanhoutte, T., Huys, G. and Swings, J. (2003c). Development and Validation
of a Nested PCR- Denaturing Gradient Gel Electrophoresis Method for Taxonomic Characterization of
Bifidobacterial Communities. Applied and Environmental Microbiology. In press.
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Samenvatting
Voorafgaand aan de succesvolle commercialisering van een probiotisch product is
onderzoek naar de veiligheid en functionaliteit van de gebruikte probiotische stammen een
noodzaak, naast een efficiënte kwaliteitscontrole van het product zelf. Dit doctoraat had tot
doel een evaluatie en optimalisatie uit te voeren van nieuwe en bestaande technieken
voor microbiële kwaliteitscontrole van probiotische producten. Zowel kweekafhankelijke
als kweekonafhankelijke analyses van producten werden uitgevoerd, alsook het screenen van
probiotische isolaten (melkzuurbacteriën) op de aanwezigheid van antibiotica-resistenties en
naar hun capaciteit om de maag-darm transit te overleven.
Een eerste studie omvatte de kweekafhankelijke analyse van 55 Europese
probiotische producten, ter bepaling van het totaal aantal aanwezige bacteriën, alsmede hun
identiteit en antibiotica resistentieprofielen (Temmerman et al., 2003a). Door gebruik te maken
van een reeks electieve groeimedia werden 268 isolaten bekomen uit 30 gedroogde preparaten
en 25 zuivelproducten. In 63% van de gedroogde voedingssupplementen werden levende
bacteriën teruggevonden, met aantallen van 103 tot 106 CFU/g. In schril contrast hiermee bleken
alle geteste zuivelproducten wel degelijk levende bacteriën te bevatten in concentraties van
105 tot 109 CFU/ml. Voornamelijk de detectie van bifidobacteriën bleek moeilijk, hetgeen naast
hun daadwerkelijke afwezigheid ook te wijten kan zijn aan de gebruikte analysemethode zoals
bvb het gebrek aan een betrouwbaar medium voor de telling van deze organismen. Voor elk
product werd de label informatie betreffende de identiteit van de aanwezige bacteriën nagegaan
door middel van taxonomische karakterisering met eiwitprofilering van de bekomen isolaten.
Een incorrect label werd vastgesteld bij 47% van de gedroogde preparaten en 40% van de
zuivelproducten. Bij 19 producten bleken de isolaten totaal verschillend te zijn van de geclaimde
species. Uit zes gedroogde voedingssupplementen werd bijvoorbeeld Enterococcus faecium
geïsoleerd, terwijl slechts twee van deze producten dit species vermelden op hun label.
Met behulp van de disk diffusie methode werd de antibioticagevoeligheid van 187
isolaten nagegaan. Hierbij werd antibiotica resistentie aangetroffen tegen kanamycine (79%
van de isolaten), vancomycine (65%), tetracycline (26%), penicillineG (23%), erythromycine
(16%) en chloramphenicol (11%). In totaal bleken 68.4% van de isolaten resistent te zijn tegen
meerdere antibiotica, intrinsieke resistenties inclusief. Initieel bleek 38% van de E. faecium
isolaten resistentie te vertonen tegen vancomycine, hetgeen weerlegd werd met aanvullende
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fenotypische en PCR tests. Hoewel een beperkte vorm van antibioticaresistentie bij probiotische
stammen voordelig kan zijn, wijst het vinden van atypische resistentieprofielen bij de isolaten
op de noodzaak van grondige moleculaire analyse naar de transfereerbaarheid van dergelijke
resistenties. Omwille van de omvang van dergelijk onderzoek werd er in het kader van deze
thesis geen verder gevolg aan gegeven, temeer er momenteel gespecialiseerde
onderzoeksgroepen (http://lmg.Ugent.be/prosafe/) bezig zijn met het opsporen van
antibioticaresistentie determinanten in probiotische stammen.
Naast het veiligheidsaspect, betekent de mogelijkheid van probiotische stammen om
de passage naar de dikke darm te overleven een belangrijk onderdeel van hun functionaliteit.
Probiotische bacteriën moeten voldoende tolerant zijn tegen de zure en protease-rijke omgeving
van de maag, alsook tegen de aanwezigheid van galzuren. Met behulp van een reeks in vitro
testen werd de resistentie van 18 probiotische isolaten tegen pepsine, lage pH, pancreatine
en galzuren bepaald. Bovendien werd aan de hand van 5 solventen het hydrofobe karakter
van de isolaten bepaald als indicatie voor mogelijk adhesiepotentieel. L. crispatus, L. reuteri
en beide L. johnsonii isolaten bleken sterk resistent te zijn tegen een zure pepsine-oplossing,
waarbij L. reuteri zelfs lichte groei vertoonde. Hoewel de andere isolaten minder resistent
bleken te zijn, scoorden ze merkelijk beter dan de starterculturen L. delbrueckii subsp.
bulgaricus en S. thermophilus die uiterst gevoelig bleken te zijn voor een lage pH. Met
uitzondering van beide L. casei isolaten vertoonden alle stammen een hoge resistentie tegen
het enzym pancreatine bij pH 8. Klassificatie van de isolaten naar hun gevoeligheid voor galzuren
is gebaseerd op het tijdsverschil voor twee bacteriesuspensies, respectievelijk met en zonder
galzuren, om een optische densiteit van 0.3 te bereiken. Zes isolaten bleken resistent te zijn,
zeven isolaten tolerant en vijf isolaten gevoelig. Zoals verwacht waren de starterculturen L.
delbrueckii subsp. bulgaricus en S. thermophilus gevoelig, hetgeen in combinatie met hun
zeer lage overleving van de maag als gevolg heeft dat deze species de dikke darm normaal
niet levend bereiken. Tenslotte werd de hydrofobiciteit van de bacteriële celwand bepaald als
maat voor het mogelijke adhesiepotentieel van de stam. Zoals het geval was bij de vorige in
vitro testen, bleken de resultaten ook hier sterk stamafhankelijk. Schommelingen en schijnbaar
tegenstrijdige resultaten kunnen het gevolg zijn van een aantal parameters zoals de ongelijke
samenstelling van de bacteriële celwand, de aanwezigheid van meerdere clones in een
reinkultuur, de invloed van de temperatuur, enz.. Alvorens hieruit conclusies te trekken is het
daarom noodzakelijk dat in vivo tests worden uitgevoerd om de verwantschap van in vitro
tests met reële situaties te bepalen.
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Om de mogelijke nadelen van kweekafhankelijke analyse te omzeilen was het
voornaamste doel van dit doctoraatswerk de optimalisatie van de Denaturerende Gradient
Gel Electroforese (DGGE) techniek voor de kweekonafhankelijke analyse van probiotische
producten. Om deze DGGE aanpak te valideren werd een vergelijkende kweekafhankelijke en
kweekonafhankelijke analyse uitgevoerd van tien probiotische producten, bestaande uit vier
zuivelproducten, één vruchtendrank en vijf gedroogde preparaten (Temmerman et al., 2003b).
De kweekonafhankelijke DGGE methode omvat extractie van totaal bacterieel DNA
rechtstreeks uit het product, gevolgd door een PCR amplificatie van de V3 regio van het 16S
rDNA en elektroforetische scheiding van deze amplicons op een DGGE gel. Identificatie van
de bacteriën gebeurt via normalisatie van de gedigitaliseerde gelpatronen aan de hand van
een standaard referentiepatroon, gevolgd door vergelijking van de bandposities op het gel met
deze van de referentiestammen van een nieuw opgebouwde BioNumerics databank. Zoals
voorheen toonde de kweekafhankelijke analyse ook nu aan dat het aantal bacteriën in de
gedroogde preparaten met waarden tussen 105 en 107 CFU/g aanzienlijk lager lag dan voor de
zuivelproducten met waarden variërend van 107 tot 109 CFU/ml. Bovendien bleken zes
producten verkeerde label informatie te bevatten wat betreft hun bacteriële samenstelling.
Vergelijking van deze resultaten met deze bekomen na kweekonafhankelijke analyse via DGGE
leverde twee situaties op. Voor vijf producten leverden beide methoden dezelfde resultaten,
terwijl voor de andere vijf producten DGGE in staat was om meer species te detecteren dan
de kweekafhankelijke methode. Deze studie toonde bijgevolg duidelijk aan dat de DGGE
methode sneller, betrouwbaarder en reproduceerbaarder is voor de kwalitatieve microbiële
analyse van probiotische producten, met een hoger detectie- en identificatiepotentieel dan de
kweekafhankelijke analyse.
De bepaling van de speciessamentelling van bacteriële gemeenschappen is moeilijk
te combineren met de opvolging van daarin optredende veranderingen in de tijd. De meeste
identificatietechnieken zijn niet ontworpen om een complete gemeenschap te visualiseren,
terwijl technieken voor de analyse van bacteriële ecosystemen gewoonlijk een laag of
arbeidsintensief identificatiepotentieel bezitten. Er werd reeds aangetoond dat DGGE zeer
geschikt is voor de analyse van probiotische producten, die in feite kunnen beschouwd worden
als eerder eenvoudige microbiële gemeenschappen. Een volgende studie richtte zich op meer
complexe gemeenschappen en omvatte de optimalisatie en validatie van een genestelde PCR-
DGGE aanpak voor de species-specifieke analyse van bifidobacteriële gemeenschappen
(Temmerman et al., 2003c). De methode omvat een Bifidobacterium-specifieke PCR stap,
gevolgd door de zuivering van de bekomen amplicons, die op hun beurt dienen als template
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DNA tijdens een tweede PCR reactie die de amplificatie beoogt van zowel de V3 als V6-V8
regio van het 16S rDNA. Beide amplicons worden geanalyseerd op een DGGE gel, waarna de
bandposities worden vergeleken met deze van een voordien opgebouwde databank van
Bifidobacterium referentiestammen. De methode werd gevalideerd aan de hand van vier
kunstmatige mengsels van reinculturen die de mogelijke bifidobacteriële flora nabootsten van
het colon van resp. de mens en de kip, het rumen en afvalwater, alsook aan de hand van twee
fecale stalen. Met uitzondering van B. coryneforme en B. indicum bleek de techniek in staat te
zijn alle bifidobacteriën te detecteren in verschillende ecosystemen. Aangezien geen verdere
clonering en sequenering van de DGGE banden noodzakelijk is, kan deze genestelde PCR-
DGGE methode worden uitgevoerd binnen een tijdspanne van 24 uur. Bovendien vertoont de
techniek goede capaciteiten om species-specifieke analyses uit te voeren van bifidobacteriële
gemeenschappen zoals de opvolging van probiotische stammen in fecale stalen.
De DGGE techniek bleek na optimalisatie zeer accuraat te zijn voor de kweek-
onafhankelijke analyse van probiotische producten op kwalitatief niveau, hoewel een
kwantificatie van het aantal bacteriën in de producten nog steeds kweekafhankelijk diende te
gebeuren. Bijgevolg omvatte de laatste studie in het kader van dit doctoraatswerk de koppeling
van real-time PCR aan DGGE, om zodoende een snelle en volledig kweekonafhankelijke
kwantitatieve en kwalitatieve analyse te bekomen van zestien probiotische producten. Real-
time PCR werd ontwikkeld om de initiële hoeveelheid DNA in een staal te bepalen, door tijdens
de PCR reactie de hoeveelheid gevormd amplicon te meten. De toepassing van de methode
voor de analyse van probiotische producten zou met zich meebrengen dat voor elk mogelijk
probiotisch species een aparte probe of primerset ontwikkeld dient te worden, hetgeen de
kostprijs en arbeidsintensiteit sterk zou opdrijven. Daarom werd besloten om real-time PCR
te optimaliseren met een combinatie van universele V3 primers en SYBR green detectie, om
zodoende een niet-specifieke kwantificatie van alle bacteriën in een product te bekomen. Na
deze PCR-stap worden de amplicons geanalyseerd met behulp van DGGE. De studie wees
uit dat deze methode resulteerde in een goede en reproduceerbare PCR, met hoge efficiëntie
van amplificatie voor alle geteste reinculturen en producten. De DGGE analyse van de
amplicons toonde een perfecte overeenkomst aan tussen de amplicons van real-time PCR
en deze van conventionele PCR. De eigenlijke kwantificatie van het aantal bacteriën in de
producten bleek echter niet betrouwbaar, waarschijnlijk door de DNA extractie methode die
geen gelijke efficiëntie oplevert voor alle types van probiotische producten. Hoewel het werk
van dit doctoraat duidelijk aantoont dat de vervanging van conventionele PCR door real-time
PCR en de koppeling ervan aan DGGE perfect mogelijk is, dient in de onmiddellijke toekomst
een grondige optimalisatie van voornamelijk de DNA extractie te worden uitgevoerd.
192
Summary - Samenvatting
De ontwikkeling van een succesvol probiotisch product omvat verscheidene aspecten
van veiligheid, functionaliteit, technologie en etikettering. De resultaten bekomen in het kader
van dit doctoraatswerk tonen duidelijk de nood aan van een grondige microbiële analyse van
probiotische producten, waarbij DGGE zeer geschikt bleek. Het is van primordiaal belang dat
in een tijd waarin de consument bewust wordt van het belang van gezonde voeding, probiotische
producten veilig en goed gedocumenteerd zijn om deze consument te laten genieten van alle
gezondheidsvoordelen van probiotica. Voornamelijk omwille van het gebrek aan wetgeving is
er een aanzienlijk tekort aan kwaliteitscontrole. Werk- en discussiegroepen van de EC en
FAO/WHO zouden een leidende positie moeten innemen in het bekomen van een stevige
wetenschappelijke basis voor het opstellen van een algemeen aanvaardbare wetgeving over
de veiligheid en kwaliteit van probiotica.
· Temmerman, R., Pot, B., Huys, G., Swings, J. (2003a). Identification and antibiotic susceptibility of
bacterial isolates from probiotic products. International Journal of Food Microbiology. 81(1):1-10.
· Temmerman, R., Scheirlinck, I., Huys, G. and Swings, J. (2003b). Culture-independent Analysis of
Probiotic Products using Denaturing Gradient Gel Electrophoresis (DGGE). Applied and Environmental
Microbiology 69(1):220-226.
· Temmerman, R., Masco, L., Vanhoutte, T., Huys, G. and Swings, J. (2003c). Development and Validation
of a Nested PCR- Denaturing Gradient Gel Electrophoresis Method for Taxonomic Characterization of
Bifidobacterial Communities. Applied and Environmental Microbiology. In press.
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Appendix - Lists of strains used in this study
Table 1: List of probiotic isolates, deposited in the Research collection of the Laboratory of
Microbiology, Ghent University (indicated by R-number). AB: Antibiotic resistance tested (+) or not
(blanc). FU: GI-tract survival capacity and hydrophobicity tested (+) or not (blanc). More informa-
tion on the test results can be found in Chapter 4 of this thesis.
Isolate    R-number Identity (% of ID-database match) Producttype AB FU
01A(28)    R10704 Enterococcus faecium (93.6%) Powder +
01B(28)    R10684 Enterococcus faecium (95.1%) Powder +
01C(28)    R10705 Enterococcus faecium (92.9%) Powder +
01D(28)    R17051 Enterococcus faecium (95.3%) Powder +
05A(28)    R11648 Lactobacillus lindneri-like (80%) Capsules
06A(28)    R11400 Bacillus cereus (ARDRA) Capsules
06B(28)    R11401 Bacillus cereus (ARDRA) Capsules
07A(37)    R11402 Lactobacillus rhamnosus (96.4%) Capsules +
07B(37)    R10688 Lactobacillus rhamnosus (95.7%) Capsules +
07C(37)    R11403 Lactobacillus rhamnosus (96.9%) Capsules +
09A(28)    R11404 Enterococcus faecium (95.2%) Capsules +
09B(28)    R17050 Enterococcus faecium (94.9%) Capsules +
09C(28)    R11644 Enterococcus faecium (96.3%) Capsules +
09D(28)    R11643 Enterococcus faecium (96.3%) Capsules +
10C(28)    R11652 Enterococcus faecium  (93.0%) Capsules
11A(28)    R12679 Enterococcus faecium (94.4%) Capsules +
11A(37)    R11406 Enterococcus faecium (94.8%) Capsules +
11B(28)    R12680 Enterococcus faecium (95.7%) Capsules +
11B(37)    R11407 Enterococcus faecium (92.6%) Capsules +
11C(37)    R11408 Enterococcus faecium (96.1%) Capsules +
11D(37)    R11409 Enterococcus faecium (96.3%) Capsules +
12A(28)    R10687 Enterococcus faecium (95.5%) Capsules
13A(28)    R10703 Enterococcus faecium (94.4%) Powder +
13A(37)    R11410 Enterococcus faecium (95.7%) Powder +
13B(28)    R10702 Enterococcus faecium (95.2%) Powder +
13B(37)    R11411 Enterococcus faecium (95.8%) Powder +
13C(28)    R12681 Enterococcus faecium (93.4%) Powder +
13C(37)    R11412 Enterococcus faecium (95.1%) Powder +
13D(28)    R12682 Enterococcus faecium (94.6%) Powder +
13D(37)    R11413 Enterococcus faecium (96.8%) Powder + +
13E(28)    R12683 Enterococcus faecium (94.1%) Powder +
13E(37)    R11702 Enterococcus faecium (90.0%) Powder
13F(28)    R12684 Enterococcus faecium (95.2%) Powder +
13F(37)    R11703 Enterococcus faecium (91.0%) Powder
13G(37)    R11704 Enterococcus faecium (92.2%) Powder
14A(28)    R10693 Lactobacillus plantarum (95.7%) Powder +
14A(37)    R11414 Lactobacillus plantarum (94.1%) Powder +
14B(28)    R10694 Lactobacillus plantarum (93.0%) Powder
14B(37)    R10692 Lactobacillus plantarum (95.4%) Powder + +
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Isolate    R-number Identity (% of ID-database match) Producttype AB FU
14C(28)    R10695 Lactobacillus plantarum (94.0%) Powder
14D(37)    R11705 Lactobacillus plantarum (93.1%) Powder
14F(37)    R11707 Lactobacillus plantarum (92.9%) Powder
17A    R15647 Lactobacillus reuteri (93.7%) Powder + +
17C    R17095 Lactobacillus reuteri (93.8%) Powder +
17D    R17092 Lactobacillus reuteri (91.2%) Powder +
24A(28)    R10689 Lactobacillus paracasei paracasei (96.0%) Capsules
24A(37)    R10691 Lactobacillus paracasei paracasei (96.2%) Capsules +
24B(28)    R10690 Lactobacillus paracasei paracasei (96.1%) Capsules +
24B(37)    R11417 Lactobacillus paracasei paracasei (95.7%) Capsules +
26A(28)    R10696 Pediococcus acidilactici spp.1 (95.1%) Capsules +
26A(37)    R12685 Bifidobacterium lactis (94.3%) Capsules
26B(28)    R10685 Pediococcus acidilactici spp.1(91.6%) Capsules +
26B(37)    R11708 Bifidobacterium lactis (94.9%) Capsules
26C(28)    R10686 Lactobacillus plantarum (95.1%) Capsules + +
26C(37)    R12686 Bifidobacterium lactis (94.6%) Capsules
27A(28)    R10699 Pediococcus acidilactici spp.1(92.1%) Capsules +
27A(37)    R10682 Pediococcus acidilactici spp.1(91.4%) Capsules +
27B(28)    R10700 Pediococcus acidilactici spp.1(90.1%) Capsules +
27C(28)    R10701 Pediococcus acidilactici spp.1(94.0%) Capsules +
27C(37)    R10698 Pediococcus acidilactici spp.1(90.7%) Capsules +
27D(28)    R12687 Pediococcus acidilactici spp.1 (92.3%) Capsules +
28A(28)    R11419 Lactobacillus rhamnosus (94.6%) Capsules
28A(37)    R11420 Lactobacillus rhamnosus (95.0%) Capsules +
28B(28)    R10683 Lactobacillus rhamnosus (95%) Capsules +
28B(37)    R11421 Lactobacillus rhamnosus (95.9%) Capsules +
29C    R17093 Lactobacillus reuteri (92.8%) Tablet +
30A(28)    R11653 Lactobacillus rhamnosus (95.4%) Dairy Drink +
30A(37)    R11647 Lactobacillus rhamnosus (94.9%) Dairy Drink +
30B(28)    R11645 Lactobacillus rhamnosus (95.1%) Dairy Drink +
30B(37)    R11649 Lactobacillus rhamnosus (94.9%) Dairy Drink +
30C(28)    R11650 Lactobacillus rhamnosus (95.7%) Dairy Drink +
30D(28)    R12688 Lactobacillus rhamnosus (95.5%) Dairy Drink +
30E(28)    R12689 Lactobacillus rhamnosus (90.1%) Dairy Drink +
30F(28)    R12690 Lactobacillus rhamnosus (90.2%) Dairy Drink +
30G(28)    R12691 Lactobacillus rhamnosus (90.9%) Dairy Drink +
31A(37)    R12692 Lactobacillus paracasei paracasei (91.5%) Dairy Drink +
31B(37)    R12693 Lactobacillus paracasei paracasei (91.2%) Dairy Drink +
31C(37)    R12694 Lactobacillus paracasei paracasei (92.5%) Dairy Drink +
32A(37)    R12695 Lactobacillus paracasei paracasei (92.4%) Dairy Drink +
32B(37)    R12696 Lactobacillus paracasei paracasei (91.7%) Dairy Drink +
32C(37)    R12697 Lactobacillus paracasei paracasei (89.0%) Dairy Drink +
32D(37)    R12698 Lactobacillus paracasei paracasei (88.9%) Dairy Drink +
32E(37)    R12699 Lactobacillus paracasei paracasei (95.1%) Dairy Drink +
32F(37)    R12700 Lactobacillus paracasei paracasei (94.0%) Dairy Drink +
32G(37)    R12701 Lactobacillus paracasei paracasei (93.3%) Dairy Drink +
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33A    R17116 Streptococcus thermophilus (90.0%) Dairy Drink
33C    R17085 Lactobacillus johnsonii (96.3%) Dairy Drink +
33E    R15650 Lactobacillus acidophilus (95.7%) Dairy Drink + +
34C    R17121 Streptococcus thermophilus (92.8%) Dairy Drink +
34E    R16044 Lactobacillus paracasei paracasei (93.2%) Dairy Drink
34F    R17062 Lactobacillus acidophilus (95.7%) Dairy Drink +
34G    R16046 Lactobacillus paracasei paracasei (95.3%) Dairy Drink
35B    R17061 Lactobacillus acidophilus (95.4%) Dairy Drink
35C    R17114 Streptococcus thermophilus (88.0%) Dairy Drink
35D    R17123 Streptococcus thermophilus (93.9%) Dairy Drink +
36C    R17109 Streptococcus thermophilus (85.9%) Dairy Drink +
37A    R17059 Lactobacillus acidophilus (95.2%) Dairy Drink
37B1    R17107 Streptococcus thermophilus (84.2%) Dairy Drink +
37B2    R17056 Lactobacillus acidophilus (92.9%) Dairy Drink +
37D    R17110 Streptococcus thermophilus (86.2%) Dairy Drink +
37E    R17136 Lactobacillus acidophilus (96.3%) Dairy Drink +
37F    R17064 Lactobacillus acidophilus (96.3%) Dairy Drink +
38A    R17118 Streptococcus thermophilus (90.9%) Dairy Drink
39A    R17088 Lactobacillus johnsonii (96.7%) Dairy Drink +
39B    R17089 Lactobacillus johnsonii (96.8%) Dairy Drink +
39C    R17083 Lactobacillus johnsonii (95.8%) Dairy Drink +
39D    R17084 Lactobacillus johnsonii (96.2%) Dairy Drink +
39E    R17081 Lactobacillus johnsonii (95.4%) Dairy Drink
39F    R17087 Lactobacillus johnsonii (96.5%) Dairy Drink +
40A    R15661 Lactobacillus delbrueckii bulgaricus (95.6%) Dairy Drink + +
40B    R17072 Lactobacillus delbrueckii bulgaricus (94.1%) Dairy Drink +
40D    R17071 Lactobacillus delbrueckii bulgaricus (93.7%) Dairy Drink +
41D    R17086 Lactobacillus johnsonii (96.4%) Dairy Drink +
41F    R17077 Lactobacillus johnsonii (94.0%) Dairy Drink +
42E    R17069 Lactobacillus crispatus (93.8%) Dairy Drink +
42F    R17068 Lactobacillus crispatus (93.7%) Dairy Drink +
43E    R16063 Lactobacillus paracasei paracasei (94.9%) Dairy Drink
43B    R16062 Lactobacillus paracasei paracasei (94.1%) Dairy Drink
44A    R15652 Streptococcus thermophilus (88.9%) Dairy Drink + +
44B    R17122 Streptococcus thermophilus (93.7%) Dairy Drink +
44C    R17108 Streptococcus thermophilus (84.7%) Dairy Drink
45A    R17112 Streptococcus thermophilus (87.7%) Dairy Drink +
45B    R17119 Streptococcus thermophilus (91.2%) Dairy Drink +
45C    R17105 Streptococcus thermophilus (75.5%) Dairy Drink +
45D    R17106 Streptococcus thermophilus (75.6%) Dairy Drink +
46C    R17101 Lactococcus lactis lactis (92.7%) Dairy Drink
47A    R17104 Lactococcus lactis lactis (93.4%) Dairy Drink +
47B    R17103 Lactococcus lactis lactis (93.1%) Dairy Drink +
48A    R17124 Streptococcus thermophilus (94.9%) Dairy Drink +
48B    R17117 Streptococcus thermophilus (90.0%) Dairy Drink +
49A    R15653 Lactobacillus rhamnosus (93.8%) Dairy Drink + +
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49B    R17060 Lactobacillus acidophilus (95.3%) Dairy Drink +
49C    R16072 Lactobacillus rhamnosus (95.8%) Dairy Drink
49E    R17135 Lactobacillus acidophilus (94.2%) Dairy Drink +
50A    R15654 Lactococcus lactis lactis (92.7%) Dairy Drink + +
51A    R15655 Lactobacillus rhamnosus (94.5%) Dairy Drink + +
51B    R16073 Lactobacillus rhamnosus (93.3%) Dairy Drink
51C    R16074 Lactobacillus rhamnosus (90.9%) Dairy Drink
51D    R17098 Lactobacillus rhamnosus (94.3%) Dairy Drink +
52D    R17120 Streptococcus thermophilus (91.2%) Dairy Drink +
52E    R15656 Lactobacillus johnsonii (95.6%) Dairy Drink + +
53A    R15657 Lactobacillus crispatus (94.5%) Tablet + +
53C    R16076 Lactobacillus rhamnosus (89.9%) Tablet
53D    R17096 Lactobacillus rhamnosus (91.7%) Tablet +
53F    R16077 Lactobacillus rhamnosus (94.5%) Tablet
54A    R17057 Lactobacillus acidophilus (93.4%) Dairy Drink +
54B    R17055 Lactobacillus acidophilus (92.1%) Dairy Drink +
54F    R17058 Lactobacillus acidophilus (94.5%) Dairy Drink +
55A    R17074 Lactobacillus johnsonii (90.6%) Dairy Drink +
55B    R17075 Lactobacillus johnsonii (91.8%) Dairy Drink +
55C    R15659 Lactobacillus johnsonii (94.6%) Dairy Drink + +
55D    R17080 Lactobacillus johnsonii (94.7%) Dairy Drink +
55E    R17076 Lactobacillus johnsonii (93.8%) Dairy Drink +
55F    R17078 Lactobacillus johnsonii (94.2%) Dairy Drink +
A14    R17140 Streptococcus thermophilus (91.2%) Dairy Drink
A3    R17137 Lactobacillus paracasei paracasei (91.3%) Dairy Drink
A4    R17138 Lactobacillus paracasei paracasei (94.4%) Dairy Drink
A9    R17139 Streptococcus thermophilus (87.9%) Dairy Drink
B1    R17141 Lactococcus lactis ssp. lactis (90.0%) Dairy Drink
B10    R17144 Lactobacillus delbrueckii ssp bulgaricus (91.1%) Dairy Drink
B11    R17145 Streptococcus thermophilus (89.6%) Dairy Drink
B12 )    R17146 Lactobacillus delbrueckii ssp bulgaricus (92.2%) Dairy Drink
B13 )    R17147 Bifidobacterium lactis (93.8%) Dairy Drink
B13B2    R16038 Enterococcus faecium (92.1%) Powder +
B13C    R17048 Enterococcus faecium (93.4%) Powder +
B13D    R15646 Lactococcus lactis lactis (92.5%) Powder + +
B13E    R14564 Enterococcus faecium (94.3%) Powder +
B13F    R17049 Enterococcus faecium (94.7%) Powder +
B32C    R15649 Lactobacillus paracasei paracasei (92.7%) Dairy Drink + +
B4    R17142 Streptococcus thermophilus (87.0%) Dairy Drink
B42A    R17070 Lactobacillus crispatus (94.0%) Dairy Drink +
B42C    R17066 Lactobacillus crispatus (92.8%) Dairy Drink +
B42E    R17067 Lactobacillus crispatus (93.1%) Dairy Drink +
B5A    R17113 Streptococcus thermophilus (87.9%) Capsules +
B5B    R17111 Streptococcus thermophilus (87.3%) Capsules +
B5E    R17054 Lactobacillus acidophilus (90.8%) Capsules +
B5G    R17134 Bifidobacterium lactis (93.3%) Capsules
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B9    R17143 Bifidobacterium lactis (91.1%) Dairy Drink
C3    R17148 Lactobacillus paracasei paracasei (96.0%) Dairy Drink
C31A    R16040 Lactobacillus paracasei paracasei (94.9%) Dairy Drink
C31B    R17091 Lactobacillus paracasei paracasei (95.6%) Dairy Drink +
C31C    R15648 Lactobacillus paracasei paracasei (95.0%) Dairy Drink + +
C4    R17149 Lactobacillus paracasei paracasei (91.8%) Dairy Drink
200
Appendix
Table 2: Strains used to construct DGGE identification databases. The LMG number indicates the accession
number of the strains in the BCCMTM/LMG culture collection.
Species LMG number Species    LMG number
Bacillus clausii 17945 Bacillus coagulans 6326T
Bacillus subtilis 7135T Bacillus cereus 6923T
Bifidobacterium adolescentis 10733 Bifidobacterium adolescentis 11579
Bifidobacterium adolescentis 18898 Bifidobacterium adolescentis 10734
Bifidobacterium adolescentis 18897 Bifidobacterium lactis 11580
Bifidobacterium angulatum 11039T Bifidobacterium angulatum 11568
Bifidobacterium angulatum 10503T Bifidobacterium minimum 11592T
Bifidobacterium animalis 17135T Bifidobacterium animalis 10508T
Bifidobacterium animalis 18900 Bifidobacterium animalis 11083T
Bifidobacterium asteroides 10735T Bifidobacterium asteroides 11581
Bifidobacterium bifidum 11041T Bifidobacterium bifidum 11583
Bifidobacterium bifidum 11582 Bifidobacterium bifidum 13195
Bifidobacterium bifidum 13200 Bifidobacterium cuniculi 10738T
Bifidobacterium boum 21815T Bifidobacterium gallinarum 11586T
Bifidobacterium breve 10645 Bifidobacterium breve 11040
Bifidobacterium breve 11613 Bifidobacterium breve 11084
Bifidobacterium breve 13208T Bifidobacterium breve 13194
Bifidobacterium catenulatum 11043T Bifidobacterium catenulatum 18894
Bifidobacterium choerinum 10510T Bifidobacterium saeculare 14325T
Bifidobacterium coryneforme 18911T Bifidobacterium boum 10736T
Bifidobacterium dentium 11045T Bifidobacterium dentium 10507T
Bifidobacterium dentium 11585 Bifidobacterium gallicum 11596T
Bifidobacterium infantis 13204 Bifidobacterium infantis 11570
Bifidobacterium infantis 18901 Bifidobacterium infantis 11588
Bifidobacterium infantis 18902 Bifidobacterium infantis 8811T
Bifidobacterium lactis 18314T Bifidobacterium lactis 18906
Bifidobacterium lactis 11615 Bifidobacterium lactis 18905
Bifidobacterium longum 18899 Bifidobacterium longum 11589
Bifidobacterium longum 13196 Bifidobacterium longum 13197T
Bifidobacterium magnum 11591T Bifidobacterium magnum 11590
Bifidobacterium merycicum 11341T Bifidobacterium indicum 11587T
Bifidobacterium pseudocatenulatum 18903 Bifidobacterium pseudocatenulatum 11593
Bifidobacterium pseudocatenulatum 18904 Bifidobacterium pseudocatenulatum 18910
Bifidobacterium pseudolongum Bifidobacterium pseudolongum
subsp. globosum 11569T subsp. globosum 11571T
Bifidobacterium pseudolongum Bifidobacterium pseudolongum
subsp. globosum 11614 subsp. pseudolongum 11595
Bifidobacterium pseudolongum
subsp. pseudolongum 11594 Bifidobacterium adolescentis 10502T
Bifidobacterium ruminantium 12588T Bifidobacterium ruminantium 21811T
Bifidobacterium ruminantium 18896 Bifidobacterium longum 11047
Bifidobacterium scardovii 21589T Bifidobacterium scardovii 21590
Bifidobacterium subtile 11597T Bifidobacterium pseudocatenulatum 10505T
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Bifidobacterium suis 18891 Bifidobacterium suis 21814T
Bifidobacterium thermacidophilum 21396 Bifidobacterium thermacidophilum 21397
Bifidobacterium thermacidophilum 21395T Bifidobacterium pullorum 21816T
Bifidobacterium thermophilum 11574 Bifidobacterium thermophilum 11573T
Bifidobacterium thermophilum 18893 Bifidobacterium thermophilum 21813T
Bifidobacterium thermophilum 11599 Bifidobacterium thermophilum 18892
Enterococcus faecalis 7937T Enterococcus faecalis 14206
Enterococcus faecium 11423T Enterococcus faecium 14204
Lactobacillus acidophilus 9433T Lactobacillus acidophilus 11466
Lactobacillus casei 13087T Lactobacillus casei  8152
Lactobacillus crispatus 9479T Lactobacillus crispatus 12003
Lactobacillus delbreuckii subsp. lactis 7942T Lactobacillus salivarius  9477
Lactobacillus delbrueckii Lactobacillus delbrueckii
subsp. bulgaricus 6901T subsp. bulgaricus 12168
Lactobacillus fermentum 6902T Lactobacillus gallinarum 9435T
Lactobacillus gasseri 9203T Lactobacillus paracasei 13717
Lactobacillus helveticus 6413T Lactobacillus reuteri 9213T
Lactobacillus johnsonii 9436T Lactobacillus johnsonii 11468
Lactobacillus plantarum 6907T Lactobacillus plantarum 18023
Lactobacillus rhamnosus 6400T Lactobacillus rhamnosus 18030
Lactococcus lactis subsp. Lactis 6890T Pediococcus acidilactici
subsp. acidilactici 11384
Propionibacterium freundenreichii 11572 Gardnerella vaginalis 7832T
Streptococcus thermophilus 6896T Streptococcus thermophilus 11164
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